<SEC-DOCUMENT>0001140361-25-041983.txt : 20251113
<SEC-HEADER>0001140361-25-041983.hdr.sgml : 20251113
<ACCEPTANCE-DATETIME>20251113161022
ACCESSION NUMBER:		0001140361-25-041983
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20251113
DATE AS OF CHANGE:		20251113

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TORONTO DOMINION BANK
		CENTRAL INDEX KEY:			0000947263
		STANDARD INDUSTRIAL CLASSIFICATION:	COMMERCIAL BANKS, NEC [6029]
		ORGANIZATION NAME:           	02 Finance
		EIN:				135640479
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-283969
		FILM NUMBER:		251478527

	BUSINESS ADDRESS:	
		STREET 1:		66 WELLINGTON STREET WEST
		STREET 2:		12TH FLOOR, TD TOWER
		CITY:			TORONTO, ONTARIO
		STATE:			A6
		ZIP:			M5K 1A2
		BUSINESS PHONE:		416-944-6367

	MAIL ADDRESS:	
		STREET 1:		66 WELLINGTON STREET WEST
		STREET 2:		12TH FLOOR, TD TOWER
		CITY:			TORONTO, ONTARIO
		STATE:			A6
		ZIP:			M5K 1A2
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>ef20058847_424b2.htm
<DESCRIPTION>PRELIMINARY PRICING SUPPLEMENT
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.10.1.5333
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: Arial; font-size: 9pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: justify; margin-top: 1pt; margin-bottom: 1pt; color: rgb(255, 0, 0); font-size: 6pt; font-weight: bold;">The information in this preliminary pricing supplement is not complete and may be changed. We may not sell these Buffered
        PLUS until the pricing supplement, the accompanying product supplement, underlier supplement and prospectus (collectively, the &#8220;Offering Documents&#8221;) are delivered in final form. The Offering Documents are not an offer to sell these Buffered PLUS
        and we are not soliciting offers to buy these Buffered PLUS in any state where the offer or sale is not permitted.</div>
      <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt; color: rgb(255, 0, 0); font-size: 6pt; font-weight: bold;">Subject to Completion</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z05dd2471ebbb4c7da6310062933d5f07">

          <tr>
            <td style="width: 50%; vertical-align: middle;">
              <div>
                <div><img width="57" height="48" src="image0.jpg"></div>
              </div>
            </td>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: right; margin-right: 1.45pt; font-size: 6pt; font-weight: bold;">November 2025</div>
              <div style="text-align: right; margin-right: 1.45pt; font-size: 6pt;">Preliminary Pricing Supplement</div>
              <div style="text-align: right; margin-right: 1.45pt; font-size: 6pt;">Dated <font style="font-size: 6.5pt;">November </font>13, 2025</div>
              <div style="text-align: right; margin-right: 1.45pt; font-size: 6pt;">Registration Statement No. 333-283969</div>
              <div style="text-align: right; margin-right: 1.45pt; font-size: 6pt;">Filed pursuant to Rule 424(b)(2)</div>
              <div style="text-align: right; margin-right: 1.45pt; font-size: 6pt;">(To Prospectus dated February 26, 2025</div>
              <div style="text-align: right; margin-right: 1.45pt; font-size: 6pt;">Underlier Supplement dated February 26, 2025</div>
              <div style="text-align: right; margin-right: 1.45pt; font-size: 6pt;">and Product Supplement MLN-EI-1 dated February 26, 2025)</div>
            </td>
          </tr>

      </table>
      <div style="color: rgb(40, 109, 193); font-size: 14pt;">STRUCTURED INVESTMENTS</div>
      <div style="color: rgb(40, 109, 193);">Opportunities in U.S. Equities</div>
      <div style="color: rgb(40, 109, 193); font-size: 11pt;">Buffered PLUS Based on the Value of the S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index due June 5, 2028</div>
      <div style="color: rgb(128, 128, 128); font-weight: bold;">Buffered Performance Leveraged Upside Securities<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup></div>
      <div style="color: rgb(126, 126, 126); font-size: 7.5pt; font-weight: bold;">Principal at Risk Securities</div>
      <div style="text-align: justify; font-size: 6.5pt;">The Buffered PLUS will pay no interest and provide a minimum payment at maturity of only 10% of the stated principal amount. At maturity, if the final index value of the underlying index is greater
        than the initial index value, investors will receive the stated principal amount of their investment <font style="font-style: italic;">plus</font> the leveraged upside performance of the underlying index, subject to the maximum payment at
        maturity. If the final index value is less than or equal to the initial index value, but not by more than the buffer amount of 10%, investors will receive the stated principal amount at maturity. However, if the final index value is less than the
        initial index value by more than the buffer amount, investors will lose 1% for every 1% that the final index value falls below the initial index value in excess of the buffer amount and could lose up to 90% of the stated principal amount. <font style="font-weight: bold;">Accordingly, the Buffered PLUS do not guarantee the full return of principal at maturity and you could lose up to 90% of your investment in the Buffered PLUS.</font>&#160;The Buffered PLUS are for investors who seek an
        equity index-based return and who are willing to risk their principal and forgo current income and upside above the maximum payment at maturity in exchange for the leverage and buffer features that each apply to a limited range of performance of
        the underlying index. The Buffered PLUS are senior unsecured debt securities issued by The Toronto-Dominion Bank (&#8220;TD&#8221; or &#8220;we&#8221;). The Buffered PLUS are notes issued as part of TD&#8217;s Senior Debt Securities, Series H.</div>
      <div style="text-align: justify; font-size: 6.5pt; font-weight: bold;">All payments on the Buffered PLUS are subject to the credit risk of TD. If TD were to default on its payment obligations, you may not receive any amounts owed to you under the
        Buffered PLUS and you could lose your entire investment in the Buffered PLUS. These Buffered PLUS are not secured obligations and you will not have any security interest in, or otherwise have any access to, any underlying reference asset or assets.</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z96ca3896d93a4031834ecf90bb4761ad">

          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(0, 112, 192); font-size: 6.5pt;">&#160;</td>
            <td colspan="2" style="vertical-align: top; background-color: rgb(0, 112, 192);">
              <div style="color: rgb(255, 255, 255); font-size: 6.5pt; font-weight: bold;">SUMMARY TERMS</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(220, 235, 244); font-size: 6.5pt;">&#160;</td>
            <td style="width: 22%; vertical-align: top; background-color: rgb(220, 235, 244);">
              <div style="color: rgb(0, 112, 192); font-size: 6.5pt; font-weight: bold;">Issuer:</div>
            </td>
            <td style="vertical-align: top; background-color: rgb(220, 235, 244); width: 77%;">
              <div style="font-size: 6.5pt;">The Toronto-Dominion Bank (&#8220;TD&#8221;)</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; font-size: 6.5pt;">&#160;</td>
            <td style="width: 22%; vertical-align: top;">
              <div style="color: rgb(0, 112, 192); font-size: 6.5pt; font-weight: bold;">Issue:</div>
            </td>
            <td style="vertical-align: top; width: 77%;">
              <div style="font-size: 6.5pt;">Senior Debt Securities, Series H</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(220, 235, 244); font-size: 6.5pt;">&#160;</td>
            <td style="width: 22%; vertical-align: top; background-color: rgb(220, 235, 244);">
              <div style="color: rgb(0, 112, 192); font-size: 6.5pt; font-weight: bold;">Underlying index:</div>
            </td>
            <td style="vertical-align: top; background-color: rgb(220, 235, 244); width: 77%;">
              <div style="font-size: 6.5pt;">S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index (Bloomberg Ticker: &#8220;SPX&#8221;)</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; font-size: 6.5pt;">&#160;</td>
            <td style="width: 22%; vertical-align: top;">
              <div style="color: rgb(0, 112, 192); font-size: 6.5pt; font-weight: bold;">Aggregate principal amount:</div>
            </td>
            <td style="vertical-align: top; width: 77%;">
              <div style="font-size: 6.5pt;">$&#9679;</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(220, 235, 244); font-size: 6.5pt;">&#160;</td>
            <td style="width: 22%; vertical-align: top; background-color: rgb(220, 235, 244);">
              <div style="color: rgb(0, 112, 192); font-size: 6.5pt; font-weight: bold;">Stated principal amount:</div>
            </td>
            <td style="vertical-align: top; background-color: rgb(220, 235, 244); width: 77%;">
              <div style="font-size: 6.5pt;">$1,000.00 per Buffered PLUS</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; font-size: 6.5pt;">&#160;</td>
            <td style="width: 22%; vertical-align: top;">
              <div style="color: rgb(0, 112, 192); font-size: 6.5pt; font-weight: bold;">Issue price:</div>
            </td>
            <td style="vertical-align: top; width: 77%;">
              <div style="font-size: 6.5pt;">$1,000.00 per Buffered PLUS (see &#8220;Commissions and issue price&#8221; below)</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(220, 235, 244); font-size: 6.5pt;">&#160;</td>
            <td style="width: 22%; vertical-align: top; background-color: rgb(220, 235, 244);">
              <div style="color: rgb(0, 112, 192); font-size: 6.5pt; font-weight: bold;">Minimum investment:</div>
            </td>
            <td style="vertical-align: top; background-color: rgb(220, 235, 244); width: 77%;">
              <div style="font-size: 6.5pt;">$1,000.00 (1 Buffered PLUS)</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; font-size: 6.5pt;">&#160;</td>
            <td style="width: 22%; vertical-align: top;">
              <div style="color: rgb(0, 112, 192); font-size: 6.5pt; font-weight: bold;">Coupon:</div>
            </td>
            <td style="vertical-align: top; width: 77%;">
              <div style="font-size: 6.5pt;">None</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(220, 235, 244); font-size: 6.5pt;">&#160;</td>
            <td style="width: 22%; vertical-align: top; background-color: rgb(220, 235, 244);">
              <div style="color: rgb(0, 112, 192); font-size: 6.5pt; font-weight: bold;">Pricing date:</div>
            </td>
            <td style="vertical-align: top; background-color: rgb(220, 235, 244); width: 77%;">
              <div style="font-size: 6.5pt;">November 28, 2025</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; font-size: 6.5pt;">&#160;</td>
            <td style="width: 22%; vertical-align: top;">
              <div style="color: rgb(0, 112, 192); font-size: 6.5pt; font-weight: bold;">Original issue date:</div>
            </td>
            <td style="vertical-align: top; width: 77%;">
              <div style="text-align: justify; font-size: 6.5pt;">December 4, 2025 (4 business days after the pricing date). Under Rule 15c6-1 of the Securities Exchange Act of 1934, as amended, trades in the secondary market generally are required to
                settle in one business day (T+1), unless the parties to a trade expressly agree otherwise. Accordingly, purchasers who wish to trade Buffered PLUS in the secondary market on any date prior to one business day before delivery of the Buffered
                PLUS will be required, by virtue of the fact that the Buffered PLUS initially will settle in four business days (T+4), to specify alternative settlement arrangements to prevent a failed settlement of the secondary market trade.</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(220, 235, 244); font-size: 6.5pt;">&#160;</td>
            <td style="width: 22%; vertical-align: top; background-color: rgb(220, 235, 244);">
              <div style="color: rgb(0, 112, 192); font-size: 6.5pt; font-weight: bold;">Valuation date:</div>
            </td>
            <td style="vertical-align: top; background-color: rgb(220, 235, 244); width: 77%;">
              <div style="font-size: 6.5pt;">May 31, 2028, subject to postponement in the event of a market disruption event as described in the accompanying product supplement</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; font-size: 6.5pt;">&#160;</td>
            <td style="width: 22%; vertical-align: top;">
              <div style="color: rgb(0, 112, 192); font-size: 6.5pt; font-weight: bold;">Maturity date:</div>
            </td>
            <td style="vertical-align: top; width: 77%;">
              <div style="font-size: 6.5pt;">June 5, 2028, subject to postponement in the event of a market disruption event, as described in the accompanying product supplement</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(220, 235, 244); font-size: 6.5pt;">&#160;</td>
            <td style="width: 22%; vertical-align: top; background-color: rgb(220, 235, 244);">
              <div style="color: rgb(0, 112, 192); font-size: 6.5pt; font-weight: bold;">Payment at maturity per Buffered PLUS:</div>
            </td>
            <td style="vertical-align: top; background-color: rgb(220, 235, 244); width: 77%; font-size: 6.5pt;">
              <div style="margin: 1pt 0px 0px 18pt; color: #0070C0; text-indent: -17.65pt;"><font style="font-size: 5pt;">&#9632;</font><font style="text-indent: 0px;" class="TRGRRTFtoHTMLTab">&#160;&#160; &#160;&#160; </font><font style="color: rgb(0, 0, 0);">If the final index
                  value is <font style="font-weight: bold;">greater than</font> the initial index value:</font></div>
              <div style="text-align: center; text-indent: 0.05pt; margin-top: 1pt; font-style: italic;">$1,000.00 + leveraged upside payment</div>
              <div style="margin-top: 1pt; font-style: italic; font-weight: bold; margin-left: 18pt;">&#160;In no event will the payment at maturity exceed the maximum payment at maturity.</div>
              <div style="margin: 1pt 0px 0px 18pt; color: #0070C0; text-indent: -17.65pt;"><font style="font-size: 5pt;">&#9632;</font><font style="text-indent: 0px;" class="TRGRRTFtoHTMLTab">&#160;&#160;&#160;&#160;&#160; </font><font style="color: rgb(0, 0, 0);">If the final index
                  value is <font style="font-weight: bold;">less than or equal to</font> the initial index value, but not by more than the buffer amount:</font></div>
              <div style="text-align: center; text-indent: 0.05pt; margin-top: 1pt; font-style: italic;">$1,000.00</div>
              <div style="margin: 1pt 0px 0px 18pt; color: #0070C0; text-indent: -17.65pt;"><font style="font-size: 5pt;">&#9632;</font><font style="text-indent: 0px;" class="TRGRRTFtoHTMLTab">&#160;&#160;&#160; &#160; </font><font style="color: rgb(0, 0, 0);">If the final index
                  value is <font style="font-weight: bold;">less than</font> the initial index value by more than the buffer amount</font></div>
              <div style="text-align: center; text-indent: 0.05pt; margin-top: 1pt; font-style: italic;">$1,000.00 + [$1,000.00 &#215; (underlying return + buffer amount)]</div>
              <div style="text-align: justify; margin-top: 1pt; font-style: italic; font-weight: bold;">If the final index value is less than the initial index value by more than the buffer amount, you will lose 1% for every 1% that the final index value
                falls below the initial index value in excess of the buffer amount and could lose up to 90% of your investment in the Buffered PLUS.</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; font-size: 6.5pt;">&#160;</td>
            <td style="width: 22%; vertical-align: top;">
              <div style="color: rgb(0, 112, 192); font-size: 6.5pt; font-weight: bold;">Underlying return:</div>
            </td>
            <td style="vertical-align: top; width: 77%;">
              <div style="font-size: 6.5pt;">(final index value &#8722; initial index value) / initial index value</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(220, 235, 244); font-size: 6.5pt;">&#160;</td>
            <td style="width: 22%; vertical-align: top; background-color: rgb(220, 235, 244);">
              <div style="color: rgb(0, 112, 192); font-size: 6.5pt; font-weight: bold;">Buffer amount:</div>
            </td>
            <td style="vertical-align: top; background-color: rgb(220, 235, 244); width: 77%;">
              <div style="font-size: 6.5pt;">10%</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; font-size: 6.5pt;">&#160;</td>
            <td style="width: 22%; vertical-align: top;">
              <div style="color: rgb(0, 112, 192); font-size: 6.5pt; font-weight: bold;">Leverage factor:</div>
            </td>
            <td style="vertical-align: top; width: 77%;">
              <div style="font-size: 6.5pt;">200%</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(220, 235, 244); font-size: 6.5pt;">&#160;</td>
            <td style="width: 22%; vertical-align: top; background-color: rgb(220, 235, 244);">
              <div style="color: rgb(0, 112, 192); font-size: 6.5pt; font-weight: bold;">Leveraged upside payment:</div>
            </td>
            <td style="vertical-align: top; background-color: rgb(220, 235, 244); width: 77%;">
              <div style="font-size: 6.5pt;">$1,000.00 &#215; leverage factor &#215; underlying return</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; font-size: 6.5pt;">&#160;</td>
            <td style="width: 22%; vertical-align: top;">
              <div style="color: rgb(0, 112, 192); font-size: 6.5pt; font-weight: bold;">Maximum gain:</div>
            </td>
            <td style="vertical-align: top; width: 77%;">
              <div style="font-size: 6.5pt;">21.20%</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(220, 235, 244); font-size: 6.5pt;">&#160;</td>
            <td style="width: 22%; vertical-align: top; background-color: rgb(220, 235, 244);">
              <div style="color: rgb(0, 112, 192); font-size: 6.5pt; font-weight: bold;">Maximum payment at maturity:</div>
            </td>
            <td style="vertical-align: top; background-color: rgb(220, 235, 244); width: 77%;">
              <div style="font-size: 6.5pt;">$1,212.00 per Buffered PLUS (121.20% of the stated principal amount)</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; font-size: 6.5pt;">&#160;</td>
            <td style="width: 22%; vertical-align: top;">
              <div style="color: rgb(0, 112, 192); font-size: 6.5pt; font-weight: bold;">Initial index value:</div>
            </td>
            <td style="vertical-align: top; width: 77%;">
              <div style="text-align: justify; font-size: 6.5pt;">The index closing value of the underlying index on the pricing date, as determined by the calculation agent and as may be adjusted as described under &#8220;General Terms of the Notes &#8212;
                Unavailability of the Level of, or Change in Law Event Affecting, the Reference Asset; Modification to Method of Calculation&#8221;, as described in the accompanying product supplement.</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(220, 235, 244); font-size: 6.5pt;">&#160;</td>
            <td style="width: 22%; vertical-align: top; background-color: rgb(220, 235, 244);">
              <div style="color: rgb(0, 112, 192); font-size: 6.5pt; font-weight: bold;">Final index value:</div>
            </td>
            <td style="vertical-align: top; background-color: rgb(220, 235, 244); width: 77%;">
              <div style="text-align: justify; font-size: 6.5pt;">The index closing value of the underlying index on the valuation date, as determined by the calculation agent and as may be adjusted as described under &#8220;General Terms of the Notes &#8212;
                Unavailability of the Level of, or Change in Law Event Affecting, the Reference Asset; Modification to Method of Calculation&#8221;, as described in the accompanying product supplement.</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; font-size: 6.5pt;">&#160;</td>
            <td style="width: 22%; vertical-align: top;">
              <div style="color: rgb(0, 112, 192); font-size: 6.5pt; font-weight: bold;">CUSIP/ISIN:</div>
            </td>
            <td style="vertical-align: middle; width: 77%;">
              <div style="text-align: justify; font-size: 6.5pt;">89115L4G0 / US89115L4G06</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(220, 235, 244); font-size: 6.5pt;">&#160;</td>
            <td style="width: 22%; vertical-align: top; background-color: rgb(220, 235, 244);">
              <div style="color: rgb(0, 112, 192); font-size: 6.5pt; font-weight: bold;">Listing:</div>
            </td>
            <td style="vertical-align: top; background-color: rgb(220, 235, 244); width: 77%;">
              <div style="text-align: justify; margin-right: 21.6pt; font-size: 6.5pt;">The Buffered PLUS will not be listed or displayed on any securities exchange or any electronic communications network.</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; font-size: 6.5pt;">&#160;</td>
            <td style="width: 22%; vertical-align: top;">
              <div style="color: rgb(0, 112, 192); font-size: 6.5pt; font-weight: bold;">Calculation agent:</div>
            </td>
            <td style="vertical-align: top; width: 77%;">
              <div style="text-align: justify; font-size: 6.5pt;">TD</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(220, 235, 244); font-size: 6.5pt;">&#160;</td>
            <td style="width: 22%; vertical-align: top; background-color: rgb(220, 235, 244);">
              <div style="color: rgb(0, 112, 192); font-size: 6.5pt; font-weight: bold;">Agent:</div>
            </td>
            <td style="vertical-align: top; background-color: rgb(220, 235, 244); width: 77%;">
              <div style="text-align: justify; font-size: 6.5pt;">TD Securities (USA) LLC (&#8220;TDS&#8221;), an affiliate of TD. See &#8220;Additional Information About the Buffered PLUS &#8212; Supplemental information regarding plan of distribution (conflicts of interest);
                secondary markets (if any).&#8221;</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; font-size: 6.5pt;">&#160;</td>
            <td style="width: 22%; vertical-align: top;">
              <div style="color: rgb(0, 112, 192); font-size: 6.5pt; font-weight: bold;">Estimated value on the pricing date:<font style="text-indent: 0px;" class="TRGRRTFtoHTMLTab">&#160;&#160;</font></div>
            </td>
            <td style="vertical-align: top; width: 77%;">
              <div style="text-align: justify; font-size: 6.5pt;">The estimated value of your Buffered PLUS at the time the terms of your Buffered PLUS will be set on the pricing date is expected to be between $925.00 and $960.00 per Buffered PLUS, as
                discussed further under &#8220;Risk Factors &#8212; Risks Relating to Estimated Value and Liquidity&#8221; beginning on page 8 and &#8220;Additional Information About the Buffered PLUS &#8212; Additional information regarding the estimated value of the Buffered PLUS&#8221;
                herein. The estimated value is expected to be less than the public offering price of the Buffered PLUS.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="vertical-align: top; width: 25%;">
              <div style="color: rgb(40, 109, 193); font-size: 6.5pt; font-weight: bold;">Commissions and issue price:</div>
            </td>
            <td style="width: 22.3%; vertical-align: top;">
              <div style="text-align: center; color: rgb(40, 109, 193); font-size: 6.5pt; font-weight: bold;">Price to Public<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
            </td>
            <td style="width: 22.3%; vertical-align: top;">
              <div style="text-align: center; color: rgb(40, 109, 193); font-size: 6.5pt; font-weight: bold;">Fees and Commissions<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
            </td>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: center; color: rgb(40, 109, 193); font-size: 6.5pt; font-weight: bold;">Proceeds to Issuer</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="vertical-align: top; width: 25%;">
              <div style="text-indent: 36pt; color: rgb(40, 109, 193); font-size: 6.5pt; font-weight: bold;">Per Buffered PLUS:</div>
            </td>
            <td style="width: 22.3%; vertical-align: top;">
              <div style="text-align: center; font-size: 6.5pt;">$1,000.00</div>
            </td>
            <td style="width: 22.3%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 128); font-size: 6.5pt;"><font style="color: rgb(0, 0, 0);">$25.00<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(a)</sup></font></div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-size: 6.5pt;"><u>+ $5.00</u><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(b)</sup></div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-size: 6.5pt;">&#160;$30.00</div>
            </td>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: center; font-size: 6.5pt;">$970.00</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="vertical-align: top; width: 25%;">
              <div style="text-indent: 36pt; color: rgb(40, 109, 193); font-size: 6.5pt; font-weight: bold;">Total:</div>
            </td>
            <td style="width: 22.3%; vertical-align: top;">
              <div style="text-align: center; font-size: 6.5pt;">$&#9679;</div>
            </td>
            <td style="width: 22.3%; vertical-align: top;">
              <div style="text-align: center; font-size: 6.5pt;">$&#9679;</div>
            </td>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: center; font-size: 6.5pt;">$&#9679;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 2pt;" class="DSPFListTable" id="z99b3b647c8a64eb9a886941208a98d07">

          <tr>
            <td style="width: 13.5pt; vertical-align: top; font-size: 6pt; font-style: italic;">(1)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; color: rgb(0, 0, 0);">
              <div style="font-size: 6pt; font-style: italic;">TDS will purchase the Buffered PLUS from TD at the price to public less a fee of $30.00 per Buffered PLUS. TDS will resell all of the Buffered PLUS to Morgan Stanley Smith Barney LLC (&#8220;Morgan
                Stanley Wealth Management&#8221;) at an underwriting discount which reflects:</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 2pt;" class="DSPFListTable" id="z439ee843615f4eb6a058126931e30d73">

          <tr>
            <td style="width: 18pt; font-size: 6pt;">&#160;</td>
            <td style="width: 22.5pt; vertical-align: top; font-size: 6pt; font-style: italic;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-size: 6pt; font-style: italic;">a<font style="color: #000080;">&#160;</font>fixed sales commission of $25.00 per $1,000.00 stated principal amount of Buffered PLUS that Morgan Stanley Wealth Management sells and</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 2pt;" class="DSPFListTable" id="z26fa22458b00430c8831b3f34d2118ec">

          <tr>
            <td style="width: 18pt; font-size: 6pt;"><br>
            </td>
            <td style="width: 22.5pt; vertical-align: top; font-size: 6pt; font-style: italic;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-size: 6pt; font-style: italic;">a fixed structuring fee of $5.00 per $1,000.00 stated principal amount of Buffered PLUS that Morgan Stanley Wealth Management sells,</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-left: 13.5pt; margin-top: 2pt; font-size: 6pt; font-style: italic; color: rgb(0, 0, 0);">each payable to Morgan Stanley Wealth Mana<font style="color: rgb(0, 0, 0);">gement. See &#8220;Additional Information About
          the Buffered PLUS &#8212; Supplemental information regarding plan of distribution (conflicts of interest); secondary markets (if any)&#8221; herein.</font></div>
      <div style="text-align: justify; margin-top: 1pt; font-size: 6.5pt; font-weight: bold; color: rgb(0, 0, 0);">The Buffered PLUS involve risks not associated with an investment in ordinary debt securities. See &#8220;Risk Factors&#8221; beginning on page 7.</div>
      <div style="text-align: justify; margin-top: 1pt; font-size: 6pt; font-weight: bold; color: rgb(0, 0, 0);">Neither the Securities and Exchange Commission (the &#8220;SEC&#8221;) nor any state securities commission has approved or disapproved of these Buffered
        PLUS or determined that this pricing supplement, the product supplement, the underlier supplement or the prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</div>
      <font style="color: rgb(0, 0, 0);"> </font>
      <div style="text-align: justify; margin-top: 1pt; font-size: 6pt; font-weight: bold; color: rgb(0, 0, 0);">The Buffered PLUS are unsecured and are not savings accounts or insured deposits of a bank. The Buffered PLUS are not insured or guaranteed by
        the Canada Deposit Insurance Corporation, the U.S. Federal Deposit Insurance Corporation or any other governmental agency or instrumentality of Canada or the United States. The Buffered PLUS will not be listed or displayed on any securities
        exchange or electronic communications network.</div>
      <font style="color: rgb(0, 0, 0);"> </font>
      <div style="text-align: justify; margin-top: 1pt; font-size: 6pt; font-weight: bold; color: rgb(0, 0, 0);">We will deliver the Buffered PLUS in book-entry only form through the facilities of The Depository Trust Company on the original issue date
        against payment in immediately available funds.</div>
      <div style="margin-top: 1pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z29134ca981c64c40bc03429896d56234">

          <tr>
            <td style="width: 33.31%; vertical-align: middle;">
              <div style="text-align: center; color: rgb(0, 0, 255); font-size: 6pt;"><a href="https://www.sec.gov/Archives/edgar/data/947263/000114036125006123/ef20044459_424b3.htm"><u>Product supplement dated February 26, 2025</u></a></div>
            </td>
            <td style="width: 34%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 255); font-size: 6pt;"><a href="https://www.sec.gov/Archives/edgar/data/947263/000114036125006121/ef20044458_424b3.htm"><u>Underlier supplement dated February 26, 2025</u></a></div>
            </td>
            <td style="width: 33.34%; vertical-align: middle;">
              <div style="text-align: center; color: rgb(0, 0, 255); font-size: 6pt;"><a href="https://www.sec.gov/Archives/edgar/data/947263/000119312525036639/d931193d424b5.htm"><u>Prospectus dated February 26, 2025</u></a></div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 100%; vertical-align: top;">
                  <div style="text-align: right;">
                    <div><img width="57" height="48" src="image0.jpg"></div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="border-bottom: 1px solid #296DC1; border-top: 1px solid #296DC1; vertical-align: top; width: 100%;">
                  <div style="color: rgb(41, 109, 193);">Buffered PLUS Based on the Value of the S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index due June 5, 2028</div>
                  <div style="color: rgb(128, 128, 128); font-size: 8pt; font-weight: bold;">Buffered Performance Leveraged Upside Securities<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup></div>
                  <div style="color: rgb(128, 128, 128); font-size: 7pt;">Principal at Risk Securities</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: center; margin-top: 3pt; font-size: 13.5pt;">
        <div style="text-align: left; margin-top: 10pt; margin-bottom: 6pt; color: rgb(41, 109, 193);">Additional Information About TD and the Buffered PLUS</div>
      </div>
      <div style="text-align: justify; margin-top: 10pt; font-size: 8pt;">You should read this pricing supplement together with the prospectus dated February 26, 2025, as supplemented by the product supplement <font style="font-size: 8.5pt;">MLN-EI-1 </font>dated









        February 26, 2025 and the underlier supplement dated February 26, 2025, relating to our Senior Debt Securities, Series H, of which these Buffered PLUS are a part. Capitalized terms used but not defined in this pricing supplement will have the
        meanings given to them in the product supplement. In the event of any conflict the following hierarchy will govern: first, this pricing supplement; second, the product supplement; third, the underlier supplement; and last, the accompanying
        prospectus. <font style="font-weight: bold;">The Buffered PLUS vary from the terms described in the product supplement in several important ways. You should read this pricing supplement carefully.</font></div>
      <div style="margin: 10pt 0px 5pt; font-size: 8pt; text-align: justify;">This pricing supplement, together with the documents listed below, contains the terms of the Buffered PLUS and supersedes all prior or contemporaneous oral statements as well as
        any other written materials including preliminary or indicative pricing terms, correspondence, trade ideas, structures for implementation, sample structures, brochures or other educational materials of ours. You should carefully consider, among
        other things, the matters set forth in &#8220;Risk Factors&#8221; herein, &#8220;Additional Risk Factors Specific to the Notes&#8221; in the product supplement and in &#8220;Risk Factors&#8221; in the prospectus, as the Buffered PLUS involve risks not associated with conventional
        debt securities. We urge you to consult your investment, legal, tax, accounting and other advisors concerning an investment in the Buffered PLUS. You may access these documents on the SEC website at www.sec.gov as follows (or if that address has
        changed, by reviewing our filings for the relevant date on the SEC website):</div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%;" id="z1a69afe53d0d4cb28ad88a762c7839ae" class="DSPFListTable">

              <tr style="vertical-align: top;">
                <td style="text-align: right; vertical-align: top; width: 18pt;">
                  <div style="font-size: 5pt; text-align: left; color: rgb(0, 112, 192);">&#9632;</div>
                </td>
                <td style="text-align: left; vertical-align: top; width: auto;">
                  <div style="font-size: 8pt;">Prospectus dated February 26, 2025:</div>
                </td>
              </tr>

          </table>
        </div>
        <div> </div>
      </div>
      <div style="margin: 6pt 0px 5pt 33.1pt; color: #0000FF; font-size: 8pt; text-indent: -15.1pt;"><a href="https://www.sec.gov/Archives/edgar/data/947263/000119312525036639/d931193d424b5.htm">http://www.sec.gov/Archives/edgar/data/947263/000119312525036639/d931193d424b5.htm</a></div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%;" id="z29d9a76d643c47489a0cf7ad9519cea9" class="DSPFListTable">

              <tr style="vertical-align: top;">
                <td style="text-align: right; vertical-align: top; width: 18pt;">
                  <div style="font-size: 5pt; text-align: left; color: rgb(0, 112, 192);">&#9632;</div>
                </td>
                <td style="text-align: left; vertical-align: top; width: auto;">
                  <div style="font-size: 8pt;">Underlier Supplement dated February 26, 2025:</div>
                </td>
              </tr>

          </table>
        </div>
        <div> </div>
      </div>
      <div style="margin: 6pt 0px 5pt 33.1pt; color: #0000FF; font-size: 8pt; text-indent: -15.1pt;"><a href="https://www.sec.gov/Archives/edgar/data/947263/000114036125006121/ef20044458_424b3.htm">http://www.sec.gov/Archives/edgar/data/947263/000114036125006121/ef20044458_424b3.htm</a></div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%;" id="zfa16bc482096494ba74b2888dc44c357" class="DSPFListTable">

              <tr style="vertical-align: top;">
                <td style="text-align: right; vertical-align: top; width: 18pt; font-size: 5pt;">
                  <div style="text-align: left; color: rgb(0, 112, 192);">&#9632;</div>
                </td>
                <td style="text-align: left; vertical-align: top; width: auto;">
                  <div style="font-size: 8pt;">Product Supplement MLN-EI-1 dated February 26, 2025:</div>
                </td>
              </tr>

          </table>
        </div>
        <div> </div>
      </div>
      <div style="text-indent: -15.1pt; margin-left: 33.1pt; margin-top: 6pt; margin-bottom: 2.5pt; font-size: 8pt;"><a href="https://www.sec.gov/Archives/edgar/data/947263/000114036125006123/ef20044459_424b3.htm">http://www.sec.gov/Archives/edgar/data/947263/000114036125006123/ef20044459_424b3.htm</a></div>
      <div style="text-align: justify; margin-top: 10pt; font-size: 8pt;">Our Central Index Key, or CIK, on the SEC website is 0000947263. As used in this pricing supplement, &#8220;TD,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221; refers to The Toronto-Dominion Bank and its
        subsidiaries.</div>
      <div style="text-align: justify; margin-top: 10pt; font-size: 8pt;">TD reserves the right to change the terms of, or reject any offer to purchase, the Buffered PLUS prior to their issuance. In the event of any changes to the terms of the Buffered
        PLUS, TD will notify you and you will be asked to accept such changes in connection with your purchase. You may also choose to reject such changes in which case TD may reject your offer to purchase.</div>
      <div><br>
      </div>
      <div> </div>
      <div> </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 65.08%; vertical-align: top;">
                  <div style="color: rgb(41, 109, 193); font-size: 8pt;">November 2025</div>
                </td>
                <td style="width: 34.79%; vertical-align: top;">
                  <div style="text-align: right; color: rgb(41, 109, 193); font-size: 8pt;">Page <font class="BRPFPageNumber">2</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 100%; vertical-align: top;">
                  <div style="text-align: right;">
                    <div><img width="57" height="48" src="image0.jpg"></div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="border-bottom: 1px solid #296DC1; border-top: 1px solid #296DC1; vertical-align: top; width: 100%;">
                  <div style="color: rgb(41, 109, 193);">Buffered PLUS Based on the Value of the S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index due June 5, 2028</div>
                  <div style="color: rgb(128, 128, 128); font-size: 8pt; font-weight: bold;">Buffered Performance Leveraged Upside Securities<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup></div>
                  <div style="color: rgb(128, 128, 128); font-size: 7pt;">Principal at Risk Securities</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="margin-top: 6pt; color: rgb(0, 112, 192); font-size: 14pt;">Investment Overview</div>
      <div style="margin-top: 3pt; color: rgb(40, 109, 193); font-size: 10pt;">Buffered Performance Leveraged Upside Securities</div>
      <div style="margin-top: 3pt; color: rgb(128, 128, 128); font-size: 8pt;">Principal at Risk Securities</div>
      <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;">The Buffered PLUS Based on the Value of the S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index due June 5, 2028 can be used:</div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 3pt;" class="DSPFListTable" id="zf78e065b2a9748ebaf394a636fd00563">

          <tr>
            <td style="width: 18pt; vertical-align: top; color: rgb(79, 129, 189); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-size: 8pt;">As an alternative to direct exposure to the underlying index that enhances returns for a certain range of positive performance of the underlying index, subject to the maximum payment at maturity; however, by
                investing in the Buffered PLUS, you will not be entitled to receive any dividends paid with respect to the stocks comprising the underlying index (the &#8220;index constituent stocks&#8221;) or any interest payments, and your return will not exceed the
                maximum payment at maturity. You should carefully consider whether an investment that does not provide for any dividends, interest payments or exposure to the positive performance of the underlying index beyond a value that, when multiplied
                by the leverage factor, exceeds the maximum gain is appropriate for you.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 3pt;" class="DSPFListTable" id="z5ff9b190f1e2497c948b8e8ed30171f2">

          <tr>
            <td style="width: 18pt; vertical-align: top; color: rgb(79, 129, 189); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-size: 8pt;">To enhance returns and potentially outperform the underlying index in a moderately bullish scenario.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 3pt;" class="DSPFListTable" id="z942e99f0d1404da9ac77fbbdb5d2936b">

          <tr>
            <td style="width: 18pt; vertical-align: top; color: rgb(79, 129, 189); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-size: 8pt;">To achieve similar levels of upside exposure to the underlying index as a direct investment, subject to the maximum payment at maturity, while using fewer dollars by taking advantage of the leverage factor.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 3pt;" class="DSPFListTable" id="z528dc87290b84ddc8b1e135a53cddfe9">

          <tr>
            <td style="width: 18pt; vertical-align: top; color: rgb(79, 129, 189); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-size: 8pt;">To obtain a buffer against a specified percentage of negative performance of the value of the underlying index.</div>
            </td>
          </tr>

      </table>
      <div style="margin-top: 3pt;"><br>
      </div>
      <div style="margin-left: 18pt;">
        <table cellspacing="0" cellpadding="0" border="0" align="" style="border-collapse: collapse; width: 90%; color: #000000; font-family: Arial; font-size: 9pt; text-align: left;" id="z34cb29fe4dd04c25a73820dae55de94b">

            <tr>
              <td style="width: 30%; vertical-align: top;">
                <div style="margin-bottom: 4pt; color: rgb(0, 112, 192); font-size: 8pt; font-weight: bold;">Maturity:</div>
              </td>
              <td style="width: 60%; vertical-align: bottom;">
                <div style="margin-bottom: 4pt; font-size: 8pt;">Approximately 30 months</div>
              </td>
            </tr>
            <tr>
              <td style="width: 30%; vertical-align: top;">
                <div style="margin-bottom: 4pt; color: rgb(0, 112, 192); font-size: 8pt; font-weight: bold;">Buffer Amount</div>
              </td>
              <td style="width: 60%; vertical-align: bottom;">
                <div style="margin-bottom: 4pt; font-size: 8pt;">10%</div>
              </td>
            </tr>
            <tr>
              <td style="width: 30%; vertical-align: top;">
                <div style="margin-bottom: 4pt; color: rgb(0, 112, 192); font-size: 8pt; font-weight: bold;">Leverage factor:</div>
              </td>
              <td style="width: 60%; vertical-align: bottom;">
                <div style="margin-bottom: 4pt; font-size: 8pt;">200% (applicable only if the final index value is greater than the initial index value)</div>
              </td>
            </tr>
            <tr>
              <td style="width: 30%; vertical-align: top;">
                <div style="margin-bottom: 4pt; color: rgb(0, 112, 192); font-size: 8pt; font-weight: bold;">Maximum payment at maturity:</div>
              </td>
              <td style="width: 60%; vertical-align: bottom;">
                <div style="margin-bottom: 4pt; font-size: 8pt;">$1,212.00 per Buffered PLUS (121.20% of the stated principal amount)</div>
              </td>
            </tr>
            <tr>
              <td style="width: 30%; vertical-align: top;">
                <div style="margin-bottom: 4pt; color: rgb(0, 112, 192); font-size: 8pt; font-weight: bold;">Maximum gain:</div>
              </td>
              <td style="width: 60%; vertical-align: bottom;">
                <div style="margin-bottom: 4pt; font-size: 8pt;">21.20%</div>
              </td>
            </tr>
            <tr>
              <td style="width: 30%; vertical-align: top;">
                <div style="margin-bottom: 4pt; color: rgb(0, 112, 192); font-size: 8pt; font-weight: bold;">Coupon:</div>
              </td>
              <td style="width: 60%; vertical-align: bottom;">
                <div style="margin-bottom: 4pt; font-size: 8pt;">None</div>
              </td>
            </tr>
            <tr>
              <td style="width: 30%; vertical-align: top;">
                <div style="margin-bottom: 4pt; color: rgb(0, 112, 192); font-size: 8pt; font-weight: bold;">Minimum payment at maturity:</div>
              </td>
              <td style="width: 60%; vertical-align: bottom;">
                <div style="margin-bottom: 4pt; font-size: 8pt;">$100.00 (10% of the stated principal amount).</div>
              </td>
            </tr>
            <tr>
              <td style="width: 30%; vertical-align: top;">
                <div style="margin-bottom: 4pt; color: rgb(0, 112, 192); font-size: 8pt; font-weight: bold;">Listing:</div>
              </td>
              <td style="width: 60%; vertical-align: bottom;">
                <div style="margin-bottom: 4pt; font-size: 8pt;">The Buffered PLUS will not be listed or displayed on any securities exchange or any electronic communications network.</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="margin-top: 8pt; color: rgb(0, 112, 192); font-size: 14pt;">Key Investment Rationale</div>
      <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;">Investors can use the Buffered PLUS to leverage returns by 200%, up to the maximum gain, and obtain contingent protection against a loss of the stated principal amount in the event
        that final index value is equal to or less than the initial index value, but not by more than the buffer amount. At maturity, investors will receive an amount in cash based upon the underlying return. If the final index value is greater than the
        initial index value, investors will receive the stated principal amount of their investment <font style="font-style: italic;">plus</font> the leveraged upside performance of the underlying index, subject to the maximum payment at maturity. If the
        final index value is less than or equal to the initial index value, but not by more than the buffer amount of 10%, investors will receive the stated principal amount at maturity. However, if the final index value is less than the initial index
        value by more than the buffer amount, investors will lose 1% for every 1% that the final index value falls below the initial index value in excess of the buffer amount. Investors may lose up to 90% of their investment in the Buffered PLUS. All
        payments on the Buffered PLUS are subject to the credit risk of TD. If TD becomes unable to meet its financial obligations as they become due, investors may not receive any amounts due under the terms of the Buffered PLUS.</div>
      <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;">Investors will not be entitled to receive any dividends paid with respect to the index constituent stocks and the Buffered PLUS do not pay periodic interest. You should carefully
        consider whether an investment that does not provide for any dividends or periodic interest is appropriate for you.</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zbbf6cda2e65544ba91ae2727fb1b5020">

          <tr>
            <td colspan="1" style="background-color: rgb(219, 229, 241); border-bottom: 1px solid rgb(255, 255, 255); vertical-align: middle; width: 1%;">&#160;</td>
            <td style="background-color: rgb(219, 229, 241); border-bottom: 1px solid rgb(255, 255, 255); vertical-align: middle; width: 32%;">
              <div style="color: rgb(0, 112, 192); font-weight: bold;">Leveraged Performance up to a Cap</div>
            </td>
            <td style="width: 2%; vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="width: 65.38%; vertical-align: bottom;">
              <div style="text-align: justify; margin-top: 4pt; margin-bottom: 4pt; font-size: 7pt;">The Buffered PLUS offer investors an opportunity to capture enhanced returns relative to a direct investment in the underlying index or the index
                constituent stocks, within a certain range of positive performance.</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="background-color: rgb(219, 229, 241); border-bottom: 1px solid rgb(255, 255, 255); vertical-align: middle; width: 1%;">&#160;</td>
            <td style="background-color: rgb(219, 229, 241); border-bottom: 1px solid rgb(255, 255, 255); vertical-align: middle; width: 32%;">
              <div style="color: rgb(0, 112, 192); font-weight: bold;">Upside Scenario</div>
            </td>
            <td style="width: 2%; vertical-align: bottom; padding-bottom: 1px;" colspan="1">&#160;</td>
            <td style="width: 65.38%; vertical-align: bottom; padding-bottom: 1px;">
              <div style="text-align: justify; margin-top: 4pt; margin-bottom: 4pt; font-size: 7pt;">If the final index value is greater than the initial index value, at maturity you will receive the stated principal amount of $1,000.00 <font style="font-style: italic;">plus</font> the leveraged upside payment, subject to the maximum payment at maturity of $1,212.00 per Buffered PLUS (121.20% of the stated principal amount).</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td colspan="1" style="background-color: rgb(219, 229, 241); border-bottom: 1px solid rgb(255, 255, 255); vertical-align: middle; width: 1%;">&#160;</td>
            <td style="background-color: rgb(219, 229, 241); border-bottom: 1px solid rgb(255, 255, 255); vertical-align: middle; width: 32%;">
              <div style="color: rgb(0, 112, 192); font-weight: bold;">Par Scenario</div>
            </td>
            <td style="width: 2%; vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="width: 65.38%; vertical-align: bottom;">
              <div style="text-align: justify; margin-top: 4pt; margin-bottom: 4pt; font-size: 7pt;">If the final index value is less than or equal to the initial index value, but not by more than the buffer amount, at maturity you will receive the stated
                principal amount.</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: middle; background-color: rgb(219, 229, 241);">&#160;</td>
            <td style="width: 32%; vertical-align: middle; background-color: rgb(219, 229, 241);">
              <div style="color: rgb(0, 112, 192); font-weight: bold;">Downside Scenario</div>
            </td>
            <td style="width: 2%; vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="width: 65.38%; vertical-align: bottom;">
              <div style="text-align: justify; margin-top: 4pt; margin-bottom: 4pt; font-size: 7pt;">If the final index value is less than the initial index value by more than the buffer amount, at maturity you will receive less than the stated principal
                amount and you will lose 1% for every 1% that the final index value has fallen below the initial index value in excess of the buffer amount. For example, if the underlying return is -40%, each Buffered PLUS will redeem for $700.00, or 70%
                of the stated principal amount. <font style="font-weight: bold;">The minimum payment at maturity on the Buffered PLUS is 10% of the stated principal amount and you could lose up to 90% of your investment in the Buffered PLUS.</font></div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 65.08%; vertical-align: top;">
                  <div style="color: rgb(41, 109, 193); font-size: 8pt;">November 2025</div>
                </td>
                <td style="width: 34.79%; vertical-align: top;">
                  <div style="text-align: right; color: rgb(41, 109, 193); font-size: 8pt;">Page <font class="BRPFPageNumber">3</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 100%; vertical-align: top;">
                  <div style="text-align: right;">
                    <div><img width="57" height="48" src="image0.jpg"></div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="border-bottom: 1px solid #296DC1; border-top: 1px solid #296DC1; vertical-align: top; width: 100%;">
                  <div style="color: rgb(41, 109, 193);">Buffered PLUS Based on the Value of the S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index due June 5, 2028</div>
                  <div style="color: rgb(128, 128, 128); font-size: 8pt; font-weight: bold;">Buffered Performance Leveraged Upside Securities<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup></div>
                  <div style="color: rgb(128, 128, 128); font-size: 7pt;">Principal at Risk Securities</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="margin-top: 10pt; color: rgb(0, 112, 192); font-size: 14pt;">Investor Suitability</div>
      <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt; font-weight: bold;">The Buffered PLUS may be suitable for you if:</div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 2.5pt; margin-top: 2.5pt;" class="DSPFListTable" id="z62e39273196749a4a4ed36e0c7251ba7">

          <tr>
            <td style="width: 15pt; vertical-align: top; color: rgb(41, 109, 193); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>You fully understand and are willing to accept the risks of an investment in the Buffered PLUS, including the risk that you may lose up to 90% of your investment in the Buffered PLUS</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 2.5pt; margin-top: 2.5pt;" class="DSPFListTable" id="z75086b3d7303416ebdf5e68b236a837d">

          <tr>
            <td style="width: 15pt; vertical-align: top; color: rgb(41, 109, 193); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>You can tolerate a loss of a substantial portion of your investment and are willing to make an investment that has similar downside market risk as that of a direct investment in the underlying index or the index constituent stocks</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 2.5pt; margin-top: 2.5pt;" class="DSPFListTable" id="zecff04707cb34387bd00b8c0c5351086">

          <tr>
            <td style="width: 15pt; vertical-align: top; color: rgb(41, 109, 193); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>You believe that the final index value will be greater than the initial index value and you understand and accept that any positive return that you earn on the Buffered PLUS will not exceed the maximum gain</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 2.5pt; margin-top: 2.5pt;" class="DSPFListTable" id="z0768ebbf17e049348216a2144e8ab81c">

          <tr>
            <td style="width: 15pt; vertical-align: top; color: rgb(41, 109, 193); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>You can tolerate fluctuations in the market prices of the Buffered PLUS prior to maturity that may be similar to or exceed the fluctuations in the value of the underlying index</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 2.5pt; margin-top: 2.5pt;" class="DSPFListTable" id="zefe8f58baefd4ee8a8e00d2d8ccebaac">

          <tr>
            <td style="width: 15pt; vertical-align: top; color: rgb(41, 109, 193); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>You do not seek current income from your investment and are willing to forgo any dividends paid on any index constituent stocks</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 2.5pt; margin-top: 2.5pt;" class="DSPFListTable" id="z28188d669a5c4673aabc4abf007b73bb">

          <tr>
            <td style="width: 15pt; vertical-align: top; color: rgb(41, 109, 193); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>You are willing and able to hold the Buffered PLUS to maturity, a term of approximately 30 months, and accept that there may be little or no secondary market for the Buffered PLUS</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 2.5pt; margin-top: 2.5pt;" class="DSPFListTable" id="z35a5475d236a4f46a00276c9555057c8">

          <tr>
            <td style="width: 15pt; vertical-align: top; color: rgb(41, 109, 193); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>You understand and are willing to accept the risks associated with the underlying index</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 2.5pt; margin-top: 2.5pt;" class="DSPFListTable" id="z4961f01d56de412283578121bd02ac4e">

          <tr>
            <td style="width: 15pt; vertical-align: top; color: rgb(41, 109, 193); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>You are willing to assume the credit risk of TD for all payments under the Buffered PLUS, and you understand that if TD defaults on its obligations you may not receive any amounts due to you including any repayment of principal</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-top: 12pt; margin-bottom: 3pt; font-weight: bold;">The Buffered PLUS may not be suitable for you if:</div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 2.5pt; margin-top: 2.5pt;" class="DSPFListTable" id="z50cd67d55e9d4139b10388e7e200f396">

          <tr>
            <td style="width: 15pt; vertical-align: top; color: rgb(41, 109, 193); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>You do not fully understand or are unwilling to accept the risks of an investment in the Buffered PLUS, including the risk that you may lose up to 90% of your investment</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 2.5pt; margin-top: 2.5pt;" class="DSPFListTable" id="zc420c08641f24376984bc9964cffe67b">

          <tr>
            <td style="width: 15pt; vertical-align: top; color: rgb(41, 109, 193); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>You require an investment that provides full protection against loss of principal</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 2.5pt; margin-top: 2.5pt;" class="DSPFListTable" id="zb286733a5cf54d7c8bc9d6c5cf01da5a">

          <tr>
            <td style="width: 15pt; vertical-align: top; color: rgb(41, 109, 193); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>You are not willing to make an investment that has similar downside market risk as that of a direct investment in the underlying index or the index constituent stocks</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z77996c8eefeb496c821e8e5eba37ba0b">

          <tr>
            <td style="width: 15pt; vertical-align: top; color: rgb(41, 109, 193); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top;">
              <div>You believe that the final index value will not be greater than the initial index value</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 2.5pt; margin-top: 2.5pt;" class="DSPFListTable" id="z86d164d83774473bb62f4ea22b1d5a21">

          <tr>
            <td style="width: 15pt; vertical-align: top; color: rgb(41, 109, 193); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>You seek an investment that has an unlimited return potential or you do not understand or cannot accept that your potential return on the Buffered PLUS is limited to the maximum gain</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 2.5pt; margin-top: 2.5pt;" class="DSPFListTable" id="z61249902aa3045a8931c6c3552062884">

          <tr>
            <td style="width: 15pt; vertical-align: top; color: rgb(41, 109, 193); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>You cannot tolerate fluctuations in the market price of the Buffered PLUS prior to maturity that may be similar to or exceed the fluctuations in the value of the underlying index</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 2.5pt; margin-top: 2.5pt;" class="DSPFListTable" id="zbab6124664cf4d8b9ba4244e09c307a7">

          <tr>
            <td style="width: 15pt; vertical-align: top; color: rgb(41, 109, 193); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>You seek current income from your investment or prefer to receive the dividends paid on the index constituent stocks</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 2.5pt; margin-top: 2.5pt;" class="DSPFListTable" id="z0c397b82f62a4a1eaef924f4ee499fb0">

          <tr>
            <td style="width: 15pt; vertical-align: top; color: rgb(41, 109, 193); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>You are unable or unwilling to hold the Buffered PLUS to maturity, a term of approximately 30 months, or seek an investment for which there will be an active secondary market</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 2.5pt; margin-top: 2.5pt;" class="DSPFListTable" id="z776fe839a5ad494e84febc3a6b93567d">

          <tr>
            <td style="width: 15pt; vertical-align: top; color: rgb(41, 109, 193); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>You do not understand or are not willing to accept the risks associated with the underlying index</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 2.5pt;" class="DSPFListTable" id="z4d498fe8899d478d81bb8858de1a1f3d">

          <tr>
            <td style="width: 15.1pt; vertical-align: top; color: rgb(41, 109, 193); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>You are not willing to assume the credit risk of TD for all payments under the Buffered PLUS, including any repayment of principal</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 65.08%; vertical-align: top;">
                  <div style="color: rgb(41, 109, 193); font-size: 8pt;">November 2025</div>
                </td>
                <td style="width: 34.79%; vertical-align: top;">
                  <div style="text-align: right; color: rgb(41, 109, 193); font-size: 8pt;">Page <font class="BRPFPageNumber">4</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 100%; vertical-align: top;">
                  <div style="text-align: right;">
                    <div><img width="57" height="48" src="image0.jpg"></div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="border-bottom: 1px solid #296DC1; border-top: 1px solid #296DC1; vertical-align: top; width: 100%;">
                  <div style="color: rgb(41, 109, 193);">Buffered PLUS Based on the Value of the S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index due June 5, 2028</div>
                  <div style="color: rgb(128, 128, 128); font-size: 8pt; font-weight: bold;">Buffered Performance Leveraged Upside Securities<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup></div>
                  <div style="color: rgb(128, 128, 128); font-size: 7pt;">Principal at Risk Securities</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="margin-top: 10pt; color: rgb(0, 112, 192); font-size: 14pt;">How the Buffered PLUS Work</div>
      <div style="margin-top: 3pt; color: rgb(40, 109, 193); font-size: 10pt;">Hypothetical Examples</div>
      <div style="text-align: justify; margin-top: 6pt;"><font style="font-size: 8pt;">T</font>he below examples are based on the following terms and are purely hypothetical (the actual terms of your Buffered PLUS will be determined on the pricing date and
        will be specified in the final pricing supplement):</div>
      <div style="text-align: justify; margin-top: 6pt;">Investors will not be entitled to receive any dividends paid with respect to the index constituent stocks or any periodic interest. You should carefully consider whether an investment that does not
        provide for any dividends or periodic interest is appropriate for you. All payments on the Buffered PLUS are subject to our credit risk.</div>
      <div style="margin-top: 10pt;"><br>
      </div>
      <div style="margin-left: 18pt;">
        <table cellspacing="0" cellpadding="0" border="0" align="" style="border-collapse: collapse; width: 90%; color: #000000; font-family: Arial; font-size: 9pt; text-align: left;" id="zb34c65fb9517468995ffd2376d65d2b1">

            <tr>
              <td style="width: 35%; vertical-align: top;">
                <div style="margin-top: 2pt; margin-bottom: 2pt; color: rgb(0, 112, 192); font-weight: bold;">Stated principal amount:</div>
              </td>
              <td style="width: 55%; vertical-align: top;">
                <div style="margin-top: 2pt; margin-bottom: 2pt;">$1,000.00 per Buffered PLUS</div>
              </td>
            </tr>
            <tr>
              <td style="width: 35%; vertical-align: top;">
                <div style="margin-top: 2pt; margin-bottom: 2pt; color: rgb(0, 112, 192); font-weight: bold;">Buffer amount:</div>
              </td>
              <td style="width: 55%; vertical-align: top;">
                <div style="margin-top: 2pt; margin-bottom: 2pt;">10%</div>
              </td>
            </tr>
            <tr>
              <td style="width: 35%; vertical-align: top;">
                <div style="margin-top: 2pt; margin-bottom: 2pt; color: rgb(0, 112, 192); font-weight: bold;">Leverage factor:</div>
              </td>
              <td style="width: 55%; vertical-align: top;">
                <div style="margin-top: 2pt; margin-bottom: 2pt;">200%</div>
              </td>
            </tr>
            <tr>
              <td style="width: 35%; vertical-align: top;">
                <div style="margin-top: 2pt; margin-bottom: 2pt; color: rgb(0, 112, 192); font-weight: bold;">Hypothetical initial index value:</div>
              </td>
              <td style="width: 55%; vertical-align: top;">
                <div style="margin-top: 2pt; margin-bottom: 2pt;">100.00</div>
              </td>
            </tr>
            <tr>
              <td style="width: 35%; vertical-align: top;">
                <div style="margin-top: 2pt; margin-bottom: 2pt; color: rgb(0, 112, 192); font-weight: bold;">Maximum payment at maturity:</div>
              </td>
              <td style="width: 55%; vertical-align: top;">
                <div style="margin-top: 2pt; margin-bottom: 2pt;">$1,212.00 per Buffered PLUS</div>
              </td>
            </tr>
            <tr>
              <td style="width: 35%; vertical-align: top;">
                <div style="margin-top: 2pt; margin-bottom: 2pt; color: rgb(0, 112, 192); font-weight: bold;">Maximum gain:</div>
              </td>
              <td style="width: 55%; vertical-align: top;">
                <div style="margin-top: 2pt; margin-bottom: 2pt;">21.20%</div>
              </td>
            </tr>
            <tr>
              <td style="width: 35%; vertical-align: top;">
                <div style="margin-top: 2pt; margin-bottom: 2pt; color: rgb(0, 112, 192); font-weight: bold;">Minimum payment at maturity:</div>
              </td>
              <td style="width: 55%; vertical-align: top;">
                <div style="margin-top: 2pt; margin-bottom: 2pt;">$100.00 (10% of the stated principal amount)</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 3pt; font-weight: bold; clear: both;">EXAMPLE 1: The value of the underlying index increases over the term of the Buffered PLUS.</div>
      <div style="margin-left: 9pt;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z13996612f40b4197b39350e86a6664fe">

            <tr>
              <td style="width: 35%; vertical-align: top;">
                <div style="margin-top: 5pt;">Final index value</div>
              </td>
              <td style="width: 65%; vertical-align: top;">
                <div style="text-align: justify; margin-top: 5pt;">103.00</div>
              </td>
            </tr>
            <tr>
              <td style="width: 35%; vertical-align: top;">
                <div style="margin-top: 5pt;">Underlying return</div>
              </td>
              <td style="width: 65%; vertical-align: top;">
                <div style="text-align: justify; margin-top: 5pt;">(103.00 &#8211; 100.00) / 100.00 = 3.00%</div>
              </td>
            </tr>
            <tr>
              <td style="width: 35%; vertical-align: top;">
                <div style="margin-top: 5pt;">Payment at maturity</div>
              </td>
              <td style="width: 65%; vertical-align: top;">
                <div style="text-align: justify; margin-top: 5pt;">= $1,000.00 + leveraged upside payment,<font style="color: #000000;"> subject to the maximum payment at maturity</font></div>
              </td>
            </tr>
            <tr>
              <td style="width: 35%; vertical-align: top;">&#160;</td>
              <td style="width: 65%; vertical-align: top;">
                <div style="text-align: justify; margin-top: 2pt;">= $1,000.00 + ($1,000.00 &#215; leverage factor &#215; underlying return), <font style="color: #000000;">subject to the maximum payment at maturity</font></div>
              </td>
            </tr>
            <tr>
              <td style="width: 35%; vertical-align: top;">&#160;</td>
              <td style="width: 65%; vertical-align: top;">
                <div style="text-align: justify; margin-top: 2pt;">= $1,000.00 + ($1,000.00 &#215; 200% &#215; 3.00%), <font style="color: #000000;">subject to the maximum payment at maturity</font></div>
              </td>
            </tr>
            <tr>
              <td style="width: 35%; vertical-align: top;">&#160;</td>
              <td style="width: 65%; vertical-align: top;">
                <div style="text-align: justify; margin-top: 2pt;">= $1,060.00</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: justify; margin-left: 9.35pt; margin-top: 3pt; margin-bottom: 12pt;">In <font style="font-weight: bold;">Example 1</font>, the final index value is greater than the initial index value and the underlying return is 3.00%.
        Accordingly, investors receive the stated principal amount at maturity plus a return equal to 200% times the underlying return, resulting in a payment at maturity of $1,060.00 per Buffered PLUS (a total return of 6.00%).</div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 3pt; font-weight: bold;">EXAMPLE 2: The value of the underlying index increases over the term of the Buffered PLUS such that the payment at maturity is equal to the maximum payment at
        maturity.</div>
      <div style="margin-left: 9pt;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zc2f4601526fc4f02bcb78e019c280140">

            <tr>
              <td style="width: 35%; vertical-align: top;">
                <div style="margin-top: 5pt;">Final index value</div>
              </td>
              <td style="width: 65%; vertical-align: top;">
                <div style="text-align: justify; margin-top: 5pt;">150.00</div>
              </td>
            </tr>
            <tr>
              <td style="width: 35%; vertical-align: top;">
                <div style="margin-top: 5pt;">Underlying return</div>
              </td>
              <td style="width: 65%; vertical-align: top;">
                <div style="text-align: justify; margin-top: 5pt;">(150.00 &#8211; 100.00) / 100.00 = 50.00%</div>
              </td>
            </tr>
            <tr>
              <td style="width: 35%; vertical-align: top;">
                <div style="margin-top: 5pt;">Payment at maturity</div>
              </td>
              <td style="width: 65%; vertical-align: top;">
                <div style="text-align: justify; margin-top: 5pt;">= $1,000.00 + leveraged upside payment<font style="color: #000000;">, subject to the maximum payment at maturity</font></div>
              </td>
            </tr>
            <tr>
              <td style="width: 35%; vertical-align: top;"><br>
              </td>
              <td style="width: 65%; vertical-align: top;">
                <div style="text-align: justify; margin-top: 2pt;">= $1,000.00 + ($1,000.00 &#215; leverage factor &#215; underlying return), <font style="color: #000000;">subject to the maximum payment at maturity</font></div>
              </td>
            </tr>
            <tr>
              <td style="width: 35%; vertical-align: top;">&#160;</td>
              <td style="width: 65%; vertical-align: top;">
                <div style="text-align: justify; margin-top: 2pt;">= maximum payment at maturity of $1,212.00 per Buffered PLUS</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: justify; margin-left: 9.35pt; margin-top: 3pt;">In <font style="font-weight: bold;">Example 2</font>, the final index value is greater than the initial index value and the underlying return is 50.00%. <font style="color: #000000;">Under the terms of the Buffered PLUS, investors will realize the maximum payment at maturity if the underlying return is 10.60% or higher. Therefore, in this example, investors receive the maximum payment at maturity of $1,212.00 per
          stated principal amount even though the underlying index has appreciated by an amount significantly greater than the return represented by the maximum payment at maturity.</font></div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 65.08%; vertical-align: top;">
                  <div style="color: rgb(41, 109, 193); font-size: 8pt;">November 2025</div>
                </td>
                <td style="width: 34.79%; vertical-align: top;">
                  <div style="text-align: right; color: rgb(41, 109, 193); font-size: 8pt;">Page <font class="BRPFPageNumber">5</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 100%; vertical-align: top;">
                  <div style="text-align: right;">
                    <div><img width="57" height="48" src="image0.jpg"></div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="border-bottom: 1px solid #296DC1; border-top: 1px solid #296DC1; vertical-align: top; width: 100%;">
                  <div style="color: rgb(41, 109, 193);">Buffered PLUS Based on the Value of the S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index due June 5, 2028</div>
                  <div style="color: rgb(128, 128, 128); font-size: 8pt; font-weight: bold;">Buffered Performance Leveraged Upside Securities<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup></div>
                  <div style="color: rgb(128, 128, 128); font-size: 7pt;">Principal at Risk Securities</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: justify; margin-top: 3pt; margin-bottom: 12pt; font-weight: bold;">EXAMPLE 3: The final index value is less than the initial index value, but not by more than the buffer amount.</div>
      <div style="margin-left: 9pt">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="za1c08030835c4ad38f69944b16261c27">

            <tr>
              <td style="width: 35%; vertical-align: top;">
                <div style="margin-right: 21.6pt; margin-top: 5pt;">Final index value</div>
              </td>
              <td style="width: 65%; vertical-align: top;">
                <div style="text-align: justify; margin-top: 5pt;">97.00</div>
              </td>
            </tr>
            <tr>
              <td style="width: 35%; vertical-align: top;">
                <div style="margin-right: 21.6pt; margin-top: 5pt;">Underlying return</div>
              </td>
              <td style="width: 65%; vertical-align: top;">
                <div style="text-align: justify; margin-top: 5pt;">(97.00 &#8211; 100.00) / 100.00 = -3.00%</div>
              </td>
            </tr>
            <tr>
              <td style="width: 35%; vertical-align: top;">
                <div style="margin-right: 21.6pt; margin-top: 5pt;">Payment at maturity</div>
              </td>
              <td style="width: 65%; vertical-align: top;">
                <div style="text-align: justify; margin-top: 5pt;">= $1,000.00</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: justify; margin-left: 9.35pt; margin-top: 3pt; margin-bottom: 12pt;">In <font style="font-weight: bold;">Example 3</font>, the final index value is less than the initial index value and the underlying return is -3.00%.
        Because the final index value is less than the initial index value but the percentage decline from the initial index value to the final index value is less than or equal to the buffer amount, investors receive the stated principal amount of
        $1,000.00 per Buffered PLUS at maturity (a total return of 0%).</div>
      <div style="text-align: justify; margin-top: 3pt; margin-bottom: 12pt; font-weight: bold;">EXAMPLE 4: The final index value is less than the initial index value by more than the buffer amount.</div>
      <div style="margin-left: 9pt">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z2292b3abd9ce47d2b3d37aa6e93930f0">

            <tr>
              <td style="width: 35%; vertical-align: top;">
                <div style="margin-right: 21.6pt; margin-top: 5pt;">Final index value</div>
              </td>
              <td style="width: 65%; vertical-align: top;">
                <div style="text-align: justify; margin-top: 5pt;">70.00</div>
              </td>
            </tr>
            <tr>
              <td style="width: 35%; vertical-align: top;">
                <div style="margin-right: 21.6pt; margin-top: 5pt;">Underlying return</div>
              </td>
              <td style="width: 65%; vertical-align: top;">
                <div style="text-align: justify; margin-top: 5pt;">(70.00 &#8211; 100.00) / 100.00 = -30.00%</div>
              </td>
            </tr>
            <tr>
              <td style="width: 35%; vertical-align: top;">
                <div style="margin-right: 21.6pt; margin-top: 5pt;">Payment at maturity</div>
              </td>
              <td style="width: 65%; vertical-align: top;">
                <div style="text-align: justify; margin-top: 5pt;">= $1,000.00 + [$1,000.00 &#215; (underlying return + buffer amount)]</div>
              </td>
            </tr>
            <tr>
              <td style="width: 35%; vertical-align: top;"><br>
              </td>
              <td style="width: 65%; vertical-align: top;">
                <div style="text-align: justify; margin-top: 5pt;">= $1,000.00 + [$1,000.00 &#215; (-30.00% + 10.00%)]</div>
              </td>
            </tr>
            <tr>
              <td style="width: 35%; vertical-align: top;">&#160;</td>
              <td style="width: 65%; vertical-align: top;">
                <div style="text-align: justify; margin-top: 5pt;">= $1,000.00 - $200.00</div>
              </td>
            </tr>
            <tr>
              <td style="width: 35%; vertical-align: top;">&#160;</td>
              <td style="width: 65%; vertical-align: top;">
                <div style="text-align: justify; margin-top: 5pt;">= $800.00</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: justify; margin-left: 9.35pt; margin-top: 3pt; margin-bottom: 12pt;">In <font style="font-weight: bold;">Example 4</font>, the final index value is less than the initial index value and the underlying return is -30.00%.
        Because the final index value is less than the initial index value by more than the buffer amount, investors receive a payment at maturity of $800.00 per Buffered PLUS (a return on investment of -20.00%).</div>
      <div style="text-align: justify; margin-left: 9.35pt; margin-top: 3pt; font-weight: bold;">If the final index value is less than the initial index value by more than the buffer amount, you will lose 1% for every 1% that the final index value falls
        below the initial index value in excess of the buffer amount and could lose up to 90% of your investment in the Buffered PLUS.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 65.08%; vertical-align: top;">
                  <div style="color: rgb(41, 109, 193); font-size: 8pt;">November 2025</div>
                </td>
                <td style="width: 34.79%; vertical-align: top;">
                  <div style="text-align: right; color: rgb(41, 109, 193); font-size: 8pt;">Page <font class="BRPFPageNumber">6</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 100%; vertical-align: top;">
                  <div style="text-align: right;">
                    <div><img width="57" height="48" src="image0.jpg"></div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="border-bottom: 1px solid #296DC1; border-top: 1px solid #296DC1; vertical-align: top; width: 100%;">
                  <div style="color: rgb(41, 109, 193);">Buffered PLUS Based on the Value of the S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index due June 5, 2028</div>
                  <div style="color: rgb(128, 128, 128); font-size: 8pt; font-weight: bold;">Buffered Performance Leveraged Upside Securities<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup></div>
                  <div style="color: rgb(128, 128, 128); font-size: 7pt;">Principal at Risk Securities</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="color: rgb(0, 112, 192); font-size: 14pt;">Risk Factors</div>
      <div style="text-align: justify; margin-top: 6pt; font-style: italic;">The following is a non-exhaustive list of certain key risk factors for investors in the Buffered PLUS. For further discussion of these and other risks, you should read the section
        entitled &#8220;Additional Risk Factors Specific to the Notes&#8221; of the accompanying product supplement and &#8220;Risk Factors&#8221; of the accompanying prospectus. We also urge you to consult your investment, legal, tax, accounting and other advisors concerning an
        investment in the Buffered PLUS.</div>
      <div style="text-align: center; margin-left: 18pt; margin-top: 6pt; font-style: italic; font-weight: bold;">Risks Relating to Return Characteristics</div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 6pt;" class="DSPFListTable" id="zedc59d7e54ab4e91b6da16df90f6211b">

          <tr>
            <td style="width: 18pt; vertical-align: top; color: rgb(79, 129, 189); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><font style="font-weight: bold;">You may lose up to 90% of your investment in the Buffered PLUS.</font> The Buffered PLUS differ from ordinary debt securities in that TD will not necessarily repay the stated principal amount of the
                Buffered PLUS at maturity. If the final index value is less than the initial index value by more than the buffer amount, you will lose 1% of your principal for every 1% that the final index value falls below the initial index value in
                excess of the buffer amount. <font style="font-weight: bold; font-style: italic;">You may lose up to 90% of your investment in the Buffered PLUS</font>.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 6pt;" class="DSPFListTable" id="zf061ff599b1849c99e492432a3ae3dae">

          <tr>
            <td style="width: 18pt; vertical-align: top; color: rgb(79, 129, 189); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><font style="font-weight: bold;">The stated payout from the issuer applies only at maturity. </font>You should be willing to hold your Buffered PLUS to maturity. The stated payout, including the benefit of the leverage factor, is
                available only if you hold your Buffered PLUS to maturity. If you are able to sell your Buffered PLUS prior to maturity in the secondary market, you may have to sell them at a loss relative to your investment in the Buffered PLUS even if
                the then-current value of the underlying index is equal to or greater than the initial index value.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 6pt;" class="DSPFListTable" id="z9b838a29db304990b021b889ce686197">

          <tr>
            <td style="width: 18pt; vertical-align: top; color: rgb(41, 109, 193); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><font style="font-weight: bold;">Your potential return on the Buffered PLUS is limited to the maximum gain.</font> The return potential of the Buffered PLUS is limited to the maximum gain. Therefore, you will not benefit from any
                positive underlying return in excess of an amount that, when multiplied by the leverage factor, exceeds the maximum gain. Your return on the Buffered PLUS may be less than that of a hypothetical direct investment in the underlying index or
                the index constituent stocks.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 6pt;" class="DSPFListTable" id="z863a33ca76de454494eff7d8215fe7e1">

          <tr>
            <td style="width: 18pt; vertical-align: top; color: rgb(41, 109, 193); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><font style="font-weight: bold;">You will not receive any interest payments.</font> TD will not pay any interest with respect to the Buffered PLUS.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 6pt;" class="DSPFListTable" id="zaeaecef694804b878d9a10add7fe2ab4">

          <tr>
            <td style="width: 18pt; vertical-align: top; color: rgb(41, 109, 193); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><font style="font-weight: bold;">The amount payable on the Buffered PLUS is not linked to the value of the underlying index at any time other than the valuation date. </font>The final index value will be based on the index closing value
                on the valuation date, subject to postponement for non-trading days and certain market disruption events. If the value of the underlying index falls on the valuation date, the payment at maturity may be significantly less than it would have
                been had the payment at maturity been linked to the value of the underlying index at any time prior to such drop. Although the index closing value on the maturity date or at other times during the term of the Buffered PLUS may be higher
                than the index closing value on the valuation date, the payment at maturity will be based solely on the index closing value on the valuation date.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 6pt;" class="DSPFListTable" id="zed2ed18c5653482c913facfb249200ba">

          <tr>
            <td style="width: 18pt; vertical-align: top; color: rgb(41, 109, 193); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><font style="font-weight: bold;">Owning the Buffered PLUS is not the same as owning the index constituent stocks.</font> The return on your Buffered PLUS may not reflect the return you would realize if you actually owned the index
                constituent stocks. For instance, you will not benefit from any positive underlying return in excess of an amount that, when multiplied by the leverage factor, exceeds the maximum gain. Furthermore, you will not receive or be entitled to
                receive any dividend payments or other distributions paid on the index constituent stocks, and any such dividends or distributions will not be factored into the calculation of the payment at maturity on your Buffered PLUS. In addition, as
                an owner of the Buffered PLUS, you will not have voting rights or any other rights that a holder of the index constituent stocks may have.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: center; margin-left: 18pt; margin-top: 6pt; font-style: italic; font-weight: bold;">Risks Relating to Characteristics of the Underlying Index</div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 6pt;" class="DSPFListTable" id="zd8b4d6de12d94a2d86ee4d2013727137">

          <tr>
            <td style="width: 18pt; vertical-align: top; color: rgb(79, 129, 189); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><font style="font-weight: bold;">An investment in the Buffered PLUS involves market risk associated with the underlying index.</font> The return on the Buffered PLUS, which may be negative, is linked to the performance of the underlying
                index and indirectly linked to the value of the index constituent stocks. The value of the underlying index can rise or fall sharply due to factors specific to the underlying index or its index constituent stocks and their issuers (the
                &#8220;index constituent stock issuers&#8221;), such as stock or commodity price volatility, earnings, financial conditions, corporate, industry and regulatory developments, management changes and decisions and other events, as well as general market
                factors, such as general stock market or commodity market volatility and values, interest rates and economic, political and other conditions. You, as an investor in the Buffered PLUS, should make your own investigation into the underlying
                index and the index constituent stocks.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 65.08%; vertical-align: top;">
                  <div style="color: rgb(41, 109, 193); font-size: 8pt;">November 2025</div>
                </td>
                <td style="width: 34.79%; vertical-align: top;">
                  <div style="text-align: right; color: rgb(41, 109, 193); font-size: 8pt;">Page <font class="BRPFPageNumber">7</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 100%; vertical-align: top;">
                  <div style="text-align: right;">
                    <div><img width="57" height="48" src="image0.jpg"></div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="border-bottom: 1px solid #296DC1; border-top: 1px solid #296DC1; vertical-align: top; width: 100%;">
                  <div style="color: rgb(41, 109, 193);">Buffered PLUS Based on the Value of the S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index due June 5, 2028</div>
                  <div style="color: rgb(128, 128, 128); font-size: 8pt; font-weight: bold;">Buffered Performance Leveraged Upside Securities<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup></div>
                  <div style="color: rgb(128, 128, 128); font-size: 7pt;">Principal at Risk Securities</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 6pt;" class="DSPFListTable" id="z87fed9db1e8846b991b0d7cbbe6a6493">

          <tr>
            <td style="width: 18pt; vertical-align: top; color: rgb(41, 109, 193); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><font style="font-weight: bold;">There can be no assurance that the investment view implicit in the Buffered PLUS will be successful.</font> It is impossible to predict whether and the extent to which the value of the underlying index
                will rise or fall and there can be no assurance that the underlying return will be positive. The final index value (and therefore the underlying return) will be influenced by complex and interrelated political, economic, financial and other
                factors that affect the index constituent stock issuers. You should be willing to accept the risks associated with the relevant markets tracked by the underlying index in general and each index constituent stock in particular, and the risk
                of losing some or almost all of your investment in the Buffered PLUS.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 6pt;" class="DSPFListTable" id="z5f641459296d49ed9207bd3fee9025b3">

          <tr>
            <td style="width: 18pt; vertical-align: top; color: rgb(79, 129, 189); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><font style="font-weight: bold;">The underlying index reflects price return, not total return.</font> The return on the Buffered PLUS is based on the performance of the underlying index, which reflects the changes in the market prices of
                the index constituent stocks. It is not, however, linked to a &#8220;total return&#8221; index or strategy, which, in addition to reflecting those price returns, would also reflect any dividends paid on the index constituent stocks. The return on the
                Buffered PLUS will not include such a total return feature or dividend component.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 6pt;" class="DSPFListTable" id="zbdb8f0d3a9324ec1a841692330f7d4f0">

          <tr>
            <td style="width: 18pt; vertical-align: top; color: rgb(79, 129, 189); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><font style="font-weight: bold;">Changes affecting the underlying index could have an adverse effect on the market value of, and any amount payable on, the Buffered PLUS.</font> The policies of the index sponsor as specified under
                &#8220;Information About the Underlying Index&#8221; (the &#8220;index sponsor&#8221;), concerning additions, deletions and substitutions of the index constituent stocks and the manner in which the index sponsor takes account of certain changes affecting those
                index constituent stocks may adversely affect the value of the underlying index. The policies of the index sponsor with respect to the calculation of the underlying index could also adversely affect the value of the underlying index. The
                index sponsor may discontinue or suspend calculation or dissemination of the underlying index. Any such actions could have an adverse effect on the market value of, and any amount payable on, the Buffered PLUS.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 6pt;" class="DSPFListTable" id="z31d8f6bf6fa24235afa398f73ad88b7b">

          <tr>
            <td style="width: 18pt; vertical-align: top; color: rgb(79, 129, 189); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><font style="font-weight: bold;">There is no affiliation between the index sponsor and TD, and TD is not responsible for any disclosure by such index sponsor.</font> We or our affiliates may currently, or from time to time engage in
                business with the index sponsor. However, we and our affiliates are not affiliated with the index sponsor and have no ability to control or predict its actions. You, as an investor in the Buffered PLUS, should conduct your own independent
                investigation of the index sponsor and the underlying index. The index sponsor is not involved in the Buffered PLUS offered hereby in any way and has no obligation of any sort with respect to your Buffered PLUS. The index sponsor has no
                obligation to take your interests into consideration for any reason, including when taking any actions that might affect the value of, and any amounts payable on, your Buffered PLUS.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: center; margin-left: 18pt; margin-top: 6pt; font-style: italic; font-weight: bold;">Risks Relating to Estimated Value and Liquidity</div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 6pt;" class="DSPFListTable" id="z5b9c5f213b084f948442e0f36fae3cb4">

          <tr>
            <td style="width: 18pt; vertical-align: top; color: rgb(79, 129, 189); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><font style="font-weight: bold;">The estimated value of your Buffered PLUS is expected to be less than the public offering price of your Buffered PLUS.</font> The estimated value of your Buffered PLUS on the pricing date is expected to
                be less than the public offering price of your Buffered PLUS. The difference between the public offering price of your Buffered PLUS and the estimated value of the Buffered PLUS reflects costs and expected profits associated with selling
                and structuring the Buffered PLUS, as well as hedging our obligations under the Buffered PLUS. Because hedging our obligations entails risks and may be influenced by market forces beyond our control, this hedging may result in a profit that
                is more or less than expected, or a loss.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 6pt;" class="DSPFListTable" id="zbe51bdf7fd874c418239b12fe60fcb4c">

          <tr>
            <td style="width: 18pt; vertical-align: top; color: rgb(79, 129, 189); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><font style="font-weight: bold;">The estimated value of your Buffered PLUS is based on our internal funding rate. </font>The estimated value of your Buffered PLUS on the pricing date is determined by reference to our internal funding
                rate. The internal funding rate used in the determination of the estimated value of the Buffered PLUS generally represents a discount from the credit spreads for our conventional, fixed-rate debt Buffered PLUS and the borrowing rate we
                would pay for our conventional, fixed-rate debt Buffered PLUS. This discount is based on, among other things, our view of the funding value of the Buffered PLUS as well as the higher issuance, operational and ongoing liability management
                costs of the Buffered PLUS in comparison to those costs for our conventional, fixed-rate debt, as well as estimated financing costs of any hedge positions, taking into account regulatory and internal requirements. If the interest rate
                implied by the credit spreads for our conventional, fixed-rate debt Buffered PLUS, or the borrowing rate we would pay for our conventional, fixed-rate debt Buffered PLUS were to be used, we would expect the economic terms of the Buffered
                PLUS to be more favorable to you. Additionally, assuming all other economic terms are held constant, the use of an internal funding rate for the Buffered PLUS is expected to increase the estimated value of the Buffered PLUS at any time.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 65.08%; vertical-align: top;">
                  <div style="color: rgb(41, 109, 193); font-size: 8pt;">November 2025</div>
                </td>
                <td style="width: 34.79%; vertical-align: top;">
                  <div style="text-align: right; color: rgb(41, 109, 193); font-size: 8pt;">Page <font class="BRPFPageNumber">8</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 100%; vertical-align: top;">
                  <div style="text-align: right;">
                    <div><img width="57" height="48" src="image0.jpg"></div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="border-bottom: 1px solid #296DC1; border-top: 1px solid #296DC1; vertical-align: top; width: 100%;">
                  <div style="color: rgb(41, 109, 193);">Buffered PLUS Based on the Value of the S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index due June 5, 2028</div>
                  <div style="color: rgb(128, 128, 128); font-size: 8pt; font-weight: bold;">Buffered Performance Leveraged Upside Securities<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup></div>
                  <div style="color: rgb(128, 128, 128); font-size: 7pt;">Principal at Risk Securities</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 6pt;" class="DSPFListTable" id="z54409749eb3c45ad8123d379fdf66f81">

          <tr>
            <td style="width: 18pt; vertical-align: top; color: rgb(79, 129, 189); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><font style="font-weight: bold;">The estimated value of the Buffered PLUS is based on our internal pricing models, which may prove to be inaccurate and may be different from the pricing models of other financial institutions.</font> The
                estimated value of your Buffered PLUS on the pricing date is based on our internal pricing models when the terms of the Buffered PLUS are set, which take into account a number of variables, such as our internal funding rate on the pricing
                date, and are based on a number of subjective assumptions, which are not evaluated or verified on an independent basis and may or may not materialize. Further, our pricing models may be different from other financial institutions&#8217; pricing
                models and the methodologies used by us to estimate the value of the Buffered PLUS may not be consistent with those of other financial institutions that may be purchasers or sellers of Buffered PLUS in the secondary market. As a result, the
                secondary market price of your Buffered PLUS may be materially less than the estimated value of the Buffered PLUS determined by reference to our internal pricing models. In addition, market conditions and other relevant factors in the
                future may change, and any assumptions may prove to be incorrect.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 6pt;" class="DSPFListTable" id="z8a630235f3d740cba6ae52dff5800b64">

          <tr>
            <td style="width: 18pt; vertical-align: top; color: rgb(79, 129, 189); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><font style="font-weight: bold;">The estimated value of your Buffered PLUS is not a prediction of the prices at which you may sell your Buffered PLUS in the secondary market, if any, and such secondary market prices, if any, will likely
                  be less than the public offering price of your Buffered PLUS and may be less than the estimated value of your Buffered PLUS. </font>The estimated value of the Buffered PLUS is not a prediction of the prices at which the agent, other
                affiliates of ours or third parties may be willing to purchase the Buffered PLUS from you in secondary market transactions (if they are willing to purchase, which they are not obligated to do). The price at which you may be able to sell
                your Buffered PLUS in the secondary market at any time, if any, will be influenced by many factors that cannot be predicted, such as market conditions, and any bid and ask spread for similar sized trades, and may be substantially less than
                the estimated value of the Buffered PLUS. Further, as secondary market prices of your Buffered PLUS take into account the levels at which our debt Buffered PLUS trade in the secondary market, and do not take into account our various costs
                and expected profits associated with selling and structuring the Buffered PLUS, as well as hedging our obligations under the Buffered PLUS, secondary market prices of your Buffered PLUS will likely be less than the public offering price of
                your Buffered PLUS. As a result, the price at which the agent, other affiliates of ours or third parties may be willing to purchase the Buffered PLUS from you in secondary market transactions, if any, will likely be less than the price you
                paid for your Buffered PLUS, and any sale prior to the maturity date could result in a substantial loss to you.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 6pt;" class="DSPFListTable" id="z94cc7bdff55d4baaa9bce05fddbbb6c9">

          <tr>
            <td style="width: 18pt; vertical-align: top; color: rgb(79, 129, 189); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><font style="font-weight: bold;">The temporary price at which the agent may initially buy the Buffered PLUS in the secondary market may not be indicative of future prices of your Buffered PLUS.</font> Assuming that all relevant factors
                remain constant after the pricing date, the price at which the agent may initially buy or sell the Buffered PLUS in the secondary market (if the agent makes a market in the Buffered PLUS, which it is not obligated to do) may exceed the
                estimated value of the Buffered PLUS on the pricing date, as well as the secondary market value of the Buffered PLUS, for a temporary period after the original issue date of the Buffered PLUS, as discussed further under &#8220;Additional
                Information About the Buffered PLUS &#8212; Additional information regarding the estimated value of the Buffered PLUS&#8221;. The price at which the agent may initially buy or sell the Buffered PLUS in the secondary market may not be indicative of
                future prices of your Buffered PLUS.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 6pt;" class="DSPFListTable" id="zd3d8947b878940e187d45210d9284e1f">

          <tr>
            <td style="width: 18pt; vertical-align: top; color: rgb(79, 129, 189); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><font style="font-weight: bold;">The underwriting discount, offering expenses and certain hedging costs are likely to adversely affect secondary market prices.</font> Assuming no changes in market conditions or any other relevant
                factors, the price, if any, at which you may be able to sell the Buffered PLUS will likely be less than the public offering price. The public offering price includes, and any price quoted to you is likely to exclude, any underwriting
                discount paid in connection with the initial distribution, offering expenses as well as the cost of hedging our obligations under the Buffered PLUS. In addition, any such price is also likely to reflect dealer discounts, mark-ups and other
                transaction costs, such as a discount to account for costs associated with establishing or unwinding any related hedge transaction.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 6pt;" class="DSPFListTable" id="zf68fbce2d7cb46829b618d2e5969a835">

          <tr>
            <td style="width: 18pt; vertical-align: top; color: rgb(79, 129, 189); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><font style="font-weight: bold;">There may not be an active trading market for the Buffered PLUS &#8212; sales in the secondary market may result in significant losses.</font> There may be little or no secondary market for the Buffered PLUS.
                The Buffered PLUS will not be listed or displayed on any Buffered PLUS exchange or electronic communications network. The agent or another one of our affiliates may make a market for the Buffered PLUS; however, it is not required to do so
                and may stop any market-making activities at any time. Even if a secondary market for the Buffered PLUS develops, it may not provide significant liquidity or trade at prices advantageous to you. We expect that transaction costs in any
                secondary market would be high. As a result, the difference between bid and ask prices for your Buffered PLUS in any secondary market could be substantial. If you sell your Buffered PLUS before the maturity date, you may have to do so at a
                substantial discount from the public offering price irrespective of the price of the underlying index, and as a result, you may suffer substantial losses.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 65.08%; vertical-align: top;">
                  <div style="color: rgb(41, 109, 193); font-size: 8pt;">November 2025</div>
                </td>
                <td style="width: 34.79%; vertical-align: top;">
                  <div style="text-align: right; color: rgb(41, 109, 193); font-size: 8pt;">Page <font class="BRPFPageNumber">9</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 100%; vertical-align: top;">
                  <div style="text-align: right;">
                    <div><img width="57" height="48" src="image0.jpg"></div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="border-bottom: 1px solid #296DC1; border-top: 1px solid #296DC1; vertical-align: top; width: 100%;">
                  <div style="color: rgb(41, 109, 193);">Buffered PLUS Based on the Value of the S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index due June 5, 2028</div>
                  <div style="color: rgb(128, 128, 128); font-size: 8pt; font-weight: bold;">Buffered Performance Leveraged Upside Securities<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup></div>
                  <div style="color: rgb(128, 128, 128); font-size: 7pt;">Principal at Risk Securities</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 6pt;" class="DSPFListTable" id="z659d240363dc46649ee6c3d591eedf33">

          <tr>
            <td style="width: 18pt; vertical-align: top; color: rgb(79, 129, 189); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><font style="font-weight: bold;">If the value of the underlying index changes, the market value of your Buffered PLUS may not change in the same manner.</font> Your Buffered PLUS may trade quite differently from the performance of the
                underlying index. Changes in the value of the underlying index may not result in a comparable change in the market value of your Buffered PLUS. Even if the closing value of the underlying index increases to greater than the initial index
                value during the term of the Buffered PLUS, the market value of your Buffered PLUS may not increase by the same amount and could decline.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: center; margin-left: 18pt; margin-top: 6pt; font-style: italic; font-weight: bold;">Risks Relating to General Credit Characteristics</div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 6pt;" class="DSPFListTable" id="z8377d57141c8451486b6f7fa49072ab7">

          <tr>
            <td style="width: 18pt; vertical-align: top; color: rgb(79, 129, 189); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><font style="font-weight: bold;">Investors are subject to TD&#8217;s credit risk, and TD&#8217;s credit ratings and credit spreads may adversely affect the market value of the Buffered PLUS. </font>Although the return on the Buffered PLUS will be
                based on the performance of the underlying index, the payment of any amount due on the Buffered PLUS is subject to TD&#8217;s credit risk. The Buffered PLUS are TD&#8217;s senior unsecured debt obligations. Investors are dependent on TD&#8217;s ability to
                pay all amounts due on the Buffered PLUS and, therefore, investors are subject to the credit risk of TD and to changes in the market&#8217;s view of TD&#8217;s creditworthiness. Any decrease in TD&#8217;s credit ratings or increase in the credit spreads
                charged by the market for taking TD&#8217;s credit risk is likely to adversely affect the market value of the Buffered PLUS. If TD becomes unable to meet its financial obligations as they become due, investors may not receive any amounts due
                under the terms of the Buffered PLUS.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: center; margin-left: 18pt; margin-top: 6pt; font-style: italic; font-weight: bold;">Risks Relating to Hedging Activities and Conflicts of Interest</div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 6pt;" class="DSPFListTable" id="z5fcb7456f6bb4f60810e558311a48d62">

          <tr>
            <td style="width: 18pt; vertical-align: top; color: rgb(79, 129, 189); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><font style="font-weight: bold;">There are potential conflicts of interest between you and the calculation agent.</font> The calculation agent will, among other things, determine the amount payable on the Buffered PLUS. We will serve as
                the calculation agent and may appoint a different calculation agent after the original issue date without notice to you. The calculation agent will exercise its judgment when performing its functions and may have a conflict of interest if
                it needs to make certain decisions. For example, the calculation agent may have to determine whether a market disruption event affecting the underlying index has occurred, and make certain adjustments if certain events occur, which may, in
                turn, depend on the calculation agent&#8217;s judgment as to whether the event has materially interfered with our ability or the ability of one of our affiliates to unwind our hedge positions. Because this determination by the calculation agent
                may affect the return on the Buffered PLUS, the calculation agent may have a conflict of interest if it needs to make a determination of this kind. For additional information on the calculation agent&#8217;s role, see &#8220;General Terms of the Notes
                &#8212; Role of Calculation Agent&#8221; in the product supplement.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 6pt;" class="DSPFListTable" id="z89afb36743f440bca8d98bd418e5f41f">

          <tr>
            <td style="width: 18pt; vertical-align: top; color: rgb(79, 129, 189); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><font style="font-weight: bold;">The valuation date, and therefore the maturity date, are subject to market disruption events and postponements.</font> The valuation date, and therefore the maturity date, are subject to postponement as
                described in the product supplement due to the occurrence of one or more market disruption events. For a description of what constitutes a market disruption event as well as the consequences of that market disruption event, see &#8220;General
                Terms of the Notes&#8212;Market Disruption Events&#8221; in the product supplement.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 6pt;" class="DSPFListTable" id="z9bd9557377af4bac96d4b190d40949c0">

          <tr>
            <td style="width: 18pt; vertical-align: top; color: rgb(79, 129, 189); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><font style="font-weight: bold;">Trading and business activities by TD or its affiliates may adversely affect the market value of, and return on, the Buffered PLUS.</font> We, the agent and/or our other affiliates may hedge our
                obligations under the Buffered PLUS by purchasing securities, futures, options or other derivative instruments with returns linked or related to changes in the value of the underlying index or one or more index constituent stocks, and we
                may adjust these hedges by, among other things, purchasing or selling at any time any of the foregoing assets. It is possible that we or one or more of our affiliates could receive substantial returns from these hedging activities while the
                market value of the Buffered PLUS declines. We or one or more of our affiliates may also issue or underwrite other securities or financial or derivative instruments with returns linked or related to changes in the underlying index or one or
                more index constituent stocks.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-left: 18pt; margin-top: 6pt;">These trading activities may present a conflict between the holders&#8217; interest in the Buffered PLUS and the interests we and our affiliates will have in our or their proprietary
        accounts, in facilitating transactions, including options and other derivatives transactions, for our or their customers&#8217; accounts and in accounts under our or their management. These trading activities could be adverse to the interests of the
        holders of the Buffered PLUS.</div>
      <div style="text-align: justify; margin-left: 18pt; margin-top: 6pt;">We, the agent and/or our other affiliates may, at present or in the future, engage in business with one or more underlying index Constituent Issuers, including making loans to or
        providing advisory services to those companies. These services could include investment banking and merger and acquisition advisory services. These business activities may present a conflict between our, the agent&#8217;s and/or our other affiliates&#8217;
        obligations, and your interests as a holder of the Buffered PLUS. Moreover, we, the agent and/or our other affiliates may have published, and in the future expect to publish, research reports with respect to the underlying index or one or more
        index constituent stocks. This research is modified from time to time without notice and may express opinions or provide recommendations that are inconsistent with purchasing or holding the Buffered PLUS. Any of these activities by us and/or our
        other affiliates may affect the value of the underlying index and, therefore, the market value of, and return on, the Buffered PLUS.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 65.08%; vertical-align: top;">
                  <div style="color: rgb(41, 109, 193); font-size: 8pt;">November 2025</div>
                </td>
                <td style="width: 34.79%; vertical-align: top;">
                  <div style="text-align: right; color: rgb(41, 109, 193); font-size: 8pt;">Page <font class="BRPFPageNumber">10</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 100%; vertical-align: top;">
                  <div style="text-align: right;">
                    <div><img width="57" height="48" src="image0.jpg"></div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="border-bottom: 1px solid #296DC1; border-top: 1px solid #296DC1; vertical-align: top; width: 100%;">
                  <div style="color: rgb(41, 109, 193);">Buffered PLUS Based on the Value of the S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index due June 5, 2028</div>
                  <div style="color: rgb(128, 128, 128); font-size: 8pt; font-weight: bold;">Buffered Performance Leveraged Upside Securities<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup></div>
                  <div style="color: rgb(128, 128, 128); font-size: 7pt;">Principal at Risk Securities</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: center; margin-left: 18pt; margin-top: 6pt; font-style: italic; font-weight: bold;">Risks Relating to Canadian and U.S. Federal Income Taxation</div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 6pt;" class="DSPFListTable" id="z8199143413544f29af1e338ea29a5a6c">

          <tr>
            <td style="width: 18pt; vertical-align: top; color: rgb(79, 129, 189); font-size: 5pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><font style="font-weight: bold;">Significant aspects of the tax treatment of the Buffered PLUS are uncertain. </font>Significant aspects of the U.S. tax treatment of the Buffered PLUS are uncertain. You should read carefully the section
                entitled &#8220;Material U.S. federal income tax consequences&#8221; herein and in the product supplement. You should consult your tax advisor as to the tax consequences of your investment in the Buffered PLUS.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-left: 18pt; margin-top: 6pt;">For a discussion of the Canadian federal income tax consequences of investing in the Buffered PLUS, please see the discussion in the prospectus under &#8220;Tax Consequences &#8211; Canadian
        Taxation&#8221; and in the product supplement under &#8220;Supplemental Discussion of Canadian Tax Consequences&#8221; and the further discussion herein under &#8220;Additional Information About the Buffered PLUS&#8221;. If you are not a Non-resident Holder (as that term is
        defined in the prospectus) for Canadian federal income tax purposes or if you acquire the Buffered PLUS in the secondary market, you should consult your tax advisors as to the consequences of acquiring, holding and disposing of the Buffered PLUS
        and receiving the payment that might be due under the Buffered PLUS.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 65.08%; vertical-align: top;">
                  <div style="color: rgb(41, 109, 193); font-size: 8pt;">November 2025</div>
                </td>
                <td style="width: 34.79%; vertical-align: top;">
                  <div style="text-align: right; color: rgb(41, 109, 193); font-size: 8pt;">Page <font class="BRPFPageNumber">11</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 100%; vertical-align: top;">
                  <div style="text-align: right;">
                    <div><img width="57" height="48" src="image0.jpg"></div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="border-bottom: 1px solid #296DC1; border-top: 1px solid #296DC1; vertical-align: top; width: 100%;">
                  <div style="color: rgb(41, 109, 193);">Buffered PLUS Based on the Value of the S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index due June 5, 2028</div>
                  <div style="color: rgb(128, 128, 128); font-size: 8pt; font-weight: bold;">Buffered Performance Leveraged Upside Securities<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup></div>
                  <div style="color: rgb(128, 128, 128); font-size: 7pt;">Principal at Risk Securities</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="color: #0070C0; font-size: 14pt; text-align: justify;">Information About the Underlying Index</div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 12pt; font-weight: bold;">All disclosures contained in this document regarding the underlying index are derived from publicly available information. TD has not conducted any independent
        review or due diligence of any publicly available information with respect to the underlying index. You should make your own investigation into the underlying index.</div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 12pt; color: rgb(41, 109, 193); font-weight: bold;">S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index</div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt;">We have derived all information regarding the S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index (&#8220;SPX&#8221;) contained in this document, including, without limitation, its make up, method of calculation
        and changes in its components, from publicly available information. Such information reflects the policies of, and is subject to change by S&amp;P Dow Jones Indices LLC (its &#8220;Index Sponsor&#8221; or &#8220;S&amp;P Dow Jones&#8221;).</div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt;">SPX is published by S&amp;P Dow Jones, but S&amp;P Dow Jones has no obligation to continue to publish SPX, and may discontinue publication of SPX at any time. SPX is determined,
        comprised and calculated by S&amp;P Dow Jones without regard to this instrument.</div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt;">As discussed more fully in the underlier supplement under the heading &#8220;Indices &#8212; S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index&#8221;, SPX is intended to provide an indication of the pattern of common
        stock price movement. The calculation of the value of SPX is based on the relative value of the aggregate market value of the common stock of 500 companies as of a particular time compared to the aggregate average market value of the common stocks
        of 500 similar companies during the base period of the years 1941 through 1943. Select information regarding top constituents and industry and/or sector weightings may be made available by the Index Sponsor on its website.</div>
      <div style="margin-top: 6pt; margin-bottom: 6pt; font-weight: bold;">Information as of market close on November 11, 2025:</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zab8c4bc34b3d4b29bc72cc367f7aea46">

          <tr>
            <td style="width: 38.64%; vertical-align: bottom;">
              <div style="margin-top: 3pt; color: rgb(41, 109, 193); font-weight: bold;">Bloomberg Ticker Symbol:</div>
            </td>
            <td style="width: 14.18%; vertical-align: bottom;">
              <div style="margin-top: 3pt;">SPX &lt;Index&gt;</div>
            </td>
            <td style="width: 36.77%; vertical-align: bottom;">
              <div style="margin-top: 3pt; color: rgb(41, 109, 193); font-weight: bold;">52 Week High (on October 28, 2025):</div>
            </td>
            <td style="width: 10.41%; vertical-align: bottom;">
              <div style="margin-top: 3pt;">6,890.89</div>
            </td>
          </tr>
          <tr>
            <td style="width: 38.64%; vertical-align: bottom;">
              <div style="margin-top: 3pt; color: rgb(41, 109, 193); font-weight: bold;">Current Index Value:</div>
            </td>
            <td style="width: 14.18%; vertical-align: bottom;">
              <div style="margin-top: 3pt;">6,846.61</div>
            </td>
            <td style="width: 36.77%; vertical-align: bottom;">
              <div style="margin-top: 3pt; color: rgb(41, 109, 193); font-weight: bold;">52 Week Low (on April 8, 2025):</div>
            </td>
            <td style="width: 10.41%; vertical-align: bottom;">
              <div style="margin-top: 3pt;">4,982.77</div>
            </td>
          </tr>
          <tr>
            <td style="width: 38.64%; vertical-align: bottom;">
              <div style="margin-top: 3pt; color: rgb(41, 109, 193); font-weight: bold;">52 Weeks Ago (on November 11, 2024):</div>
            </td>
            <td style="width: 14.18%; vertical-align: bottom;">
              <div style="margin-top: 3pt;">6,001.35</div>
            </td>
            <td style="width: 36.77%; vertical-align: bottom;">&#160;</td>
            <td style="width: 10.41%; vertical-align: bottom;">&#160;</td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 65.08%; vertical-align: top;">
                  <div style="color: rgb(41, 109, 193); font-size: 8pt;">November 2025</div>
                </td>
                <td style="width: 34.79%; vertical-align: top;">
                  <div style="text-align: right; color: rgb(41, 109, 193); font-size: 8pt;">Page <font class="BRPFPageNumber">12</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 100%; vertical-align: top;">
                  <div style="text-align: right;">
                    <div><img width="57" height="48" src="image0.jpg"></div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="border-bottom: 1px solid #296DC1; border-top: 1px solid #296DC1; vertical-align: top; width: 100%;">
                  <div style="color: rgb(41, 109, 193);">Buffered PLUS Based on the Value of the S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index due June 5, 2028</div>
                  <div style="color: rgb(128, 128, 128); font-size: 8pt; font-weight: bold;">Buffered Performance Leveraged Upside Securities<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup></div>
                  <div style="color: rgb(128, 128, 128); font-size: 7pt;">Principal at Risk Securities</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="color: #0070C0; font-size: 14pt; text-align: justify;">Historical Information</div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 10pt;">The table below sets forth the published high and low index closing values, as well as the end-of-quarter index closing values, of the underlying index for the specified period.
        The index closing value of the underlying index on November 11, 2025 was 6,846.61. The graph below sets forth the index closing values of the underlying index for each day from January 1, 2020 through November 11, 2025. We obtained the information
        in the table below from Bloomberg Professional<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> service (&#8220;Bloomberg&#8221;), without independent verification. TD has not undertaken an independent review or due diligence of any publicly available information obtained from Bloomberg. <font style="font-style: italic;">The historical performance of the underlying index should not be taken as an indication of its future performance, and no assurance can be given as to the index closing value of the underlying index at any time,
          including the valuation date.</font></div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z39b4cfc24b3f44ef8def41ca03c3c7c2">

          <tr>
            <td style="background-color: #296DC1; vertical-align: top; width: 1%;" colspan="1">&#160;</td>
            <td style="background-color: rgb(41, 109, 193); border-right: 1px solid rgb(255, 255, 255); vertical-align: top; width: 42%;">
              <div style="color: rgb(255, 255, 255); font-weight: bold;">S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index</div>
            </td>
            <td style="background-color: rgb(41, 109, 193); border-left: 1px solid rgb(255, 255, 255); border-right: 1px solid rgb(255, 255, 255); vertical-align: top; width: 18.66%;">
              <div style="text-align: center; color: rgb(255, 255, 255); font-weight: bold;">High</div>
            </td>
            <td style="background-color: rgb(41, 109, 193); border-left: 1px solid rgb(255, 255, 255); border-right: 1px solid rgb(255, 255, 255); vertical-align: top; width: 18.66%;">
              <div style="text-align: center; color: rgb(255, 255, 255); font-weight: bold;">Low</div>
            </td>
            <td style="background-color: rgb(41, 109, 193); border-left: 1px double rgb(255, 255, 255); vertical-align: top; width: 18.66%;">
              <div style="text-align: center; color: rgb(255, 255, 255); font-weight: bold;">Period End</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; background-color: rgb(217, 231, 247);" colspan="1">&#160;</td>
            <td style="width: 42%; vertical-align: top; background-color: rgb(217, 231, 247);">
              <div style="margin-top: 3pt; color: rgb(41, 109, 193); font-weight: bold;">2020</div>
            </td>
            <td style="width: 18.66%; vertical-align: middle; background-color: #D9E7F7;">&#160;</td>
            <td style="width: 18.66%; vertical-align: middle; background-color: #D9E7F7;">&#160;</td>
            <td style="width: 18.66%; vertical-align: middle; background-color: #D9E7F7;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 42%; vertical-align: top;">
              <div style="margin-left: 18pt; margin-top: 3pt;">First Quarter</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">3,386.15</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">2,237.40</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">2,584.59</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 42%; vertical-align: top;">
              <div style="margin-left: 18pt; margin-top: 3pt;">Second Quarter</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">3,232.39</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">2,470.50</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">3,100.29</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 42%; vertical-align: top;">
              <div style="margin-left: 18pt; margin-top: 3pt;">Third Quarter</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">3,580.84</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">3,115.86</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">3,363.00</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 42%; vertical-align: top;">
              <div style="margin-left: 18pt; margin-top: 3pt;">Fourth Quarter</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">3,756.07</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">3,269.96</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">3,756.07</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; background-color: rgb(217, 231, 247);" colspan="1">&#160;</td>
            <td style="width: 42%; vertical-align: top; background-color: rgb(217, 231, 247);">
              <div style="margin-top: 3pt; color: rgb(41, 109, 193); font-weight: bold;">2021</div>
            </td>
            <td style="width: 18.66%; vertical-align: middle; background-color: #DEEAF6;">&#160;</td>
            <td style="width: 18.66%; vertical-align: middle; background-color: #DEEAF6;">&#160;</td>
            <td style="width: 18.66%; vertical-align: middle; background-color: #DEEAF6;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 42%; vertical-align: top;">
              <div style="margin-left: 18pt; margin-top: 3pt;">First Quarter</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">3,974.54</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">3,700.65</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">3,972.89</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 42%; vertical-align: top;">
              <div style="margin-left: 18pt; margin-top: 3pt;">Second Quarter</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">4,297.50</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">4,019.87</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">4,297.50</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 42%; vertical-align: top;">
              <div style="margin-left: 18pt; margin-top: 3pt;">Third Quarter</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">4,536.95</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">4,258.49</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">4,307.54</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 42%; vertical-align: top;">
              <div style="margin-left: 18pt; margin-top: 3pt;">Fourth Quarter</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">4,793.06</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">4,300.46</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">4,766.18</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; background-color: rgb(222, 234, 246);" colspan="1">&#160;</td>
            <td style="width: 42%; vertical-align: top; background-color: rgb(222, 234, 246);">
              <div style="margin-top: 3pt; color: rgb(41, 109, 193); font-weight: bold;">2022</div>
            </td>
            <td style="width: 18.66%; vertical-align: middle; background-color: #DEEAF6;">&#160;</td>
            <td style="width: 18.66%; vertical-align: middle; background-color: #DEEAF6;">&#160;</td>
            <td style="width: 18.66%; vertical-align: middle; background-color: #DEEAF6;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 42%; vertical-align: top;">
              <div style="margin-left: 18pt; margin-top: 3pt;">First Quarter</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">4,796.56</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">4,170.70</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">4,530.41</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 42%; vertical-align: top;">
              <div style="margin-left: 18pt; margin-top: 3pt;">Second Quarter</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">4,582.64</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">3,666.77</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">3,785.38</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 42%; vertical-align: top;">
              <div style="margin-left: 18pt; margin-top: 3pt;">Third Quarter</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">4,305.20</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">3,585.62</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">3,585.62</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 42%; vertical-align: top;">
              <div style="margin-left: 18pt; margin-top: 3pt;">Fourth Quarter</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">4,080.11</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">3,577.03</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">3,839.50</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; background-color: rgb(222, 234, 246);" colspan="1">&#160;</td>
            <td style="width: 42%; vertical-align: top; background-color: rgb(222, 234, 246);">
              <div style="margin-top: 3pt; color: rgb(41, 109, 193); font-weight: bold;">2023</div>
            </td>
            <td style="width: 18.66%; vertical-align: middle; background-color: #DEEAF6;">&#160;</td>
            <td style="width: 18.66%; vertical-align: middle; background-color: #DEEAF6;">&#160;</td>
            <td style="width: 18.66%; vertical-align: middle; background-color: #DEEAF6;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 42%; vertical-align: top;">
              <div style="margin-left: 18pt; margin-top: 3pt;">First Quarter</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">4,179.76</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">3,808.10</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">4,109.31</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 42%; vertical-align: top;">
              <div style="margin-left: 18pt; margin-top: 3pt;">Second Quarter</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">4,450.38</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">4,055.99</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">4,450.38</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 42%; vertical-align: top;">
              <div style="margin-left: 18pt; margin-top: 3pt;">Third Quarter</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">4,588.96</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">4,273.53</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">4,288.05</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 42%; vertical-align: top;">
              <div style="margin-left: 18pt; margin-top: 3pt;">Fourth Quarter</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">4,783.35</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">4,117.37</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">4,769.83</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; background-color: rgb(222, 234, 246);" colspan="1">&#160;</td>
            <td style="width: 42%; vertical-align: top; background-color: rgb(222, 234, 246);">
              <div style="margin-top: 3pt; color: rgb(41, 109, 193); font-weight: bold;">2024</div>
            </td>
            <td style="width: 18.66%; vertical-align: middle; background-color: #DEEAF6;">&#160;</td>
            <td style="width: 18.66%; vertical-align: middle; background-color: #DEEAF6;">&#160;</td>
            <td style="width: 18.66%; vertical-align: middle; background-color: #DEEAF6;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 42%; vertical-align: top;">
              <div style="margin-left: 18pt; margin-top: 3pt;">First Quarter</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">5,254.35</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">4,688.68</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">5,254.35</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 42%; vertical-align: top;">
              <div style="margin-left: 18pt; margin-top: 3pt;">Second Quarter</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">5,487.03</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">4,967.23</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">5,460.48</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 42%; vertical-align: top;">
              <div style="margin-left: 18pt; margin-top: 3pt;">Third Quarter</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">5,762.48</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">5,186.33</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">5,762.48</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 42%; vertical-align: top;">
              <div style="margin-left: 18pt; margin-top: 3pt;">Fourth Quarter</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">6,090.27</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">5,695.94</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">5,881.63</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; background-color: rgb(222, 234, 246);" colspan="1">&#160;</td>
            <td style="width: 42%; vertical-align: top; background-color: rgb(222, 234, 246);">
              <div style="margin-top: 3pt; color: rgb(41, 109, 193); font-weight: bold;">2025</div>
            </td>
            <td style="width: 18.66%; vertical-align: middle; background-color: #DEEAF6;">&#160;</td>
            <td style="width: 18.66%; vertical-align: middle; background-color: #DEEAF6;">&#160;</td>
            <td style="width: 18.66%; vertical-align: middle; background-color: #DEEAF6;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="width: 42%; vertical-align: bottom;">
              <div style="margin-left: 18pt; margin-top: 3pt;">First Quarter</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">6,144.15</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">5,521.52</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">5,611.85</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="width: 42%; vertical-align: bottom;">
              <div style="margin-left: 18pt; margin-top: 3pt;">Second Quarter</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">6,204.95</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">4,982.77</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">6,204.95</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="width: 42%; vertical-align: bottom;">
              <div style="margin-left: 18pt; margin-top: 3pt;">Third Quarter</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">6,693.75</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">6,198.01</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">6,688.46</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="width: 42%; vertical-align: bottom;">
              <div style="margin-left: 18pt; margin-top: 3pt;">Fourth Quarter (through November 11, 2025)</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">6,890.89</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">6,552.51</div>
            </td>
            <td style="width: 18.66%; vertical-align: bottom;">
              <div style="text-align: center;">6,846.61</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 65.08%; vertical-align: top;">
                  <div style="color: rgb(41, 109, 193); font-size: 8pt;">November 2025</div>
                </td>
                <td style="width: 34.79%; vertical-align: top;">
                  <div style="text-align: right; color: rgb(41, 109, 193); font-size: 8pt;">Page <font class="BRPFPageNumber">13</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 100%; vertical-align: top;">
                  <div style="text-align: right;">
                    <div><img width="57" height="48" src="image0.jpg"></div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="border-bottom: 1px solid #296DC1; border-top: 1px solid #296DC1; vertical-align: top; width: 100%;">
                  <div style="color: rgb(41, 109, 193);">Buffered PLUS Based on the Value of the S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index due June 5, 2028</div>
                  <div style="color: rgb(128, 128, 128); font-size: 8pt; font-weight: bold;">Buffered Performance Leveraged Upside Securities<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup></div>
                  <div style="color: rgb(128, 128, 128); font-size: 7pt;">Principal at Risk Securities</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" align="center" style="border-collapse: collapse; width: 95%; color: #000000; font-family: Arial; font-size: 9pt; text-align: left;" id="zb5eaa88046904d549846c47537a5fd48">

          <tr>
            <td style="width: 95%; vertical-align: middle; background-color: rgb(220, 235, 244);">
              <div style="text-align: center; margin-top: 1.5pt; margin-bottom: 1.5pt; color: rgb(41, 109, 193); font-size: 8.5pt; font-weight: bold;">S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index &#8211; Daily Index Closing Values</div>
              <div style="text-align: center; margin-top: 1.5pt; margin-bottom: 1.5pt; color: rgb(41, 109, 193); font-size: 8.5pt; font-weight: bold;">January 1, 2020 to November 11, 2025</div>
            </td>
          </tr>

      </table>
      <div style="text-align: center;">
        <div><img width="523" height="323" src="image1.jpg"></div>
      </div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">This document relates only to the Buffered PLUS offered hereby and does not relate to the underlying index or other Buffered PLUS linked to the underlying index. We have derived
        all disclosures contained in this document regarding the underlying index from the publicly available documents described in the preceding paragraphs. In connection with the offering of the Buffered PLUS, none of us or any of our affiliates have
        participated in the preparation of such documents or made any due diligence inquiry with respect to the underlying index.</div>
      <div style="text-align: justify; margin-top: 10pt; font-weight: bold;">Neither the issuer nor any of its affiliates makes any representation to you as to the performance of the underlying index.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 65.08%; vertical-align: top;">
                  <div style="color: rgb(41, 109, 193); font-size: 8pt;">November 2025</div>
                </td>
                <td style="width: 34.79%; vertical-align: top;">
                  <div style="text-align: right; color: rgb(41, 109, 193); font-size: 8pt;">Page <font class="BRPFPageNumber">14</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 100%; vertical-align: top;">
                  <div style="text-align: right;">
                    <div><img width="57" height="48" src="image0.jpg"></div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="border-bottom: 1px solid #296DC1; border-top: 1px solid #296DC1; vertical-align: top; width: 100%;">
                  <div style="color: rgb(41, 109, 193);">Buffered PLUS Based on the Value of the S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index due June 5, 2028</div>
                  <div style="color: rgb(128, 128, 128); font-size: 8pt; font-weight: bold;">Buffered Performance Leveraged Upside Securities<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup></div>
                  <div style="color: rgb(128, 128, 128); font-size: 7pt;">Principal at Risk Securities</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="margin-top: 10pt; color: rgb(0, 112, 192); font-size: 14pt;">Additional Information About the Buffered PLUS</div>
      <div style="text-align: justify; margin-top: 3pt;">Please read this information in conjunction with the summary terms on the front cover of this document.</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z912ff6148d9542958bddd54940688fdf">

          <tr>
            <td rowspan="1" style="background-color: #0070C0; vertical-align: top; width: 1%;" colspan="1">&#160;</td>
            <td rowspan="1" style="background-color: rgb(0, 112, 192); vertical-align: top; width: 27%;">
              <div style="margin-top: 6pt; color: rgb(255, 255, 255); font-weight: bold;">Additional Provisions:</div>
            </td>
            <td rowspan="1" colspan="1" style="background-color: #0070C0; vertical-align: top; width: 1%;"><br>
            </td>
            <td rowspan="1" style="background-color: rgb(0, 112, 192); vertical-align: top; width: 71%;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 27%; vertical-align: top;">
              <div style="margin-top: 6pt; color: rgb(0, 112, 192); font-size: 8pt; font-weight: bold;">Trustee:</div>
            </td>
            <td colspan="1" style="vertical-align: top; width: 1%;">&#160;</td>
            <td style="vertical-align: top; width: 71%;">
              <div style="text-align: justify; margin-top: 6pt; font-size: 8pt;">The Bank of New York</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; background-color: rgb(217, 226, 243);" colspan="1">&#160;</td>
            <td style="width: 27%; vertical-align: top; background-color: rgb(217, 226, 243);">
              <div style="margin-top: 6pt; color: rgb(0, 112, 192); font-size: 8pt; font-weight: bold;">Calculation agent:</div>
            </td>
            <td colspan="1" style="vertical-align: top; background-color: rgb(217, 226, 243); width: 1%;">&#160;</td>
            <td style="vertical-align: top; background-color: rgb(217, 226, 243); width: 71%;">
              <div style="text-align: justify; margin-top: 6pt; font-size: 8pt;">TD</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 27%; vertical-align: top;">
              <div style="margin-top: 6pt; color: rgb(0, 112, 192); font-size: 8pt; font-weight: bold;">Trading day:</div>
            </td>
            <td colspan="1" style="vertical-align: top; width: 1%;">&#160;</td>
            <td style="vertical-align: top; width: 71%;">
              <div style="text-align: justify; margin-top: 6pt; font-size: 8pt;">As specified in the product supplement under &#8220;General Terms of the Notes &#8212; Special Calculation Provisions &#8212; Trading Day&#8221;.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; background-color: rgb(217, 226, 243);" colspan="1">&#160;</td>
            <td style="width: 27%; vertical-align: top; background-color: rgb(217, 226, 243);">
              <div style="margin-top: 6pt; color: rgb(0, 112, 192); font-size: 8pt; font-weight: bold;">Business day:</div>
            </td>
            <td colspan="1" style="vertical-align: top; background-color: rgb(217, 226, 243); width: 1%;">&#160;</td>
            <td style="vertical-align: top; background-color: rgb(217, 226, 243); width: 71%;">
              <div style="text-align: justify; margin-right: 21.6pt; margin-top: 6pt; font-size: 8pt;">Any day that is a Monday, Tuesday, Wednesday, Thursday or Friday that is neither a legal holiday nor a day on which banking institutions are authorized
                or required by law to close in New York City.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 27%; vertical-align: top;">
              <div style="margin-top: 6pt; color: rgb(0, 112, 192); font-size: 8pt; font-weight: bold;">Canadian bail-in:</div>
            </td>
            <td colspan="1" style="vertical-align: top; width: 1%;">&#160;</td>
            <td style="vertical-align: top; width: 71%;">
              <div style="text-align: justify; margin-top: 6pt; font-size: 8pt;">The Buffered PLUS are not bail-inable debt securities (as defined in the prospectus) under the Canada Deposit Insurance Corporation Act.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; background-color: rgb(217, 226, 243);" colspan="1">&#160;</td>
            <td style="width: 27%; vertical-align: top; background-color: rgb(217, 226, 243);">
              <div style="margin-top: 3pt; color: rgb(0, 112, 192); font-size: 8pt; font-weight: bold;">Change in law event:</div>
            </td>
            <td colspan="1" style="vertical-align: top; background-color: rgb(217, 226, 243); width: 1%;">&#160;</td>
            <td style="vertical-align: top; background-color: rgb(217, 226, 243); width: 71%;">
              <div style="text-align: justify; margin-top: 6pt; font-size: 8pt;">Not applicable, notwithstanding anything to the contrary in the product supplement</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td rowspan="12" style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td rowspan="12" style="width: 27%; vertical-align: top;">
              <div style="margin-top: 6pt; color: rgb(0, 112, 192); font-size: 8pt; font-weight: bold;">Terms incorporated:</div>
            </td>
            <td colspan="1" style="vertical-align: top; width: 1%;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">
              <div style="text-align: justify; margin-top: 6pt; font-size: 8pt;">All of the terms appearing above the item under the caption &#8220;General Terms of the Notes&#8221; in the accompanying product supplement, as modified by this document, and for purposes
                of the foregoing, the terms used herein mean the corresponding terms as defined in the accompanying product supplement, as specified below:</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: middle;" colspan="1">&#160;</td>
            <td style="width: 35%; vertical-align: middle;">
              <div style="text-align: center; margin-top: 3pt; font-size: 8pt; font-style: italic;"><u>Term used herein</u></div>
            </td>
            <td style="width: 36%; vertical-align: middle;">
              <div style="text-align: center; margin-top: 3pt; font-size: 8pt; font-style: italic;"><u>Corresponding term in the</u></div>
              <div style="font-size: 8pt; font-style: italic; text-align: center;"><u> accompanying product supplement</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 35%; vertical-align: top;">
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;">underlying index</div>
            </td>
            <td style="width: 36%; vertical-align: top;">
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;">reference asset</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 35%; vertical-align: top;">
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;">index constituent stocks</div>
            </td>
            <td style="width: 36%; vertical-align: top;">
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;">reference asset constituents</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 35%; vertical-align: top;">
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;">stated principal amount</div>
            </td>
            <td style="width: 36%; vertical-align: top;">
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;">principal amount</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 35%; vertical-align: top;">
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;">original issue date</div>
            </td>
            <td style="width: 36%; vertical-align: top;">
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;">issue date</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 35%; vertical-align: top;">
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;">valuation date</div>
            </td>
            <td style="width: 36%; vertical-align: top;">
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;">final valuation date</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 35%; vertical-align: top;">
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;">index closing value</div>
            </td>
            <td style="width: 36%; vertical-align: top;">
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;">closing level</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 35%; vertical-align: top;">
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;">initial index value</div>
            </td>
            <td style="width: 36%; vertical-align: top;">
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;">initial level</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 35%; vertical-align: top;">
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;">final index value</div>
            </td>
            <td style="width: 36%; vertical-align: top;">
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;">final level</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 35%; vertical-align: top;">
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;">buffer amount</div>
            </td>
            <td style="width: 36%; vertical-align: top;">
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;">buffer percentage</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 35%; vertical-align: top;">
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;">underlying return</div>
            </td>
            <td style="width: 36%; vertical-align: top;">
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;">percentage change</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 1%; vertical-align: top; background-color: rgb(222, 234, 246);" colspan="1">&#160;</td>
            <td style="width: 27%; vertical-align: top; background-color: rgb(222, 234, 246);">
              <div style="margin-top: 6pt; color: rgb(0, 112, 192); font-size: 8pt; font-weight: bold;">Additional information regarding the </div>
              <div style="color: #0070C0; font-size: 8pt; font-weight: bold;">estimated value of the Buffered PLUS:</div>
            </td>
            <td colspan="1" style="vertical-align: top; background-color: rgb(222, 234, 246); width: 1%;">&#160;</td>
            <td style="vertical-align: top; background-color: rgb(222, 234, 246); width: 71%;">
              <div style="text-align: justify; margin-top: 6pt; font-size: 8pt;">The final terms for the Buffered PLUS will be determined on the date the Buffered PLUS are initially priced for sale to the public, which we refer to as the pricing date,
                based on prevailing market conditions, and will be communicated to investors in the final pricing supplement.</div>
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;">The economic terms of the Buffered PLUS are based on our internal funding rate (which is our internal borrowing rate based on variables such as market benchmarks and our
                appetite for borrowing), and several factors, including any sales commissions expected to be paid to TDS or another affiliate of ours, any selling concessions, discounts, commissions or fees expected to be allowed or paid to non-affiliated
                intermediaries, the estimated profit that we or any of our affiliates expect to earn in connection with structuring the Buffered PLUS, estimated costs which we may incur in connection with the Buffered PLUS and the estimated cost which we
                may incur in hedging our obligations under the Buffered PLUS. Because our internal funding rate generally represents a discount from the levels at which our benchmark debt Buffered PLUS trade in the secondary market, the use of an internal
                funding rate for the Buffered PLUS rather than the levels at which our benchmark debt Buffered PLUS trade in the secondary market is expected to have an adverse effect on the economic terms of the Buffered PLUS.</div>
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;">On the cover page of this pricing supplement, we have provided the estimated value range for the Buffered PLUS. The estimated value range was determined by reference to our
                internal pricing models which take into account a number of variables and are based on a number of assumptions, which may or may not materialize, typically including volatility, interest rates (forecasted, current and historical rates),
                price-sensitivity analysis, time to maturity of the Buffered PLUS and our internal funding rate. For more information about the estimated value, see &#8220;Risk Factors &#8212; Risks Relating to Estimated Value and Liquidity&#8221; herein. Because our
                internal funding rate generally represents a discount from the levels at which our benchmark debt Buffered PLUS trade in the secondary market, the use of an internal funding rate for</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 65.08%; vertical-align: top;">
                  <div style="color: rgb(41, 109, 193); font-size: 8pt;">November 2025</div>
                </td>
                <td style="width: 34.79%; vertical-align: top;">
                  <div style="text-align: right; color: rgb(41, 109, 193); font-size: 8pt;">Page <font class="BRPFPageNumber">15</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 100%; vertical-align: top;">
                  <div style="text-align: right;">
                    <div><img width="57" height="48" src="image0.jpg"></div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="border-bottom: 1px solid #296DC1; border-top: 1px solid #296DC1; vertical-align: top; width: 100%;">
                  <div style="color: rgb(41, 109, 193);">Buffered PLUS Based on the Value of the S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index due June 5, 2028</div>
                  <div style="color: rgb(128, 128, 128); font-size: 8pt; font-weight: bold;">Buffered Performance Leveraged Upside Securities<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup></div>
                  <div style="color: rgb(128, 128, 128); font-size: 7pt;">Principal at Risk Securities</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td rowspan="1" style="width: 1%; vertical-align: top; background-color: rgb(222, 234, 246);" colspan="1">&#160;</td>
            <td rowspan="1" style="width: 27%; vertical-align: top; background-color: rgb(222, 234, 246);">&#160;</td>
            <td rowspan="1" colspan="1" style="vertical-align: top; background-color: rgb(222, 234, 246); width: 1%;">&#160;</td>
            <td rowspan="1" style="vertical-align: top; background-color: rgb(222, 234, 246); width: 71%;">
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;"> the Buffered PLUS rather than the levels at which our benchmark debt Buffered PLUS trade in the secondary market is expected, assuming all other economic terms are held
                constant, to increase the estimated value of the Buffered PLUS. For more information see the discussion under &#8220;Risk Factors &#8212; Risks Relating to Estimated Value and Liquidity &#8212; The estimated value of your Buffered PLUS is based on our
                internal funding rate&#8221;.</div>
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;">Our estimated value on the pricing date is not a prediction of the price at which the Buffered PLUS may trade in the secondary market, nor will it be the price at which the
                agent may buy or sell the Buffered PLUS in the secondary market. Subject to normal market and funding conditions, the agent or another affiliate of ours intends to offer to purchase the Buffered PLUS in the secondary market but it is not
                obligated to do so.</div>
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;">Assuming that all relevant factors remain constant after the pricing date, the price at which the agent may initially buy or sell the Buffered PLUS in the secondary market, if
                any, may exceed our estimated value on the pricing date for a temporary period expected to be approximately 6 weeks after the original issue date because, in our discretion, we may elect to effectively reimburse to investors a portion of
                the estimated cost of hedging our obligations under the Buffered PLUS and other costs in connection with the Buffered PLUS which we will no longer expect to incur over the term of the Buffered PLUS. We made such discretionary election and
                determined this temporary reimbursement period on the basis of a number of factors, including the tenor of the Buffered PLUS and any agreement we may have with the distributors of the Buffered PLUS. The amount of our estimated costs which
                we effectively reimburse to investors in this way may not be allocated ratably throughout the reimbursement period, and we may discontinue such reimbursement at any time or revise the duration of the reimbursement period after the original
                issue date of the Buffered PLUS based on changes in market conditions and other factors that cannot be predicted.</div>
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt; font-weight: bold;">We urge you to read the &#8220;Risk Factors&#8221; in this pricing supplement for additional information.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 27%; vertical-align: top;">
              <div style="margin-top: 6pt; color: rgb(0, 112, 192); font-size: 8pt; font-weight: bold;">Material Canadian income tax </div>
              <div style="color: #0070C0; font-size: 8pt; font-weight: bold;">consequences:</div>
            </td>
            <td colspan="1" style="vertical-align: top; width: 1%;">&#160;</td>
            <td style="vertical-align: top; width: 71%;">
              <div style="margin: 6pt 0px 0px; font-size: 8pt; text-align: justify;">Please see the discussion in the prospectus under &#8220;Tax Consequences &#8211; Canadian Taxation&#8221; and in the product supplement under &#8220;Supplemental Discussion of Canadian Tax
                Consequences&#8221;, which applies to the Buffered PLUS. We will not pay any additional amounts as a result of any withholding required by reason of the rules governing hybrid mismatch arrangements contained in section 18.4 of the Canadian Tax
                Act (as defined in the prospectus).</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; background-color: rgb(222, 234, 246);" colspan="1">&#160;</td>
            <td style="width: 27%; vertical-align: top; background-color: rgb(222, 234, 246);">
              <div style="margin: 6pt 0px 0px; color: #0070C0; font-size: 8pt; font-weight: bold;">Material U.S. federal income tax </div>
              <div style="color: #0070C0; font-size: 8pt; font-weight: bold;">consequences:</div>
            </td>
            <td colspan="1" style="vertical-align: top; background-color: rgb(222, 234, 246); width: 1%;">&#160;</td>
            <td style="vertical-align: top; background-color: rgb(222, 234, 246); width: 71%;">
              <div style="margin: 6pt 0px 0px; font-size: 8pt; text-align: justify;"><font style="font-weight: bold;">The U.S. federal income tax consequences of your investment in the Buffered PLUS are uncertain. There are no statutory provisions,
                  regulations, published rulings or judicial decisions addressing the characterization for U.S. federal income tax purposes of securities with terms that are substantially the same as the Buffered PLUS. Some of these tax consequences are
                  summarized below, but we urge you to read the more detailed discussion in &#8220;Material U.S. Federal Income Tax Consequences&#8221;, in the accompanying product supplement and to discuss the tax consequences of your particular situation with your
                  tax advisor.</font>&#160;<font style="font-weight: bold;">This discussion is based upon the U.S. Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), final, temporary and proposed U.S. Department of the Treasury (the &#8220;Treasury&#8221;)
                  regulations, rulings and decisions, in each case, as available and in effect as of the date hereof, all of which are subject to change, possibly with retroactive effect. Tax consequences under state, local and non-U.S. laws are not
                  addressed herein. No ruling from the U.S. Internal Revenue Service (the &#8220;IRS&#8221;) has been sought as to the U.S. federal income tax consequences of your investment in the Buffered PLUS, and the following discussion is not binding on the IRS.</font></div>
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;"><font style="font-style: italic;">U.S. Tax Treatment. </font>Pursuant to the terms of the Buffered PLUS, TD and you agree, in the absence of a statutory or regulatory change
                or an administrative determination or judicial ruling to the contrary, to characterize your Buffered PLUS as prepaid derivative contracts with respect to the underlying index. If your Buffered PLUS are so treated, you should generally
                recognize long-term capital gain or loss if you hold your Buffered PLUS for more than one year (and, otherwise, short-term capital gain or loss) upon the taxable disposition (including cash settlement) of your Buffered PLUS, in an amount
                equal to the difference between the amount you receive at such time and the amount you paid for your Buffered PLUS. The deductibility of capital losses is subject to limitations.</div>
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt; font-weight: bold;">Based on certain factual representations received from us, our special U.S. tax counsel, Fried, Frank, Harris, Shriver &amp; Jacobson LLP, is of the opinion
                that it would be reasonable to treat your Buffered PLUS in the manner described above. However, because there is no authority that specifically addresses the tax treatment of the Buffered PLUS, it is possible that your Buffered PLUS could <br>
              </div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 65.08%; vertical-align: top;">
                  <div style="color: rgb(41, 109, 193); font-size: 8pt;">November 2025</div>
                </td>
                <td style="width: 34.79%; vertical-align: top;">
                  <div style="text-align: right; color: rgb(41, 109, 193); font-size: 8pt;">Page <font class="BRPFPageNumber">16</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 100%; vertical-align: top;">
                  <div style="text-align: right;">
                    <div><img width="57" height="48" src="image0.jpg"></div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="border-bottom: 1px solid #296DC1; border-top: 1px solid #296DC1; vertical-align: top; width: 100%;">
                  <div style="color: rgb(41, 109, 193);">Buffered PLUS Based on the Value of the S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index due June 5, 2028</div>
                  <div style="color: rgb(128, 128, 128); font-size: 8pt; font-weight: bold;">Buffered Performance Leveraged Upside Securities<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup></div>
                  <div style="color: rgb(128, 128, 128); font-size: 7pt;">Principal at Risk Securities</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td rowspan="1" style="width: 1%; vertical-align: top; background-color: rgb(222, 234, 246);" colspan="1">&#160;</td>
            <td rowspan="1" style="width: 27%; vertical-align: top; background-color: rgb(222, 234, 246);">&#160;</td>
            <td rowspan="1" colspan="1" style="vertical-align: top; background-color: rgb(222, 234, 246); width: 1%;">&#160;</td>
            <td rowspan="1" style="vertical-align: top; background-color: rgb(222, 234, 246); width: 71%;">
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt; font-weight: bold;">alternatively be treated for tax purposes as a single contingent payment debt instrument, or pursuant to some other characterization, such that the timing
                and character of your income from the Buffered PLUS could differ materially and adversely from the treatment described above, as described further under &#8220;Material U.S. Federal Income Tax Consequences&#8221;, in the accompanying product
                supplement.</div>
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;">Except to the extent otherwise required by law, TD intends to treat your Buffered PLUS for U.S. federal income tax purposes in accordance with the treatment described above
                and under &#8220;Material U.S. Federal Income Tax Consequences&#8221; in the accompanying product supplement, unless and until such time as the Treasury and the IRS determine that some other treatment is more appropriate.</div>
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;"><font style="font-style: italic;">Notice 2008-2. </font>In 2007, the IRS released a notice that may affect the taxation of holders of the Buffered PLUS. According to Notice
                2008-2, the IRS and the Treasury are considering whether a holder of an instrument such as the Buffered PLUS should be required to accrue ordinary income on a current basis. It is not possible to determine what guidance they will ultimately
                issue, if any. It is possible, however, that under such guidance, holders of the Buffered PLUS will ultimately be required to accrue income currently and this could be applied on a retroactive basis. According to the Notice, the IRS and the
                Treasury are also considering other relevant issues, including whether additional gain or loss from such instruments should be treated as ordinary or capital, whether non-U.S. holders of such instruments should be subject to withholding tax
                on any deemed income accruals, and whether the special &#8220;constructive ownership rules&#8221; of Section 1260 of the Code should be applied to such instruments. Both U.S. and non-U.S. holders are urged to consult their tax advisors concerning the
                significance, and the potential impact, of the above considerations.</div>
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;"><font style="font-style: italic;">Medicare Tax on Net Investment Income</font>. U.S. holders that are individuals, estates or certain trusts are subject to an additional 3.8%
                tax on all or a portion of their &#8220;net investment income,&#8221; or &#8220;undistributed net investment income&#8221; in the case of an estate or trust, which may include any income or gain realized with respect to the Buffered PLUS, to the extent of their
                net investment income or undistributed net investment income (as the case may be) that, when added to their other modified adjusted gross income, exceeds $200,000 for an unmarried individual, $250,000 for a married taxpayer filing a joint
                return (or a surviving spouse), $125,000 for a married individual filing a separate return or the dollar amount at which the highest tax bracket begins for an estate or trust. The 3.8% Medicare tax is determined in a different manner than
                the regular income tax. U.S. holders should consult their tax advisors as to the consequences of the 3.8% Medicare tax.</div>
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;"><font style="font-style: italic;">Specified Foreign Financial Assets. </font>Certain U.S. holders that own &#8220;specified foreign financial assets&#8221; in excess of an applicable
                threshold may be subject to reporting obligations with respect to such assets with their tax returns, especially if such assets are held outside the custody of a U.S. financial institution. U.S. holders are urged to consult their tax
                advisors as to the application of this legislation to their ownership of the Buffered PLUS.</div>
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;"><font style="font-style: italic;">Non-U.S. Holders. </font>Subject to Section 871(m) of the Code and &#8220;FATCA&#8221;, discussed below, if the Buffered PLUS are offered to non-U.S.
                holders, you should generally not be subject to U.S. withholding tax with respect to payments on your Buffered PLUS or to generally applicable information reporting and backup withholding requirements with respect to payments on your
                Buffered PLUS if you comply with certain certification and identification requirements as to your non-U.S. status (by providing us (and/or the applicable withholding agent) with a fully completed and duly executed applicable IRS Form W-8).
                Subject to Section 897 of the Code and Section 871(m) of the Code, discussed below, gain realized from the taxable disposition of a Buffered PLUS generally should not be subject to U.S. tax unless (i) such gain is effectively connected with
                a trade or business conducted by you in the U.S., (ii) you are a non-resident alien individual and are present in the U.S. for 183 days or more during the taxable year of such taxable disposition and certain other conditions are satisfied
                or (iii) you have certain other present or former connections with the U.S.</div>
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;"><font style="font-style: italic;">Section 897</font>. We will not attempt to ascertain whether any index constituent stock issuer would be treated as a &#8220;United States real
                property holding corporation&#8221; (&#8220;USRPHC&#8221;) within the meaning of Section 897 of the Code. We also have not attempted to determine whether the Buffered PLUS should be treated as &#8220;United States real property interests&#8221; (&#8220;USRPI&#8221;) as defined in
                Section 897 of the Code. If any such entity and/or the Buffered PLUS were so treated, certain adverse U.S. federal income tax consequences could possibly apply, including subjecting any gain to a non-U.S. holder in respect of a Buffered
                PLUS upon a taxable disposition of the Buffered PLUS to the U.S. federal income tax on a net basis, and the proceeds from such a taxable disposition to a 15% withholding tax. Non-U.S. holders should consult their tax advisors regarding the
                potential treatment of any index constituent stock</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 65.08%; vertical-align: top;">
                  <div style="color: rgb(41, 109, 193); font-size: 8pt;">November 2025</div>
                </td>
                <td style="width: 34.79%; vertical-align: top;">
                  <div style="text-align: right; color: rgb(41, 109, 193); font-size: 8pt;">Page <font class="BRPFPageNumber">17</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 100%; vertical-align: top;">
                  <div style="text-align: right;">
                    <div><img width="57" height="48" src="image0.jpg"></div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="border-bottom: 1px solid #296DC1; border-top: 1px solid #296DC1; vertical-align: top; width: 100%;">
                  <div style="color: rgb(41, 109, 193);">Buffered PLUS Based on the Value of the S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index due June 5, 2028</div>
                  <div style="color: rgb(128, 128, 128); font-size: 8pt; font-weight: bold;">Buffered Performance Leveraged Upside Securities<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup></div>
                  <div style="color: rgb(128, 128, 128); font-size: 7pt;">Principal at Risk Securities</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td rowspan="1" style="width: 1%; vertical-align: top; background-color: rgb(222, 234, 246);" colspan="1">&#160;</td>
            <td rowspan="1" style="width: 27%; vertical-align: top; background-color: rgb(222, 234, 246);">&#160;</td>
            <td rowspan="1" colspan="1" style="vertical-align: top; background-color: rgb(222, 234, 246); width: 1%;">&#160;</td>
            <td rowspan="1" style="vertical-align: top; background-color: rgb(222, 234, 246); width: 71%;">
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;"> issuer as a USRPHC and/or the Buffered PLUS as USRPI.</div>
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;"><font style="font-style: italic;">Section 871(m)</font>. A 30% withholding tax (which may be reduced by an applicable income tax treaty) is imposed under Section 871(m) of the
                Code on certain &#8220;dividend equivalents&#8221; paid or deemed paid to a non-U.S. holder with respect to a &#8220;specified equity-linked instrument&#8221; that references one or more dividend-paying U.S. equity securities or indices containing U.S. equity
                securities. The withholding tax can apply even if the instrument does not provide for payments that reference dividends. Treasury regulations provide that the withholding tax applies to all dividend equivalents paid or deemed paid on
                specified equity-linked instruments that have a delta of one (&#8220;delta-one specified equity-linked instruments&#8221;) issued after 2016 and to all dividend equivalents paid or deemed paid on all other specified equity-linked instruments issued
                after 2017. However, the IRS has issued guidance that states that the Treasury and the IRS intend to amend the effective dates of the Treasury regulations to provide that withholding on dividend equivalents paid or deemed paid will not
                apply to specified equity-linked instruments that are not delta-one specified equity-linked instruments and are issued before January 1, 2027.</div>
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;">Based on the nature of the underlying index and our determination that the Buffered PLUS are not &#8220;delta-one&#8221; with respect to the underlying index or any index constituent
                stocks, our special U.S. tax counsel is of the opinion that the Buffered PLUS should not be delta-one specified equity-linked instruments and thus should not be subject to withholding on dividend equivalents. Our determination is not
                binding on the IRS, and the IRS may disagree with this determination. Furthermore, the application of Section 871(m) of the Code will depend on our determinations on the date the terms of the Buffered PLUS are set. If withholding is
                required, we will not make payments of any additional amounts.</div>
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;">Nevertheless, after the date the terms are set, it is possible that your Buffered PLUS could be deemed to be reissued for tax purposes upon the occurrence of certain events
                affecting the underlying index, any index constituent stocks or your Buffered PLUS, and following such occurrence your Buffered PLUS could be treated as delta-one specified equity-linked instruments that are subject to withholding on
                dividend equivalents. It is also possible that withholding tax or other tax under Section 871(m) of the Code could apply to the Buffered PLUS under these rules. If you enter, or have entered, into other transactions in respect of the
                underlying index, any index constituent stocks or the Buffered PLUS should consult your tax advisor regarding the application of Section 871(m) of the Code to your Buffered PLUS in the context of your other transactions.</div>
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt; font-weight: bold;">Because of the uncertainty regarding the application of the 30% withholding tax on dividend equivalents to the Buffered PLUS, you are urged to consult your
                tax advisor regarding the potential application of Section 871(m) of the Code and the 30% withholding tax to an investment in the Buffered PLUS.</div>
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;"><font style="font-style: italic;">FATCA. </font>The Foreign Account Tax Compliance Act (&#8220;FATCA&#8221;) was enacted on March 18, 2010, and imposes a 30% U.S. withholding tax on
                &#8220;withholdable payments&#8221; (i.e., certain U.S.-source payments, including interest (and original issue discount), dividends, other fixed or determinable annual or periodical gain, profits and income, and the gross proceeds from a disposition
                of property of a type which can produce U.S.-source interest or dividends) and &#8220;passthru payments&#8221; (i.e., certain payments attributable to withholdable payments) made to certain foreign financial institutions (and certain of their
                affiliates) unless the payee foreign financial institution agrees (or is required), among other things, to disclose the identity of any U.S. individual with an account at the institution (or the relevant affiliate) and to annually report
                certain information about such account. FATCA also requires withholding agents making withholdable payments to certain foreign entities that do not disclose the name, address, and taxpayer identification number of any substantial U.S.
                owners (or do not certify that they do not have any substantial U.S. owners) to withhold tax at a rate of 30%. Under certain circumstances, a holder may be eligible for refunds or credits of such taxes.</div>
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;">Pursuant to final and temporary Treasury regulations and other IRS guidance, the withholding and reporting requirements under FATCA will generally apply to certain
                &#8220;withholdable payments&#8221;, will not apply to gross proceeds on a sale or disposition, and will apply to certain foreign passthru payments only to the extent that such payments are made after the date that is two years after final regulations
                defining the term &#8220;foreign passthru payment&#8221; are published. If withholding is required, we (or the applicable paying agent) will not be required to pay additional amounts with respect to the amounts so withheld. Foreign financial
                institutions and non-financial foreign entities located in jurisdictions that have an intergovernmental agreement with the U.S. governing FATCA may be subject to different rules.</div>
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;">Investors should consult their tax advisors about the application of FATCA, in</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 65.08%; vertical-align: top;">
                  <div style="color: rgb(41, 109, 193); font-size: 8pt;">November 2025</div>
                </td>
                <td style="width: 34.79%; vertical-align: top;">
                  <div style="text-align: right; color: rgb(41, 109, 193); font-size: 8pt;">Page <font class="BRPFPageNumber">18</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 100%; vertical-align: top;">
                  <div style="text-align: right;">
                    <div><img width="57" height="48" src="image0.jpg"></div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="border-bottom: 1px solid #296DC1; border-top: 1px solid #296DC1; vertical-align: top; width: 100%;">
                  <div style="color: rgb(41, 109, 193);">Buffered PLUS Based on the Value of the S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index due June 5, 2028</div>
                  <div style="color: rgb(128, 128, 128); font-size: 8pt; font-weight: bold;">Buffered Performance Leveraged Upside Securities<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup></div>
                  <div style="color: rgb(128, 128, 128); font-size: 7pt;">Principal at Risk Securities</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td rowspan="1" style="width: 1%; vertical-align: top; background-color: rgb(222, 234, 246);" colspan="1">&#160;</td>
            <td rowspan="1" style="width: 27%; vertical-align: top; background-color: rgb(222, 234, 246);">&#160;</td>
            <td rowspan="1" colspan="1" style="vertical-align: top; background-color: rgb(222, 234, 246); width: 1%;">&#160;</td>
            <td rowspan="1" style="vertical-align: top; background-color: rgb(222, 234, 246); width: 71%;">
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;">particular if they may be classified as financial institutions (or if they hold their Buffered PLUS through a foreign entity) under the FATCA rules.</div>
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;"><font style="font-style: italic;">Backup Withholding and Information Reporting.</font> The proceeds received from a taxable disposition of the Buffered PLUS will be subject to
                information reporting unless you are an &#8220;exempt recipient&#8221; and may also be subject to backup withholding at the rate specified in the Code if you fail to provide certain identifying information (such as an accurate taxpayer number, if you
                are a U.S. holder) or meet certain other conditions.</div>
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;">Amounts withheld under the backup withholding rules are not additional taxes and may be refunded or credited against your U.S. federal income tax liability, provided the
                required information is furnished to the IRS.</div>
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;"><font style="font-style: italic;">U.S. Federal Estate Tax Treatment of Non-U.S. Holders.</font> The Buffered PLUS may be subject to U.S. federal estate tax if an individual
                non-U.S. holder holds the Buffered PLUS at the time of his or her death. The gross estate of a non-U.S. holder domiciled outside the U.S. includes only property situated in the U.S. Individual non-U.S. holders should consult their tax
                advisors regarding the U.S. federal estate tax consequences of holding the Buffered PLUS at death.</div>
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;"><font style="font-style: italic;">Proposed Legislation.</font> In 2007, legislation was introduced in Congress that, if it had been enacted, would have required holders of
                Buffered PLUS purchased after the bill was enacted to accrue interest income over the term of the Buffered PLUS despite the fact that there will be no interest payments over the term of the Buffered PLUS.</div>
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;">Furthermore, in 2013, the House Ways and Means Committee released in draft form certain proposed legislation relating to financial instruments. If it had been enacted, the
                effect of this legislation generally would have been to require instruments such as the Buffered PLUS to be marked to market on an annual basis with all gains and losses to be treated as ordinary, subject to certain exceptions.</div>
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;">It is not possible to predict whether any similar or identical bills will be enacted in the future, or whether any such bill would affect the tax treatment of your Buffered
                PLUS. You are urged to consult your tax advisor regarding the possible changes in law and their possible impact on the tax treatment of your Buffered PLUS.</div>
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt; font-weight: bold;">Both U.S. and non-U.S. holders are urged to consult their tax advisors concerning the application of U.S. federal income tax laws to their particular
                situations, as well as any tax consequences of the purchase, beneficial ownership and disposition of the Buffered PLUS arising under the laws of any state, local, non-U.S. or other taxing jurisdiction (including that of TD).</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 27%; vertical-align: top;">
              <div style="margin-top: 6pt; color: rgb(41, 109, 193); font-size: 8pt; font-weight: bold;">Supplemental information regarding </div>
              <div style="color: #296DC1; font-size: 8pt; font-weight: bold;">plan of distribution (conflicts of</div>
              <div style="color: #296DC1; font-size: 8pt; font-weight: bold;"> interest); secondary markets (if any):</div>
            </td>
            <td colspan="1" style="vertical-align: top; width: 1%;">&#160;</td>
            <td style="vertical-align: top; width: 71%;">
              <div style="margin: 6pt 0px 0px; font-size: 8pt; text-align: justify;">We have appointed TDS, an affiliate of TD, as the agent for the sale of the Buffered PLUS. Pursuant to the terms of a distribution agreement, TDS will purchase the<font style="font-size: 9pt;">&#160;</font>Buffered PLUS from TD at the price to public less a fee of $30.00 per Buffered PLUS. TDS will resell all of the Buffered PLUS to Morgan Stanley Wealth Management with an underwriting discount of $30.00
                reflecting a fixed sales commission of $25.00 and fixed structuring fee of $5.00 per $1,000.00 stated principal amount of Buffered PLUS that Morgan Stanley Wealth Management sells. TD or an affiliate will also pay a fee to LFT Securities,
                LLC, an entity in which TD and an affiliate of Morgan Stanley Wealth Management have an ownership interest, for providing certain electronic platform services with respect to this offering.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 27%; vertical-align: top;"><br>
            </td>
            <td colspan="1" style="vertical-align: top; width: 1%;">&#160;</td>
            <td style="vertical-align: top; width: 71%;">
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;"><font style="font-weight: bold;">Conflicts of Interest</font>&#160;<font style="font-weight: bold;">&#8212; </font>TDS is an affiliate of TD and, as such, has a &#8216;&#8216;conflict of interest&#8217;&#8217;
                in this offering within the meaning of Financial Industry Regulatory Authority, Inc. (&#8220;FINRA&#8221;) Rule 5121. If any other affiliate of TD participates in this offering, that affiliate will also have a &#8220;conflict of interest&#8221; within the meaning
                of FINRA Rule 5121. In addition, TD will receive the net proceeds from the initial public offering of the Buffered PLUS, thus creating an additional conflict of interest within the meaning of FINRA Rule 5121. This offering of the Buffered
                PLUS will be conducted in compliance with the provisions of FINRA Rule 5121. In accordance with FINRA Rule 5121, neither TDS nor any other affiliate of ours is permitted to sell the Buffered PLUS in this offering to an account over which it
                exercises discretionary authority without the prior specific written approval of the account holder.</div>
              <div style="text-align: justify; margin-top: 3pt; font-size: 8pt;">We, TDS, another of our affiliates or third parties may use this pricing supplement in the initial sale of the Buffered PLUS. In addition, we, TDS, another of our affiliates
                or third parties may use this pricing supplement in a market-making transaction in the Buffered PLUS after their initial sale. If a purchaser buys the Buffered PLUS from us, TDS, another of our affiliates or third parties, this pricing
                supplement is being used in a market-making transaction unless we, TDS, another of our affiliates or third parties informs such purchaser otherwise in the confirmation of sale.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 65.08%; vertical-align: top;">
                  <div style="color: rgb(41, 109, 193); font-size: 8pt;">November 2025</div>
                </td>
                <td style="width: 34.79%; vertical-align: top;">
                  <div style="text-align: right; color: rgb(41, 109, 193); font-size: 8pt;">Page <font class="BRPFPageNumber">19</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 100%; vertical-align: top;">
                  <div style="text-align: right;">
                    <div><img width="57" height="48" src="image0.jpg"></div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="border-bottom: 1px solid #296DC1; border-top: 1px solid #296DC1; vertical-align: top; width: 100%;">
                  <div style="color: rgb(41, 109, 193);">Buffered PLUS Based on the Value of the S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index due June 5, 2028</div>
                  <div style="color: rgb(128, 128, 128); font-size: 8pt; font-weight: bold;">Buffered Performance Leveraged Upside Securities<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup></div>
                  <div style="color: rgb(128, 128, 128); font-size: 7pt;">Principal at Risk Securities</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 1%; vertical-align: top; background-color: rgb(222, 234, 246);" colspan="1">&#160;</td>
            <td style="width: 27%; vertical-align: top; background-color: rgb(222, 234, 246);">
              <div style="margin: 6pt 0px 0px; color: #296DC1; font-size: 8pt; font-weight: bold;">Prohibition of sales in Canada and to </div>
              <div style="color: #296DC1; font-size: 8pt; font-weight: bold;">Canadian residents:</div>
            </td>
            <td colspan="1" style="vertical-align: top; background-color: rgb(222, 234, 246); width: 1%;">&#160;</td>
            <td style="vertical-align: top; background-color: rgb(222, 234, 246); width: 71%;">
              <div style="margin: 6pt 0px 0px; font-size: 8pt; text-align: justify;">The Buffered PLUS may not be offered, sold or otherwise made available directly or indirectly in Canada or to any resident of Canada.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 27%; vertical-align: top;">
              <div style="margin: 6pt 0px 0px; color: #296DC1; font-size: 8pt; font-weight: bold;">Prohibition on sales to EEA retail</div>
              <div style="color: #296DC1; font-size: 8pt; font-weight: bold;"> investors:</div>
            </td>
            <td colspan="1" style="vertical-align: top; width: 1%;">&#160;</td>
            <td style="vertical-align: top; width: 71%;">
              <div style="margin: 6pt 0px 0px; font-size: 8pt; text-align: justify;">The Buffered PLUS are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in
                the European Economic Area (the &#8220;EEA&#8221;). For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, &#8220;MiFID II&#8221;); (ii) a
                customer within the meaning of Directive (EU) 2016/97, where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II; or (iii) not a qualified investor as defined in Regulation (EU)
                2017/1129, as amended. Consequently no key information document required by Regulation (EU) No 1286/2014 (the &#8220;PRIIPs Regulation&#8221;), for offering or selling the Buffered PLUS or otherwise making them available to retail investors in the EEA
                has been prepared and therefore offering or selling the Buffered PLUS or otherwise making them available to any retail investor in the EEA may be unlawful under the PRIIPs Regulation.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; background-color: rgb(222, 234, 246);" colspan="1">&#160;</td>
            <td style="width: 27%; vertical-align: top; background-color: rgb(222, 234, 246);">
              <div style="margin: 6pt 0px 0px; color: #0070C0; font-size: 8pt; font-weight: bold;">Prohibition on sales to United Kingdom <br>
                retail investors:</div>
            </td>
            <td colspan="1" style="vertical-align: top; background-color: rgb(222, 234, 246); width: 1%;">&#160;</td>
            <td style="vertical-align: top; background-color: rgb(222, 234, 246); width: 71%;">
              <div style="margin: 6pt 0px 0px; font-size: 8pt; text-align: justify;">The Buffered PLUS are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in
                the United Kingdom ( &#8220;UK&#8221;). For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client, as defined in point (8) of Article 2 of Regulation (EU) No 2017/565 as it forms part of domestic law by virtue of
                the European Union (Withdrawal) Act 2018 (the &#8220;EUWA&#8221;); or (ii) a customer within the meaning of the provisions of the Financial Services and Markets Act 2000 (the &#8220;FSMA&#8221;) and any rules or regulations made under the FSMA to implement
                Directive (EU) 2016/97, where that customer would not qualify as a professional client, as defined in point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the EUWA. Consequently no key
                information document required by Regulation (EU) No 1286/2014 as it forms part of domestic law by virtue of the EUWA (the &#8220;UK PRIIPs Regulation&#8221;) for offering or selling the Buffered PLUS or otherwise making them available to retail
                investors in the UK has been prepared and therefore offering or selling the Buffered PLUS or otherwise making them available to any retail investor in the UK may be unlawful under the UK PRIIPs Regulation.</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div> <br>
      </div>
      <div>
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 65.08%; vertical-align: top;">
                  <div style="color: rgb(41, 109, 193); font-size: 8pt;">November 2025</div>
                </td>
                <td style="width: 34.79%; vertical-align: top;">
                  <div style="text-align: right; color: rgb(41, 109, 193); font-size: 8pt;">Page <font class="BRPFPageNumber">20</font></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="margin-bottom: 10pt;">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !+ %H# 2(  A$! Q$!_\0
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M91^2G_#W'_@H5_T<#_YBCX(__.VIDG_!6[_@H3)&\;?M!.%D1D8Q_"SX*12
M."I*2Q?#A)8W /RR1NDB'#(RL 1\W'BSP A559<!\12J1G[1>T:JTY33YO?I
M5.*YTIQ;^*$X2A):2BUH?GD/%/Z"-/$QQB\#O$"I7A6^L)8APQ%"=53Y_P!]
MAL1XH5L-6IRE\=*K1J49Q;C*G*+<3^RWP5X+\#?"#P'HG@GP7I&E>#/ /@?1
M18Z3IEN_V;3-&TBQ22>>:XNKN5I'8DW%_J>J:A<S7=Y=2W6HZC=3W4]Q</\
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image1.jpg
<TEXT>
begin 644 image1.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" 'M R4# 2(  A$! Q$!_\0
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MG_HY7X ?^'D^'7_S1T?\-8?LL_\ 1ROP _\ #R?#K_YHZ/\ AD_]EG_HVKX
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M?PZ_^9R@ _X:P_99_P"CE?@!_P"'D^'7_P T='_#6'[+/_1ROP _\/)\.O\
MYHZ/^&3_ -EG_HVKX ?^&;^'7_S.4?\ #)_[+/\ T;5\ /\ PS?PZ_\ F<H
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M]'*_ #_P\GPZ_P#FCH_X9/\ V6?^C:O@!_X9OX=?_,Y1_P ,G_LL_P#1M7P
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M>3X=?_-'1_PUA^RS_P!'*_ #_P /)\.O_FCH_P"&3_V6?^C:O@!_X9OX=?\
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M_AK#]EG_ *.5^ '_ (>3X=?_ #1T?\-8?LL_]'*_ #_P\GPZ_P#FCH_X9/\
MV6?^C:O@!_X9OX=?_,Y1_P ,G_LL_P#1M7P _P##-_#K_P"9R@ _X:P_99_Z
M.5^ '_AY/AU_\T='_#6'[+/_ $<K\ /_  \GPZ_^:.C_ (9/_99_Z-J^ '_A
MF_AU_P#,Y1_PR?\ LL_]&U? #_PS?PZ_^9R@ _X:P_99_P"CE?@!_P"'D^'7
M_P T='_#6'[+/_1ROP _\/)\.O\ YHZ/^&3_ -EG_HVKX ?^&;^'7_S.4?\
M#)_[+/\ T;5\ /\ PS?PZ_\ F<H /^&L/V6?^CE?@!_X>3X=?_-'1_PUA^RS
M_P!'*_ #_P /)\.O_FCH_P"&3_V6?^C:O@!_X9OX=?\ S.4?\,G_ ++/_1M7
MP _\,W\.O_F<H /^&L/V6?\ HY7X ?\ AY/AU_\ -'1_PUA^RS_T<K\ /_#R
M?#K_ .:.C_AD_P#99_Z-J^ '_AF_AU_\SE'_  R?^RS_ -&U? #_ ,,W\.O_
M )G* #_AK#]EG_HY7X ?^'D^'7_S1T?\-8?LL_\ 1ROP _\ #R?#K_YHZ/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %> ?M8?\FL_M*_]D ^,G_JNO$=>_P!> ?M8?\FL
M_M*_]D ^,G_JNO$= !^R?_R:S^S5_P!D ^#?_JNO#E%'[)__ ":S^S5_V0#X
M-_\ JNO#E% 'O]%%% !1110 4444 ?D#^RK_ ,IDO^"O/_9O_P#P2P_],?[9
ME?K]7Y _LJ_\IDO^"O/_ &;_ /\ !+#_ -,?[9E?K]0 4444 %%%% !1110
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M_IEE'_#9'[17_2)W]O\ _P##C?\ !++_ .F64 ??]%? '_#9'[17_2)W]O\
M_P##C?\ !++_ .F64?\ #9'[17_2)W]O_P#\.-_P2R_^F64 ??\ 17P!_P -
MD?M%?](G?V__ /PXW_!++_Z991_PV1^T5_TB=_;_ /\ PXW_  2R_P#IEE '
MW_17P!_PV1^T5_TB=_;_ /\ PXW_  2R_P#IEE'_  V1^T5_TB=_;_\ _#C?
M\$LO_IEE 'W_ $5\ ?\ #9'[17_2)W]O_P#\.-_P2R_^F64?\-D?M%?](G?V
M_P#_ ,.-_P $LO\ Z990!]_T5\ ?\-D?M%?](G?V_P#_ ,.-_P $LO\ Z991
M_P -D?M%?](G?V__ /PXW_!++_Z990!]_P!%? '_  V1^T5_TB=_;_\ _#C?
M\$LO_IEE'_#9'[17_2)W]O\ _P##C?\ !++_ .F64 ??]%? '_#9'[17_2)W
M]O\ _P##C?\ !++_ .F64?\ #9'[17_2)W]O_P#\.-_P2R_^F64 ??\ 17P!
M_P -D?M%?](G?V__ /PXW_!++_Z991_PV1^T5_TB=_;_ /\ PXW_  2R_P#I
MEE 'W_17P!_PV1^T5_TB=_;_ /\ PXW_  2R_P#IEE'_  V1^T5_TB=_;_\
M_#C?\$LO_IEE 'W_ $5\ ?\ #9'[17_2)W]O_P#\.-_P2R_^F64?\-D?M%?]
M(G?V_P#_ ,.-_P $LO\ Z990!]_T5\ ?\-D?M%?](G?V_P#_ ,.-_P $LO\
MZ991_P -D?M%?](G?V__ /PXW_!++_Z990!]_P!%? '_  V1^T5_TB=_;_\
M_#C?\$LO_IEE'_#9'[17_2)W]O\ _P##C?\ !++_ .F64 ??]%? '_#9'[17
M_2)W]O\ _P##C?\ !++_ .F64?\ #9'[17_2)W]O_P#\.-_P2R_^F64 ??\
M17P!_P -D?M%?](G?V__ /PXW_!++_Z991_PV1^T5_TB=_;_ /\ PXW_  2R
M_P#IEE 'W_17P!_PV1^T5_TB=_;_ /\ PXW_  2R_P#IEE'_  V1^T5_TB=_
M;_\ _#C?\$LO_IEE 'W_ $5\ ?\ #9'[17_2)W]O_P#\.-_P2R_^F64?\-D?
MM%?](G?V_P#_ ,.-_P $LO\ Z990!]_T5\ ?\-D?M%?](G?V_P#_ ,.-_P $
MLO\ Z991_P -D?M%?](G?V__ /PXW_!++_Z990!]_P!%? '_  V1^T5_TB=_
M;_\ _#C?\$LO_IEE'_#9'[17_2)W]O\ _P##C?\ !++_ .F64 ??]%? '_#9
M'[17_2)W]O\ _P##C?\ !++_ .F64?\ #9'[17_2)W]O_P#\.-_P2R_^F64
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MTB=_;_\ _#C?\$LO_IEE'_#9'[17_2)W]O\ _P##C?\ !++_ .F64 ??]%?
M'_#9'[17_2)W]O\ _P##C?\ !++_ .F64?\ #9'[17_2)W]O_P#\.-_P2R_^
MF64 ??\ 17P!_P -D?M%?](G?V__ /PXW_!++_Z991_PV1^T5_TB=_;_ /\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK\JO\
M@J)_P5M_9_\ ^"5.E?L[ZG\;M&\0^))/V@OBJW@BPTWPS-;1:AX9\#>'XM,G
M^)?Q5NH;J&7^U]*^'R>(O"D=UX?LC%JNLW?B73X+*6)4N)HO7R+(<XXGS7"9
M'D&7XC-,WQ[JQP> PL5*O7=##U<56Y%*48_N\/0K5IMR24*<GT(JU:=&$JE6
M2A3C;FE+97:2OZMI?,_56OXW_P!H_P#X.#+/P3_P4*_X*<_L&_%Y]&U#]FBQ
M^#?Q6\ _!CQ_:KHOAJZ^&7Q'^$?[(_COQ7\8/#&O3W*_;/B+JWQ+^+>GW/PZ
M\%:8NH65]8^)O^$:T72[.Y;6)Q+\:Z__ ,'"/[5OA7X^_M#?MB^/O%L_@']D
M[X\_L<_M<:+_ ,$N_A+J6D ^'_$OC3X9?&OPWX ^#7Q>\:^$[2369+GQ_K'B
M+1/'$7BQ/$U_;P6^F6.OZ+IYM_#!\.W=]['\4/\ @@U\;/C;_P $:/@???'G
M1_"7P[_;D\$?M1?M&?MS_M;>*/B)XI.H^(M9\$_%"Y\;W?Q@T+P[>_"ZW\5>
M$+[X@?$CP+\/?V=O$UMINHBST[3M=\)3:->>(?"3R:M9O_27#WA7PSX?0Q>(
M\9ZF EE/%6#I<,Y7/+\5SYAD>;U*=?-<VSC"1E2A.MB>$,=D^"X?SF6%E4H4
ML9G4\NQ'UBC6E0Q/CU<;6Q3BLOY^>A)UYJ4?=JTTXPA3EKHL1&I*K3YM7&FI
MQLU>/]<_[$/B73_&G[%W[(?C'28[R'2O%G[+_P  ?$NF1:C;&SU"+3]=^%'A
M/5+*._M"SFUO$MKJ-;JV+N8)P\19MN25M_LC6\%G^RC^S%:6L,=O:VO[/7P6
MM[:WA18X8+>#X;^&HH88HU 6..*-52-% 554*  **_ES$2HRKUI8:G.EAY5J
MDJ%*I-5:E.BYR=*G4J*,%4G"'+&4U"*G).2C&]E[2O97=W97:5KOJ[=+L^A:
M***Q&%%%% !1110!^0/[*O\ RF2_X*\_]F__ /!+#_TQ_MF5^OU?D#^RK_RF
M2_X*\_\ 9O\ _P $L/\ TQ_MF5^OU !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MG3^3F/\ 8H^&/_!Q[^T_^V7\;?VC?C9\5Y_V.OV/OCKX@_9&_8G\/_ /Q?\
M#_2O#EYJ_ASPOX4OOV@/BM_PD&J>!_'=MXNM?'NOMX%USPKXATYET[5-"32[
M)[K6-)T33(8OYV/V:?\ @AS_ ,%"OV^?$7Q2_9(^(_Q]U#X<>)_V$_@%^S!X
MJ^''PS^.=E\29/A_X/7]KCP]:?'%/A-<J]O)K7PM\0^"M'\2>,[?Q?%8> O%
M=PGQ \,W/@:6"PT>VCUK2O\ 2,_8\_9B\!?L9_LQ?!#]F/X;V.F6_AOX._#K
MPOX-EU+3=&L-"?Q?XATO2;6#Q5X_UFQTV.*W;Q-X]\1KJ?B[Q+>'S)[[6]8O
MKF>6620N?VOB/*\@\!Z->IPCQ]3XE\1<SIX?#8;,,LRQX&'"N18VE@<[I9M@
ML3B9XQ3QW$.38G+\'&IA:MJ."QV;X2.(JKVO/YU&=7,W:OA71PD&VX3GS>WJ
MQYJ;IR2Y?=I5%*6JUE"G*RTM^)/_  4M_P""*WAW]K[]J#_@D)X4\-_!K0[[
M]B+]ES2OC#\/?VA/#UIXLM?!]KX9^$NC>$_AY?\ P:\(65KI_B7P]X]UFT\3
M:_X2U/PI<W'@IKW4])_M#^U=8N;"SN+G4*_<O]K#_DUG]I7_ +(!\9/_ %77
MB.O?Z\ _:P_Y-9_:5_[(!\9/_5=>(Z_#\\XOSSB+*N&LGS3%2KX+A7"9GA<L
M@YUYRE/.,XQN=9CC<4ZM:K&IC\5B,7##UL13A1]KA,#@*=6$ZE"5:IZ5+#TJ
M,ZU2$;2KRA*>BVITXTX1C9*T8J+:6MI2DUH[(_9/_P"36?V:O^R ?!O_ -5U
MX<HH_9/_ .36?V:O^R ?!O\ ]5UX<HKY@V/?Z*\C\;?$/Q)IWB>R\ _#GPCI
M/C3QO-H3^*]3@\2>+I_!'A3PYX;^WG2[&ZUS7].\+>.M;34O$.H1:C;^&M.T
M[P?J4-^-"U^;4-0T>*PA:]VY_&5]X0^%UQX_^*^GZ)X6U'PUX)F\5_$'2O"7
MB#4/&OA_0KO2=&?5/$>G^&_$VK>%_ FJ>*=.L98+JWTG5M0\'>$[[684@N+C
MP_H\]PUC  >@T5\N6GQ_\6^$O[6NOCY\-M%^&&D2^%?'/C_PAJ/A;X@W?Q&-
MYX2\!V&G:OJFE>.(-0\!?#Y/"/Q-DT;43J47@[PU=?$;P]+%I'B(6?CZ]&EQ
M/?%I\?\ Q;X2_M:Z^/GPVT7X8:1+X5\<^/\ PAJ/A;X@W?Q&-YX2\!V&G:OJ
MFE>.(-0\!?#Y/"/Q-DT;43J47@[PU=?$;P]+%I'B(6?CZ]&EQ/? 'U'17S_X
M$^*OQ%O?%FG^%/BU\+]"^',_C*S\1:W\-[KPU\1+OX@QZCHWAXZ/-/I'CY=0
M\ > (_!?Q'DT[6H]2_X1/PW<?$?PY]ET?Q(]IX]OETF-[[Z H _(']E7_E,E
M_P %>?\ LW__ ()8?^F/]LROU^K\@?V5?^4R7_!7G_LW_P#X)8?^F/\ ;,K]
M?J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **\D^/?QO^'O[-7P4^*O[0'Q8U<Z'\-_@Y
MX"\3_$3QEJ$:PRWHT3PMI5SJMS9:1:3W%JNIZ_JOV=-*\/:+%.EUK>N7NGZ1
M9![R]@C;\./V!O\ @YA_X)Z?MM^(CX \2:CKW[*OQ"MO"7C3QMJ2?'O6/!?A
M_P"%]OH7@R\N+BZ2W^+<WB"QT/\ M0^$(E\7WMIK6FZ#:V-G;:U:0:AJ+:2+
MF]^KR;@?B_B')\TS_(^'LSS7)\EJTZ.:8W X=XB&$J5:52O%3IP;KS4*5-U*
MTZ5*I##QE2=>5/V]'VF%3$T*52%*K5A"I4NX1D[<UFEN]%=NRNU?6U[.W]$5
M%9FBZUH_B31])\1>'=6TS7_#^OZ98:UH6NZ+?VNJ:/K6CZI:Q7VF:MI.IV,L
M]EJ.F:C93P7EA?V<\UK>6LT5Q;RR0R(Y_DU_9O\ ^#N?]ASQ;8?'2Z_:8TCQ
MK\*KOPS\6O&47P,TWP/X"U_Q@_Q!^ \&I>#M*\ :IK]TVJ&+2OBQJ(U?Q3K_
M (IT.:+1O"^G>'_#<BZ=JMUK<UCI6J;\,>'W&7&=#.*_"_#^89W_ &%/+X9G
M1P%%U\50GF=7$4<''ZK&]>?//"8EU'"#5&%&I4JN$8W%6Q>'P[IJM5C3]KS.
M#D[1?(DY>]M]I6[MI(_K=HK^63_@BM_P5L_;=_;I_:[A\'?M(V_P=LOA%^T/
M^PUX\_;<^"_@SX?>$]7T;7?@WI?P]_;/\1?LAVO@35/$FJ7LUYXR_P"$E/A+
M7_&FJ:SJ@O/.\_P[-H1T"TGU+0H_ZFZRXUX,SC@+/*O#V>2P4\?1HTZU5X#$
M/%8>,I2J4:M#VSITKUL+B:&(PM?EBZ3K4)RH5:]"5*M4>'Q%/$TU5I\W*VTN
M96?1IVN])1:DNMGJD[I%%%%?)&X5#<7$%I!/=74T-M:VT,EQ<W-Q(D,%O!"C
M233SS2,L<4,4:M)))(RHB*S,P4$U-7XJ_P#!:/\ ;D^#WPF_X)F?\%%H? ?Q
M.^'OCSXL>%_@5K_PG\1_#SP1\3O"]U\2/A[>_'?Q3X;_ &:E\4Z[H&C:Q<>)
M?#3^!-?^+>F:Q<M?65C-'?65OIPDAO;NW!]WAK(,=Q/GF4Y'@*56=;-<TRS*
MU4ITG4C0GF>.P^ HU:KO&$(*MB(+FJU*4')J+G&]S.M5C1ISJ3:2A"<[-VNH
M1<FEU;LNB;\C^=O7?V\_^"_G_!5;XI_M2_ +_@GI)%I'[)#_ +0WQM\.?#7]
MM+P?X2OO@QH[? ;2_C1X3\(^"H_"7[1M\^E6UQXC\*^#4M_&.IV?PZ>?XU:Q
MX7\2>-KJVTO4KG3?#^G:7]5:7_P07\-> ?\ @L3_ ,$XOA[X+T#]H;5?V*OV
M#?V--%^+?AOXU^*AH]_!XA^.W@K]N+X^_'K0_A;XQ^(.E_#_ $?P-?ZM<^,/
MB[I?B+4?!6E:'X?UV_\ AO:S"SD@6WO-9']._P"PQ^S7IG['O['7[-'[,NG:
M?X6L[OX,_!;X>>"/%5WX-T>WT/0O$OQ!TGPSIT7Q&\<1V-O# 9+_ ,>>.3X@
M\8ZQJ-VKZEJNK:W>ZGJ<]QJ%U<3/]6U^RYSXW5LLQ.8Y-P!D.1\,\,4L+G>5
M8265X;ZOC\WJ8[ SR6CQ/G.*IJFL7FM++I8J6 A&A1H8'^U,="$9^T4H^?3R
MY3C"IBJM6M6;I5)<\KQI\LO:.C3B[\L'/E4M6Y<D=@HHHK^?3U KP#]K#_DU
MG]I7_L@'QD_]5UXCKW^O /VL/^36?VE?^R ?&3_U77B.@ _9/_Y-9_9J_P"R
M ?!O_P!5UX<HH_9/_P"36?V:O^R ?!O_ -5UX<HH ^;/CY\-/@_'^T->^.OV
MAOA%XJ^./PW^)/PY^$WA'P?X8MO@/X__ &DO!7A+XH_!'Q?\7OB=;^*M=\"^
M"O!/Q!M/ _B*2T\2:-<^!_BKXDT/1K/3-?\ #D?AS2O&&G^*-=\.Z1K'7:?H
M6N^+OV6]6_9HUZ\UNQ^-'B3]G?Q;-;>&/%6JZIK?B;PYX=UXZSX<\"Z=X]\=
MP:WXJL;OQ-80S:;X9UG5[KQUKE_XFUC0_$NMV.I:_:V.IZBOW)69%HFC0:S?
M>(X-(TR'Q#J>FZ7HVI:[%86L>LZAH^B76K7NBZ3?:HD0OKO3=(O-?UV[TNQG
MGDM;"ZUK5I[2**74KQY@#X(^*MKJW[6^BWWAGP=X,^)WA"7PM\./C=H&O7OQ
M(\#?$'X3VUM\1/%G@,>!]!\'Z1/XPTCPJGQ!TNYEUS6]0F\?> 9_%WPXBC\/
M0RVGB"]GU31YP?%6UU;]K?1;[PSX.\&?$[PA+X6^''QNT#7KWXD>!OB#\)[:
MV^(GBSP&/ ^@^#](G\8:1X53X@Z7<RZYK>H3>/O ,_B[X<11^'H9;3Q!>SZI
MH\X_0JB@#Y,\.^+9/C;\4?AGK>C^"/BAX4TSX1)X]G\:7?Q$^'OCWX9QVWC'
M5-!L/"EAX1T./QKHGAN#XDV$L6K>(-3/C?P&_C#X<#_A'+=K/Q!=W.JZ+<K]
M">/O#6L^,/!OB'PQX>^(/B_X5:WK6G2V6F_$7P#9> M1\9>$;F1D9=8\/6/Q
M0\$?$CX?7.HPA62*+Q9X%\3Z25D<S:7*XC9.OHH _FR_9J_9<^.&H_\ !6#_
M (*D^%[3_@I!^V?H6M^&O@?_ ,$VKW6?B-I7@;_@GA-XR^(-MXAT?]K-](TG
MQ?8ZY^P7K/P]LM/\"KI=]%X5D\!>!/!&JWB>(]:/C?4_&,L'AZ30?U._X8V_
M:*_Z2Q?M_P#_ (;G_@EE_P#2TZ\ _95_Y3)?\%>?^S?_ /@EA_Z8_P!LROU^
MH ^ /^&-OVBO^DL7[?\ _P"&Y_X)9?\ TM.C_AC;]HK_ *2Q?M__ /AN?^"6
M7_TM.OO^B@#X _X8V_:*_P"DL7[?_P#X;G_@EE_]+3H_X8V_:*_Z2Q?M_P#_
M (;G_@EE_P#2TZ^_Z* /@#_AC;]HK_I+%^W_ /\ AN?^"67_ -+3H_X8V_:*
M_P"DL7[?_P#X;G_@EE_]+3K[_HH ^ /^&-OVBO\ I+%^W_\ ^&Y_X)9?_2TZ
M/^&-OVBO^DL7[?\ _P"&Y_X)9?\ TM.OO^B@#X _X8V_:*_Z2Q?M_P#_ (;G
M_@EE_P#2TZ/^&-OVBO\ I+%^W_\ ^&Y_X)9?_2TZ^_Z* /@#_AC;]HK_ *2Q
M?M__ /AN?^"67_TM.C_AC;]HK_I+%^W_ /\ AN?^"67_ -+3K[_HH ^ /^&-
MOVBO^DL7[?\ _P"&Y_X)9?\ TM.C_AC;]HK_ *2Q?M__ /AN?^"67_TM.OO^
MB@#X _X8V_:*_P"DL7[?_P#X;G_@EE_]+3H_X8V_:*_Z2Q?M_P#_ (;G_@EE
M_P#2TZ^_Z* /@#_AC;]HK_I+%^W_ /\ AN?^"67_ -+3H_X8V_:*_P"DL7[?
M_P#X;G_@EE_]+3K[_HH ^ /^&-OVBO\ I+%^W_\ ^&Y_X)9?_2TZ/^&-OVBO
M^DL7[?\ _P"&Y_X)9?\ TM.OO^B@#X _X8V_:*_Z2Q?M_P#_ (;G_@EE_P#2
MTZ/^&-OVBO\ I+%^W_\ ^&Y_X)9?_2TZ^_Z* /@#_AC;]HK_ *2Q?M__ /AN
M?^"67_TM.C_AC;]HK_I+%^W_ /\ AN?^"67_ -+3K[_HH ^ /^&-OVBO^DL7
M[?\ _P"&Y_X)9?\ TM.C_AC;]HK_ *2Q?M__ /AN?^"67_TM.OO^B@#X _X8
MV_:*_P"DL7[?_P#X;G_@EE_]+3H_X8V_:*_Z2Q?M_P#_ (;G_@EE_P#2TZ^_
MZ* /@#_AC;]HK_I+%^W_ /\ AN?^"67_ -+3H_X8V_:*_P"DL7[?_P#X;G_@
MEE_]+3K[_HH ^ /^&-OVBO\ I+%^W_\ ^&Y_X)9?_2TZ/^&-OVBO^DL7[?\
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MK_I+%^W_ /\ AN?^"67_ -+3K[_HH ^ /^&-OVBO^DL7[?\ _P"&Y_X)9?\
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M+3H_X8V_:*_Z2Q?M_P#_ (;G_@EE_P#2TZ^_Z* /@#_AC;]HK_I+%^W_ /\
MAN?^"67_ -+3H_X8V_:*_P"DL7[?_P#X;G_@EE_]+3K[_HH ^ /^&-OVBO\
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M=2I4G&%.G",ISG.;480A"*<I3E)J,8Q3<FTDFV#=M7HEJV^A\2_\,;?M%?\
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M.4QE*$LTS/ 9=&<8J4H/&XJEAE*,6XJ4HNK=1;2;5FUN=E2?LZ<ZCVA"4_\
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MR@>V? '_  QM^T5_TEB_;_\ _#<_\$LO_I:='_#&W[17_26+]O\ _P##<_\
M!++_ .EIU]_T4 ? '_#&W[17_26+]O\ _P##<_\ !++_ .EIUY!^T)^R?\>?
M#GP#^.'B'6/^"FW[;_CW2-!^$'Q+UG5/ OBSP%_P3<L_"OC33M+\&:U?7WA/
MQ+=^!?\ @GSX+\;6OA_Q';02Z/K-SX.\8^$_%4&G7ES+X>\2Z%JZVFJ6OZO5
MX!^UA_R:S^TK_P!D ^,G_JNO$= !^R?_ ,FL_LU?]D ^#?\ ZKKPY11^R?\
M\FL_LU?]D ^#?_JNO#E% 'O]%%% !1110 4444 ?D#^RK_RF2_X*\_\ 9O\
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MO/B3X/\ "7PK^!WA_P"$.G^ OV<_$UC\/M"U>Y\-7,7ACQ-XDO[;QEJ9\/\
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MXM75+7X_?$K1/BAI47A/QQ\/_"6G^%/A[>?#<6GA3QY8:=I&K:MXVEU'Q_\
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M_P#/&K[_ ** /@#_ (>Q?\$LO^DEG[ '_B9'[.O_ ,\:C_A[%_P2R_Z26?L
M?^)D?LZ__/&K[_HH ^ /^'L7_!++_I)9^P!_XF1^SK_\\:C_ (>Q?\$LO^DE
MG[ '_B9'[.O_ ,\:OO\ HH ^ /\ A[%_P2R_Z26?L ?^)D?LZ_\ SQJ/^'L7
M_!++_I)9^P!_XF1^SK_\\:OO^B@#X _X>Q?\$LO^DEG[ '_B9'[.O_SQJ/\
MA[%_P2R_Z26?L ?^)D?LZ_\ SQJ^_P"B@#X _P"'L7_!++_I)9^P!_XF1^SK
M_P#/&H_X>Q?\$LO^DEG[ '_B9'[.O_SQJ^_Z* /@#_A[%_P2R_Z26?L ?^)D
M?LZ__/&H_P"'L7_!++_I)9^P!_XF1^SK_P#/&K[_ ** /@#_ (>Q?\$LO^DE
MG[ '_B9'[.O_ ,\:C_A[%_P2R_Z26?L ?^)D?LZ__/&K[_HH ^ /^'L7_!++
M_I)9^P!_XF1^SK_\\:C_ (>Q?\$LO^DEG[ '_B9'[.O_ ,\:OO\ HH ^ /\
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M1^SK_P#/&H_X>Q?\$LO^DEG[ '_B9'[.O_SQJ^_Z* /@#_A[%_P2R_Z26?L
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M)9?])+/V /\ Q,C]G7_YXU'_  ]B_P""67_22S]@#_Q,C]G7_P">-7W_ $4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI7B3PAI-OX:T+QS\(]7\06>C2Q-X9BN+C^SM;^''B'6=)T"^O;<K:ZMH6O\
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MZ***^2-PHHHH *_F(_X+%_\ !7K]HKX5_M)?!/\ X)]?\$W8;%_VG?$/QW^
M?PW^.7Q;\;^ )_%'P<^#=_\ M(V]Q:_!+X9>+-2N=*U2ST[Q'\08+^+XC7FI
M1V4\NE>!_#,_]CKK%_>:U::#]C_\%$_^"]W[!'_!/*?XC_#CQ+X]?XL_M4>
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MK_Z4[0!]_P!%? '_  L?_@J;_P!&;_L ?^++/VBO_I3M'_"Q_P#@J;_T9O\
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MK]QXJ\3MK7A[P+X1\:1>+(] M-"TT>)=?TW4)H6\-03ZS_6'_P +'_X*F_\
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M-^ '_!?[5O\ @H/>_P#!.CQ)\:/B!^SA^RU\+;W]DGXV_L^?M-_#7XH? _\
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M&-=)SE3JRI>SY(TZ4HW<.5JHZE2/-9JHXTY/>*<4S^6&'_@GS_P5U_X+=?\
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M?]@#_P 66?M%?_2G:/\ A8__  5-_P"C-_V /_%EG[17_P!*=K\P.T^_Z*^
M/^%C_P#!4W_HS?\ 8 _\66?M%?\ TIVC_A8__!4W_HS?]@#_ ,66?M%?_2G:
M /LS1?AS\/?#?C#QM\0_#O@/P9H'C_XEQ^&(OB/XYT7POHFE^,/B!%X*T^ZT
MGP;'XV\36-C!K7BJ/PEI5]>Z9X837;V_70=/O+JRTH6EM<31O_+'_P $V/\
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MV /_ !99^T5_]*=H_P"%C_\ !4W_ *,W_8 _\66?M%?_ $IV@#[_ **^ /\
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M!G_!1G]OO]JOPC^T#/J/PD^*/B;X[? WQCX>N]4F\-_%CX_?!KQ5\'O%_P
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M4T77="UFRFT[5]&U?3+V*:SU'2]4T^YN++4+&[AEMKNTGEMYXI(I'4_R7_\
M!4S_ ()V_LZ?\$K++]BK_@I/^Q'X$LOV</!_[%_[:&B>.?VGO#WP^37-0U3X
MA_!?]ICQA\*/AE\38[KQ5XDUS7];LM!L-)T&V^'>A?#BQ0>#;'1OBWXNE\/:
M?X>NWG36/ZYZ_+?_ (+4?LH_%7]MW_@F)^U7^S/\$+;2K_XJ^/?#_P /]8\&
M:3K&H1:5::_J7PQ^,'P\^+,_AJ'4KG;966J^)=/\#7F@Z%<:E-::4FMZCIYU
M;4-.TW[5?6_R'A7Q/B<AXQX?PF(SBKE_#&<YU@<LXKPU;%3IY1B<BS5U,ESB
MKF6%G)X.LL/D^9YBZ6(Q-&H\&Y.O2<)QN=&-HJKAZLHTU*M3IRG0:C>HJD+5
M*:@_B7-4A"Z37-LS[2\+?M._L_\ C7X\_$_]E[PM\6?!VM?M"?!CP_X7\5?$
M_P"$=KJ./&?A'PYXST_3M5\.ZS?:9-'$;BPO-/UK0KNYGTZ2]728O$/AS^U_
ML#>(=%6^_P _/_@K]_P52\=WW_!4C]K;5;?5?B)H_P"Q]%^R;^W!_P $N--F
M\.KJFH> /BQ\3;']FWXA6/B"WFAEGB\+7NM>"_VH/C3\+;GQ3J&D33ZSX?\
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M'\36GB/Q]XIL[]].\0W7@ZXU;469[4'^D_\ 9M^"^F?LW?L[? /]G;1-:O\
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M#WX@^'+SP'\,=8U/5)8/&GB^[\;2:))JVA7.DO<?BG^W9^QCJO\ P26\*_\
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M;KZ* /YLOV:OV"_@?K/_  5@_P""I/@2\\<_MGPZ)X(^!_\ P3:U/1K[2O\
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M%?@S_P %$_VF?V'_ -A;]H/]FCX<:=\1?VNOBE\.?BA\$OVR?C7\3/%.E_\
M!9K_ (*??;;"W_9U^%OCC7/AEX(\ :U8_MKW/A>Z\6_%CXP_#WQ'\(&M]9-Q
M]@\1P1:3#;_VNTL,/VY_P<(?MK_'_P#9^_9X\#_LH_LD_!WQA\8_VEOV_=)^
M/?PF\(:7X&T?Q1KOBSPW\//"'PHN]0^+7BSP1I?@UO\ A(+WXAZ%HOBC2=4\
M,1VL<L-C8V7B'7YDD?1(+>?^<;_@BI_P;U>#OVUOA%^V)H__  4)G^(_@W7/
MV?/VI=,_9B\!6?PT\?:?:?$?X9^+O@1;^./$WQ]\(PWWB'PC\0/AO>_"?QYX
MA^.'A&_L;OPK_:;ZUXH\+>(M?TV_TB&YBU/Q-])X:^&_!M'A'$^)OB?FCH<.
M7KX++>'<"J>(SC-</CJF,X;>?4:-''X?%T:.39W46(H\U-4\14RK%1<IVA1J
MXXS%XAUXX/!PO5TE.K*\80<%&M[)MP<6ZE/1ZW2J1>FK72?L<?"OXO\ _!PE
M^T5X=UK2-"_:.^"'_!*CX)>)?A[>?M"_#KXQ_P#!2/\ ;6_:CU/XI_$WPO8V
M_BV_^&NBS_%_XY>(96U37+S7-.AMO&7AKP5\.[CP1X$TYO$6F^+M(^(.J:=H
M.I_US?\ #H/]BC_A97_"Z,?M@?\ "Y/^$&_X5?\ \+=_X>7?\%*?^%I?\*R_
MM_\ X2O_ (5Q_P +#_X:U_X3#_A /^$J_P"*G_X0S^V?^$;_ .$B_P")Y_9G
M]J#[56S_ ,$T/^"<7@3_ ()F?#K]H+X3_#+Q?)XF\!?&/]J[XH?M(^$M$?PO
M#X93X6>'/'_AWP!X9T3X26LD.NZV/$MAX)TWP';P67BAX]!DU*"\6*3P_8O:
M--=_H_7Q'B5QGEF:9V\MX$I1R/@3)\'6RSA_+\O6.P=2O@LPI86KFM?.*F*J
MRQF89AF6(HTJ68UL7.I&O2P6#I)3I4*=2?3@\/.%/GQ+]KB:DE.K*?+)*4&U
M!4U%<L(03;@HI6<I/1NR_+SX6_\ !'3]AKX&^$;7X??!&Q_:T^#/@"QN[Z_L
M? GPE_X*2_\ !2+X;>"[*_U.<W6IWUGX4\%_M9:)H-K>:E=,UUJ%S;Z?'/>W
M+/<73RS.SGT3_AVG^SK_ -%&_;__ /%L7_!4W_Z,BOO^BOS+%XS%YABL3CL?
MBL1C<;C*]7$XO&8NM5Q.*Q6)K3=2MB,3B*TIUJ]>M4E*=6K5G*I4G)RG)R;9
MV1C&$5&,5&,4HQC%*,8I*R22LDDM$EHD? '_  [3_9U_Z*-^W_\ ^+8O^"IO
M_P!&11_P[3_9U_Z*-^W_ /\ BV+_ (*F_P#T9%??]%<XSX _X=I_LZ_]%&_;
M_P#_ !;%_P %3?\ Z,BC_AVG^SK_ -%&_;__ /%L7_!4W_Z,BOO^B@#X _X=
MI_LZ_P#11OV__P#Q;%_P5-_^C(H_X=I_LZ_]%&_;_P#_ !;%_P %3?\ Z,BO
MO^B@#X _X=I_LZ_]%&_;_P#_ !;%_P %3?\ Z,BC_AVG^SK_ -%&_;__ /%L
M7_!4W_Z,BOO^B@#X _X=I_LZ_P#11OV__P#Q;%_P5-_^C(H_X=I_LZ_]%&_;
M_P#_ !;%_P %3?\ Z,BOO^B@#X _X=I_LZ_]%&_;_P#_ !;%_P %3?\ Z,BC
M_AVG^SK_ -%&_;__ /%L7_!4W_Z,BOO^B@#X _X=I_LZ_P#11OV__P#Q;%_P
M5-_^C(H_X=I_LZ_]%&_;_P#_ !;%_P %3?\ Z,BOO^B@#X _X=I_LZ_]%&_;
M_P#_ !;%_P %3?\ Z,BC_AVG^SK_ -%&_;__ /%L7_!4W_Z,BOO^B@#X _X=
MI_LZ_P#11OV__P#Q;%_P5-_^C(H_X=I_LZ_]%&_;_P#_ !;%_P %3?\ Z,BO
MO^B@#X _X=I_LZ_]%&_;_P#_ !;%_P %3?\ Z,BC_AVG^SK_ -%&_;__ /%L
M7_!4W_Z,BOO^B@#X _X=I_LZ_P#11OV__P#Q;%_P5-_^C(H_X=I_LZ_]%&_;
M_P#_ !;%_P %3?\ Z,BOO^B@#X _X=I_LZ_]%&_;_P#_ !;%_P %3?\ Z,BC
M_AVG^SK_ -%&_;__ /%L7_!4W_Z,BOO^B@#X _X=I_LZ_P#11OV__P#Q;%_P
M5-_^C(H_X=I_LZ_]%&_;_P#_ !;%_P %3?\ Z,BOO^B@#X _X=I_LZ_]%&_;
M_P#_ !;%_P %3?\ Z,BC_AVG^SK_ -%&_;__ /%L7_!4W_Z,BOO^B@#X _X=
MI_LZ_P#11OV__P#Q;%_P5-_^C(H_X=I_LZ_]%&_;_P#_ !;%_P %3?\ Z,BO
MO^B@#X _X=I_LZ_]%&_;_P#_ !;%_P %3?\ Z,BC_AVG^SK_ -%&_;__ /%L
M7_!4W_Z,BOO^B@#X _X=I_LZ_P#11OV__P#Q;%_P5-_^C(H_X=I_LZ_]%&_;
M_P#_ !;%_P %3?\ Z,BOO^B@#X _X=I_LZ_]%&_;_P#_ !;%_P %3?\ Z,BC
M_AVG^SK_ -%&_;__ /%L7_!4W_Z,BOO^B@#X _X=I_LZ_P#11OV__P#Q;%_P
M5-_^C(H_X=I_LZ_]%&_;_P#_ !;%_P %3?\ Z,BOO^B@#X _X=I_LZ_]%&_;
M_P#_ !;%_P %3?\ Z,BC_AVG^SK_ -%&_;__ /%L7_!4W_Z,BOO^B@#X _X=
MI_LZ_P#11OV__P#Q;%_P5-_^C(H_X=I_LZ_]%&_;_P#_ !;%_P %3?\ Z,BO
MO^B@#X _X=I_LZ_]%&_;_P#_ !;%_P %3?\ Z,BC_AVG^SK_ -%&_;__ /%L
M7_!4W_Z,BOO^B@#X _X=I_LZ_P#11OV__P#Q;%_P5-_^C(H_X=I_LZ_]%&_;
M_P#_ !;%_P %3?\ Z,BOO^B@#X _X=I_LZ_]%&_;_P#_ !;%_P %3?\ Z,BC
M_AVG^SK_ -%&_;__ /%L7_!4W_Z,BOO^B@#X _X=I_LZ_P#11OV__P#Q;%_P
M5-_^C(H_X=I_LZ_]%&_;_P#_ !;%_P %3?\ Z,BOO^B@#X _X=I_LZ_]%&_;
M_P#_ !;%_P %3?\ Z,BC_AVG^SK_ -%&_;__ /%L7_!4W_Z,BOO^B@#X _X=
MI_LZ_P#11OV__P#Q;%_P5-_^C(H_X=I_LZ_]%&_;_P#_ !;%_P %3?\ Z,BO
MO^B@#X _X=I_LZ_]%&_;_P#_ !;%_P %3?\ Z,BC_AVG^SK_ -%&_;__ /%L
M7_!4W_Z,BOO^B@#X _X=I_LZ_P#11OV__P#Q;%_P5-_^C(H_X=I_LZ_]%&_;
M_P#_ !;%_P %3?\ Z,BOO^B@#X _X=I_LZ_]%&_;_P#_ !;%_P %3?\ Z,BC
M_AVG^SK_ -%&_;__ /%L7_!4W_Z,BOO^B@#X _X=I_LZ_P#11OV__P#Q;%_P
M5-_^C(H_X=I_LZ_]%&_;_P#_ !;%_P %3?\ Z,BOO^B@#X _X=I_LZ_]%&_;
M_P#_ !;%_P %3?\ Z,BC_AVG^SK_ -%&_;__ /%L7_!4W_Z,BOO^B@#X _X=
MI_LZ_P#11OV__P#Q;%_P5-_^C(H_X=I_LZ_]%&_;_P#_ !;%_P %3?\ Z,BO
MO^B@#X _X=I_LZ_]%&_;_P#_ !;%_P %3?\ Z,BC_AVG^SK_ -%&_;__ /%L
M7_!4W_Z,BOO^B@#X _X=I_LZ_P#11OV__P#Q;%_P5-_^C(H_X=I_LZ_]%&_;
M_P#_ !;%_P %3?\ Z,BOO^B@#X _X=I_LZ_]%&_;_P#_ !;%_P %3?\ Z,BC
M_AVG^SK_ -%&_;__ /%L7_!4W_Z,BOO^B@#X _X=I_LZ_P#11OV__P#Q;%_P
M5-_^C(H_X=I_LZ_]%&_;_P#_ !;%_P %3?\ Z,BOO^B@#X _X=I_LZ_]%&_;
M_P#_ !;%_P %3?\ Z,BC_AVG^SK_ -%&_;__ /%L7_!4W_Z,BOO^B@#X _X=
MI_LZ_P#11OV__P#Q;%_P5-_^C(H_X=I_LZ_]%&_;_P#_ !;%_P %3?\ Z,BO
MO^B@#X _X=I_LZ_]%&_;_P#_ !;%_P %3?\ Z,BC_AVG^SK_ -%&_;__ /%L
M7_!4W_Z,BOO^B@#X _X=I_LZ_P#11OV__P#Q;%_P5-_^C(H_X=I_LZ_]%&_;
M_P#_ !;%_P %3?\ Z,BOO^B@#X _X=I_LZ_]%&_;_P#_ !;%_P %3?\ Z,BO
M(/VA/^"?'P&\%_ /XX>,='\??MOWFK^$_A!\2_$VEV?BS_@IM_P4D\>^%;K4
M="\&:UJEC;>)? OCK]J_Q'X)\:>'Y[FUBBUGPGXQ\/:[X5\1Z<USH_B'1M4T
MB\N[&?\ 5ZO /VL/^36?VE?^R ?&3_U77B.@ _9/_P"36?V:O^R ?!O_ -5U
MX<HH_9/_ .36?V:O^R ?!O\ ]5UX<HH ]_HHHH **** "BBB@#\@?V5?^4R7
M_!7G_LW_ /X)8?\ IC_;,K]?J_(']E7_ )3)?\%>?^S?_P#@EA_Z8_VS*_7Z
M@ K^>SQ9XFFT?_@Z,^&&C&YD2#Q5_P $6M4T-+<R2>4\B?M=>._%$VR,.L8D
MD7PC!)(Q1MZV<6X$PQ/'_0G7\,O_  <,?&3XB?L+_P#!<G_@F-^W0_B'Q5X*
M^#"_"[X6^ _'6M>!=1MI?$OBSX??";]IOQ;XR_:0^'\GA^.]M[N^TW6/AA\6
M?"]D;/4/LFF^(Y-:FT^TO#/IM\]I^P^"F1U.)^),_P"&\-.E#'YYP)Q?@<MA
M4NW7QZRR6+H4:4(IU*E62PTY*%.,I\D)SMRQDUP9C4]C1I5FGRTL3AYS:Z0Y
M^5MOHO>M\['J'[,7_!83X;_\%D?^"NO_  2?U/X:?"3QC\(-:_9@U'_@HEK_
M (]\.^+-8T[Q,EUX0^(/[,.C^$OA_P"(=-UW2K+3+07&JZJ-=M=9T5K2671)
M],M-E]J%MJ<%R/[2J_A!_P"#6C_@D1^UE\#OCYI7_!0?XZ^#O#G@KX)>/OV5
MH;WX#O+XQT'6_%WCT_'*X\*^(M \3VOAWPY=:M-X=T33_A[I%[=:LOC&?P[J
M\DOC7PK%HNE:N%\3/X<_N^KU_I#8?@W*N-<NX9X#Q.'Q/#W"G#M+)Z3PV82S
M2%#&8C/N(.(,PPDL=*I6E6J87%YW5HSC*K4J8=Q^K59>UHS2SRIXB>&E6Q*:
MJUZKJ.\>1N*I4J4)<J2M>---:)/=:,****_!STPHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ KP#]K#_DUG]I7_L@'QD_]5UXCKW^O /VL/^36
M?VE?^R ?&3_U77B.@ _9/_Y-9_9J_P"R ?!O_P!5UX<HH_9/_P"36?V:O^R
M?!O_ -5UX<HH ]_HHHH **** "BBB@#\@?V5?^4R7_!7G_LW_P#X)8?^F/\
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MJ;_]!O7W_10!\ ?\/+/V=?\ HG/[?_\ XJ=_X*F__0;T?\/+/V=?^B<_M_\
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M*G?^"IO_ -!O7W_10!\ ?\/+/V=?^B<_M_\ _BIW_@J;_P#0;T?\/+/V=?\
MHG/[?_\ XJ=_X*F__0;U]_T4 ? '_#RS]G7_ *)S^W__ .*G?^"IO_T&]'_#
MRS]G7_HG/[?_ /XJ=_X*F_\ T&]??]% 'P!_P\L_9U_Z)S^W_P#^*G?^"IO_
M -!O1_P\L_9U_P"B<_M__P#BIW_@J;_]!O7W_10!\ ?\/+/V=?\ HG/[?_\
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M/V=?^B<_M_\ _BIW_@J;_P#0;U]_T4 ? '_#RS]G7_HG/[?_ /XJ=_X*F_\
MT&]'_#RS]G7_ *)S^W__ .*G?^"IO_T&]??]% 'P!_P\L_9U_P"B<_M__P#B
MIW_@J;_]!O1_P\L_9U_Z)S^W_P#^*G?^"IO_ -!O7W_10!\ ?\/+/V=?^B<_
MM_\ _BIW_@J;_P#0;T?\/+/V=?\ HG/[?_\ XJ=_X*F__0;U]_T4 ? '_#RS
M]G7_ *)S^W__ .*G?^"IO_T&]'_#RS]G7_HG/[?_ /XJ=_X*F_\ T&]??]%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 5X!^UA_R:S^TK_P!D ^,G_JNO$=>_UX!^UA_R:S^T
MK_V0#XR?^JZ\1T '[)__ ":S^S5_V0#X-_\ JNO#E%'[)_\ R:S^S5_V0#X-
M_P#JNO#E% 'O]%%% !1110 4444 ?D#^RK_RF2_X*\_]F_\ _!+#_P!,?[9E
M?K]7Y _LJ_\ *9+_ (*\_P#9O_\ P2P_],?[9E?K]0 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5X!^UA_R:S^TK_P!D
M ^,G_JNO$=>_UX!^UA_R:S^TK_V0#XR?^JZ\1T '[)__ ":S^S5_V0#X-_\
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M]\3[?P7#9^-_A[X0&ER:]XZT)O WC;QS/H>FV5OKFC7<WAOXBV_@;XB6]MJ
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M ?\ BM/]HK_Z;%1_PKG_ (*F_P#1Y'[ '_BM/]HK_P"FQ4 ??]%? '_"N?\
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M_"N?^"IO_1Y'[ '_ (K3_:*_^FQ4?\*Y_P""IO\ T>1^P!_XK3_:*_\ IL5
M'W_17P!_PKG_ (*F_P#1Y'[ '_BM/]HK_P"FQ4?\*Y_X*F_]'D?L ?\ BM/]
MHK_Z;%0!]_T5\ ?\*Y_X*F_]'D?L ?\ BM/]HK_Z;%1_PKG_ (*F_P#1Y'[
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M_P"FQ4?\*Y_X*F_]'D?L ?\ BM/]HK_Z;%0!]_T5\ ?\*Y_X*F_]'D?L ?\
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MT_VBO_IL5'_"N?\ @J;_ -'D?L ?^*T_VBO_ *;%0!]_T5\ ?\*Y_P""IO\
MT>1^P!_XK3_:*_\ IL5'_"N?^"IO_1Y'[ '_ (K3_:*_^FQ4 ??]> ?M8?\
M)K/[2O\ V0#XR?\ JNO$=?/_ /PKG_@J;_T>1^P!_P"*T_VBO_IL5>0?M">
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *\ _:P_Y-9_:5_[(!\9/_5=>(Z]_KP#]K#_DUG]I7_L@'QD_]5UXCH /
MV3_^36?V:O\ L@'P;_\ 5=>'**/V3_\ DUG]FK_L@'P;_P#5=>'** /?Z***
M "BBB@ HHHH _(']E7_E,E_P5Y_[-_\ ^"6'_IC_ &S*_7ZOR!_95_Y3)?\
M!7G_ +-__P""6'_IC_;,K]?J "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1T?\-8?LL_\ 1ROP _\ #R?#K_YHZ /?Z*\ _P"&L/V6?^CE?@!_X>3X=?\
MS1T?\-8?LL_]'*_ #_P\GPZ_^:.@#W^BO /^&L/V6?\ HY7X ?\ AY/AU_\
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M?\-8?LL_]'*_ #_P\GPZ_P#FCH ]_HKP#_AK#]EG_HY7X ?^'D^'7_S1T?\
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M]'*_ #_P\GPZ_P#FCH ]_HKP#_AK#]EG_HY7X ?^'D^'7_S1T?\ #6'[+/\
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MFOO^B@#X _X=._\ !++_ *1I_L ?^(;_ +.O_P [FC_AT[_P2R_Z1I_L ?\
MB&_[.O\ \[FOO^B@#X _X=._\$LO^D:?[ '_ (AO^SK_ /.YH_X=._\ !++_
M *1I_L ?^(;_ +.O_P [FOO^O*?&WQM^&GPY\=?#;X=>-?$:Z!XG^+3>((_
ML=WI^IG2=2N?#=WX7TZ]L[[Q!#:2:'H-W>ZIXT\,:-H,&NW^G-XCU[6=/T#0
M_M^M7EI83@'YQ^'_ /@BY_P3UTW]I;XM?%;4_P!A+]@S4?A/XT^!G[/'P]\%
M?"U_V2_@C-I_@[XA_#'Q]^U!XD^)_C^UT2X^'I\-Z?>?$KPW\7/A%X=O]5TF
M&/7-9@^%&G6GB&6:PT+PPD'N?_#IW_@EE_TC3_8 _P#$-_V=?_G<U]_T4 ?
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M?^"67_2-/]@#_P 0W_9U_P#G<U]_T4 ? '_#IW_@EE_TC3_8 _\ $-_V=?\
MYW-'_#IW_@EE_P!(T_V /_$-_P!G7_YW-??]% 'P!_PZ=_X)9?\ 2-/]@#_Q
M#?\ 9U_^=S1_PZ=_X)9?](T_V /_ !#?]G7_ .=S7W_10!\ ?\.G?^"67_2-
M/]@#_P 0W_9U_P#G<T?\.G?^"67_ $C3_8 _\0W_ &=?_G<U]_T4 ? '_#IW
M_@EE_P!(T_V /_$-_P!G7_YW-'_#IW_@EE_TC3_8 _\ $-_V=?\ YW-??]%
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M$4'AO3])AC]S_P"'3O\ P2R_Z1I_L ?^(;_LZ_\ SN:^_P"B@#X _P"'3O\
MP2R_Z1I_L ?^(;_LZ_\ SN:/^'3O_!++_I&G^P!_XAO^SK_\[FOO^B@#X _X
M=._\$LO^D:?[ '_B&_[.O_SN:/\ AT[_ ,$LO^D:?[ '_B&_[.O_ ,[FOO\
MHH ^ /\ AT[_ ,$LO^D:?[ '_B&_[.O_ ,[FC_AT[_P2R_Z1I_L ?^(;_LZ_
M_.YK[_HH ^ /^'3O_!++_I&G^P!_XAO^SK_\[FC_ (=._P#!++_I&G^P!_XA
MO^SK_P#.YK[_ ** /@#_ (=._P#!++_I&G^P!_XAO^SK_P#.YH_X=._\$LO^
MD:?[ '_B&_[.O_SN:^_Z* /@#_AT[_P2R_Z1I_L ?^(;_LZ__.YH_P"'3O\
MP2R_Z1I_L ?^(;_LZ_\ SN:^_P"B@#X _P"'3O\ P2R_Z1I_L ?^(;_LZ_\
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M^*O#G@CQ1XIAOKSPWH>I?9K>Y:WU+Q?H]A;Z+XMT^2X^JJ** "BBB@ HHHH
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M/X?^&O"/BG7P#S[0_!_P5_:GU[Q+\3-1^#FD:IX.GTW1O"'A;XM7-[>:1?\
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M/"_Q$UW6[^;^V/'$-SJ]SJ6LWVC>,[9H9[31/&).L>&]+%OX.FBDTO0M.FG
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MK>?#[Q79_#L^ O (\+:;X?\ A?X+TOPG^HU%% !1110 4444 %%%% !1110
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M$:]MM8^(_B;2[#QW\3OB;?\ B_\ 06BB@ HHHH **** "BBB@ HHHH ****
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:1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
